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Increasing evidence suggests that anxiety and depression disorders have 
neurodevelopmental roots, with a strong case for early-life serotonergic dysfunction in their 
ontogeny. For instance, disrupting serotonergic tone during critical developmental periods results 
in dysregulated adult affective behaviors, in mice. However, insight into the mechanism by 
which early-life serotonin levels impact emotional behaviors in later-life, remains scarce. Based 
on its potent neurotrophic properties, we hypothesized that serotonin acts during development to 
guide the maturation of brain regions implicated in the modulation of both the emotional and 
cognitive features of anxiety and depression disorders, namely the medial prefrontal cortex 
(mPFC) and hippocampus (HC).  
 To address this hypothesis, we employed a pharmacological mouse model in which 
serotonin levels were increased using a selective serotonin reuptake inhibitor, fluoxetine (FLX), 
during a previously established critical post-natal time window (post-natal day 2-11; “PN-FLX” 
mouse model). The effect of this post-natal serotonergic disruption on the structural, 
physiological and functional properties of the adult mPFC and HC was assessed. In the mPFC, 
we found morphological and electrophysiological changes specific to cortical layer 2/3.  
Pyramidal neurons in layer 2/3 of the infralimbic (IL) sub-region of the mPFC, displayed 
decreased dendritic arborization, concomitant with reduced intrinsic excitability. Conversely, 
 
 
prelimbic (PL) layer 2/3 neurons displayed normal dendritic arborization, but increased intrinsic 
excitability. Together, these changes produce a reduced IL/PL output ratio. In order to probe the 
functional consequences of these changes, we investigated the ability of PN-FLX mice to 
extinguish learned fear (“fear extinction”), as performance in this behavioral paradigm is 
modulated by IL/PL output. Congruent with their altered IL/PL balance, PN-FLX mice display 
deficits in fear extinction learning and recall. Mimicking the diminished IL/PL ratio by 
selectively lesioning the IL, in control mice, phenocopied some features of the PN-FLX anxiety 
and depression-behavioral profile, demonstrating a causal relationship between mPFC changes 
and the emotional phenotype of PN-FLX mice.  
In the HC, PN-FLX treatment produced retraction of dendritic arbors but increased 
branching in the cornu ammonis 3 (CA3) sub-field. PN-FLX treatment also reduced total 
synapse number and synaptic density of CA3 neurons. In order to probe the functional 
consequences of these morphological changes, we investigated spatial learning in the Morris 
water maze and contextual fear conditioning in PN-FLX mice, as these behaviors are sensitive to 
CA3 manipulations. In line with reduced CA3 function, PN-FLX mice displayed deficits in both 
these learning paradigms. 
Taken together, our findings demonstrate that serotonin acts during a key developmental 
epoch to set the structural and physiological properties, and ultimately the functional output, of 
two key brain regions that underlie affective and cognitive behaviors, the mPFC and HC. Our 
findings provide a mechanism by which reported genetic (polymorphisms, mutations) and 
environmental factors (exposure to pharmacological agents or stress) that alter serotonergic tone 
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CHAPTER 1: Introduction 
 
1.) Anxiety and Depression Disorders 
a.) Clinical presentation and epidemiology 
Anxiety, in its non-pathological form, is a natural response to threatening or 
fearful circumstances. In this sense, anxiety can be perceived as an evolutionarily 
beneficial phenomenon as it mobilizes the physiological systems that enhance arousal, 
vigilance and preparedness, all of which aid in dealing with, or escaping from, potential 
threats (“fight or flight response”) (Nutt, 2005). An increase in the intensity and duration 
of anxiety yield its pathological form. In this form, anxiety becomes maladaptive and is 
considered a disorder (Nutt and Ballenger, 2003; Nutt, 2005). Anxiety disorders are the 
most pervasive of the psychiatric maladies with a lifetime prevalence of 31.2% in the 
United States (Kessler et al., 2005), and are classified into five general categories: 
obsessive-compulsive disorder (OCD), panic, (social and simple) phobias, post-traumatic 
stress disorder (PTSD) and generalized anxiety disorder (GAD) as specified in the 
Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision (DSM- 
IV-TR, 2000). The unifying symptom of all categories of anxiety disorders is excessive 
uncontrollable worry and fear, often in response to non-threatening, nebulous, or no 
specific stimuli (Nutt, 2005). Patients, such as those with PTSD, often have a 
disproportionately high fear response to environmental cues that serve as reminders of 
their initial traumatic experience (Heim and Nemeroff, 2009). Without intervention, these 
triggered fear responses tend to stay consistently high throughout a patient’s lifetime 





characteristic of pathological anxiety include increased heart rate, sweating, nausea, sleep 
disturbances and avoidance and/or helpless behaviors in response to fearful and anxiety-
provoking situations (DSM-IV-TR, 2000; Nutt and Ballenger, 2003). Excess stress is 
another key characteristic and/or consequence of anxiety disorders which may also 
participate in its etiology, as will be described in subsequent chapters (Kendler et al., 
2003; Nutt and Ballenger, 2003; Lupien et al., 2009). Cognitive symptoms such as 
memory and attention deficits and diminished cognitive flexibility are also frequently 
described in anxiety disorder patients (Castaneda et al., 2008; Gualtieri and Morgan, 
2008).  
As with anxiety, mood disturbances associated with depression lie on a spectrum. 
Short-lived, mildly intense feelings of sadness may be normal responses to adversity, but 
when recurrent, enduring or intensified, indicate a psychiatric disorder (DSM-IV-TR, 
2000). Depression has been categorized into several classes including major depressive 
disorder (MDD), dysthymic disorder and minor depression (DSM-IV-TR, 2000). Further 
sub-typing within these classes exists based on symptom and origin specificity such as 
hormonal changes, aging, seasonal variations, psychotic, manic or catatonic features, 
injury and co-morbid neurobiological disorders (DSM-IV-TR, 2000, Ninan and Berger, 
2001). MDD is one of the severest forms of unipolar depression and is associated with 
negative affect, pessimism, hopelessness and a loss of interest in formally pleasurable 
activities (anhedonia), concomitant with changes in appetite, sleep patterns and energy 
levels (DSM-IV-TR, 2000, Ninan and Berger, 2001). The lifetime prevalence of a mood 
disorder in the US is about 20% with the probability of having a depressive episode being 





Although anxiety and depression can be considered distinct phenomena, they are 
highly co-morbid (Kendler et al., 1992; Kaufman and Charney, 2000; Ninan and Berger, 
2001; Hettema et al., 2006). The National Co-morbidity Survey Replication (NCS-R, 
2001-2003) found that in the United States, almost 50% of patients with MDD also 
suffered from an anxiety disorder, and the lifetime prevalence of a co-morbid 
anxiety/depression disorder was around 28% (Kessler et al., 2005; Khan et al., 2005). 
Factor analyses showed a similar high correlation between GAD and MDD (Kendler et 
al., 1992; Hettema et al., 2006). Underscoring the co-morbidity between these two 
disorders is the finding that pharmacological agents used to treat one disorder often 
alleviate the symptoms of the other (Kaufman and Charney, 2000; Blier, 2003; Nutt et al., 
2005; Ravindran and Stein, 2010). For instance, the frontline class of anti-depressant 
drugs, known as the selective serotonin reuptake inhibitors (SSRIs), have been used 
efficaciously to treat various subtypes of anxiety disorders including OCD, PTSD and 
GAD  (Ninan and Berger, 2001; Ravindran and Stein, 2010). There is also significant 
overlap in both the genetic risk and symptomatology of the two disorders (Kendler et al., 
1992; Roy et al., 1995; Ninan and Berger, 2001). For instance, GAD and PTSD patients 
often display depressive symptoms such as negative affect, helplessness and anhedonia as 
well as many of the cognitive deficits characteristic of mood disorders (DSM-IV-TR, 
2000; Kaufman and Charney, 2010). Taken together, these findings suggest that anxiety 
and depression-related behaviors may be mediated by similar neurocircuits and may have 







b.) Pathophysiology  
Although studies in humans have provided some insight into the neuropathology 
of anxiety and depression, studies in animals, such as rodents, whose neurobiological 
systems are highly homologous to those of humans (Tarantino and Bucan, 2000; Cooper 
et al., 2003; Strand et al., 2007), have greatly advanced our understanding. Additionally, 
the presence of pharmacologically validated tests to gauge anxiety and depression 
behaviors in rodents (Fig A.4 – A.6) and the high amenability of these species to genetic 
and other experimental interventions, makes them useful models to study the pathology 
of emotional dysfunction (Kalueff and Tuohimaa, 2004).  As such, this review will 
present data from both human and animal studies. 
 
c.) Dysregulated neurocircuits 
As anxiety and depression are multifaceted disorders with diverse 
symptomatology, it is not surprising that they are associated with dysfunction in multiple 
brain regions. This review will focus primarily on the alterations in corticolimbic 
regions/circuits as they are the most consistently altered in depression and/or anxious 
states (Nestler, 2002; Drevets et al., 2008; Price and Drevets, 2010), most 
comprehensively studied, and the focus of the current body of work.  
 Putative anxiety/depression circuits were described as early as the late nineteenth 
century but began to really coalesce in the mid-1900s with the work of such scientists as 
Papez and Maclean, who proposed the existence of an interconnected network of 





“Papez circuit” in its antiquated form) which regulated emotional responses (Andersen et 
al., 2006; Baars and Gage, 2007; Price and Drevets, 2010). Notable structures include the 
prefrontal cortex (PFC), hippocampus (HC) and amygdala. Extant data in humans and 
rodents supports the involvement of these regions in emotional regulation, as depression 
and anxiety-like states are often associated with structural, physiological and functional 
abnormalities in these areas (Drevets et al., 2008; Price and Drevets, 2010). For instance, 
in the medial prefrontal cortex (mPFC) changes in gray-matter volume, dendritic 
morphology, receptor expression, theta power and functional connectivity to lower limbic 
structures are found in human patients and rodent models of affective disorders (Pezawas 
et al., 2005; Gordon et al., 2005; Altamura et al., 2007; Bhansali et al., 2007; Wellman et 
al., 2007; Adhikari et al., 2010). Similar associations between anxiety/depression and 
abnormal structure and physiology of the HC have been observed. For instance, volume 
reductions, decreased neuronal metabolism, viability, proliferation, theta power and 
receptor expression in the HC of depressed patients/rodent models have been well 
documented (Sheline et al., 1996; Reagan and McEwen, 1997; Bhansali et al., 2005; 
Czeh and Lucassen, 2007; Sahay and Hen, 2007; Taylor Tavares et al., 2007; Price and 
Drevets, 2010). Interestingly, pro-depressive and anxiogenic factors such as the maternal 
separation, learned helplessness and chronic stress paradigms in rodents, yield similar 
mPFC and HC phenotypes (Sunanda et al., 1995; Sousa et al., 2000; Cook and Wellman, 
2004; Kole et al., 2004; Radley et al., 2005; Izquierdo et al., 2006; Hajszan et al., 2009; 
Farrell et al., 2010; Magariños et al., 2011). Conversely, diverse therapeutic regimens, 
such as treatment with SSRIs, deep brain stimulation or electroconvulsive therapy reverse 





et al., 2003; Ansorge et al., 2007; Sahay and Hen, 2007; Price and Drevets, 2010). These 
data suggest that the structural/physiological changes in the mPFC and HC may be causal 
to at least some aspects of the depressive/anxious phenotype. 
The mPFC and HC also have well characterized impacts on cognitive functions 
such as mnemonic processes, various types of learning, information processing and 
attention (Moser and Moser, 1998; Bannerman et al., 2004; Nachev et al., 2005; Bars and 
Gage, 2007). As such, dysregulation in these regions may also account for the cognitive 
deficits commonly observed in patients. Moreover, these regions have profuse reciprocal 
connections to the amygdala, a structure that has been shown to be a major processor of 
fearful stimuli and a mediator of fear-induced behaviors (LeDoux et al., 1988; Milad and 
Quirk, 2002). Cortico-amydala connectivity and its role in responding to anxiety-
provoking and fearful stimuli has been comprehensively characterized and alterations in 
functional connectivity between these regions are found in human subjects with, and 
rodent models of, anxiety and depression disorders (Milad and Quirk, 2002; Pezawas et 
al., 2005; Quirk et al., 2006; Hariri et al., 2006; Price and Drevets, 2010). HC-amygdala 
connectivity also plays an important role in the integration of cues (contextual, auditory, 
and olfactory) in the process of learned fear, which might be particularly relevant to some 
subtypes of anxiety such as PTSD (Phillips and LeDoux, 1992; Fanselow, 2000; Maren, 
2008). These data reinforce the strong correlation between mPFC and HC dysfunction 







d.) Dysregulated neurosystems 
Changes in various brain systems have been implicated in the pathophysiology of 
anxiety and depression disorders (Nestler et al., 2002; Mann and Currier, 2006). 
Alterations in the hypothalamic-pituitary-adrenal (HPA) axis, variations in growth factors 
and changes in glutamate, γ-amino butyric acid (GABA), cannabinoid, opioid, 
dopaminergic and noradrenergic transmission have all been implicated in some aspect of 
the neuropathology of affective disorders (Leonard, 1997; Sibille et al., 2000; Park et al., 
2005; Nestler, 2002; Paul and Skolnik, 2003; Ansorge et al., 2007; Hill et al., 2007; 
Dobson and Dozois, 2008;  Peters et al., 2011). Perhaps the most comprehensive studies, 
however, have been done on the involvement of the neurotransmitter serotonin in 
regulation of anxiety, fear and depressive states (Hirschfeld, 2000; Nutt, 2002). 
Serotonin, also known as 5-hydroxytryptamine (5-HT), is part of the monoamine family 
of neurotransmitters and, as its chemical name and classification suggests, is 
biochemically derived from the essential amino acid tryptophan via sequential metabolic 
reactions (Fig. A.1). Evidence for the involvement of serotonin in mood disorders has 
been especially robust with both genetic and pharmacological data underscoring its 
important role in regulation of affective states (Hirschfeld, 2000; Nutt, 2002; Gaspar et 
al., 2003; Mann and Currier, 2006; Ansorge et al., 2007). Genetically, there is evidence 
that polymorphisms/mutations in genes encoding various elements of the serotonin 
system, such as transcriptional factors that specify serotonergic fate, enzymes in the 5-HT 
synthetic or degradatory pathway, 5-HT receptors and 5-HT reuptake transporters impact 
emotional behaviors (summarized in Fig. A.1; Gaspar et al., 2003; Sodhi and Sanders-





reuptake transporter (5-HTT) or the inhibitory 5-HT1A receptor have been associated 
with enhanced vulnerability to anxiety and depression-like behaviors, and treatment 
response, in both humans and mice (Lesch et al., 1996; Gutierrez et al., 1998; Caspi et al., 
2003; Gross et al., 2002; Lira et al., 2003; Richardson-Jones, 2011). Additionally, many 
of the early-life genetic and environmental states that promote the development of 
depressive and anxious symptoms in adulthood typically involve changes in the serotonin 
system. For instance, animals that are exposed to the learned helplessness and maternal 
separation paradigms display enhanced anxiety/depression-like behaviors with 
concomitant changes in 5-HT release, receptor expression and 5-HT signaling in brain 
regions associated with the mediation of affective behaviors, such as the mPFC and HC 
(Meaney et al., 1994; Smythe et al., 1994; Petty et al., 1994; Inoue et al., 1994; Kaufman 
et al., 2000; Bland et al., 2003; Vicentic et al., 2006; Bhansali et al., 2007; Goodfellow et 
al., 2009; Benekareddy et al., 2010). Pharmacologically, drugs that target the serotonin 
system, such as 5-HTT inhibitors (the SSRIs) have anti-depressant and anxiolytic effects, 
while tryptophan and 5-HT depletion tend to be pro-depressive (Neumeister, 2002; Sodhi 
and Sanders-Bush, 2004; Fernandez and Gaspar, 2012). Firing rates of serotonergic 
neurons may also modulate emotional states, as reduced firing of these neurons is often 
observed in animal models of depression and anxiety (Kinney et al, 1997; Lira et al., 
2003), while enhancement of firing partly mirrors onset of therapeutic efficacy of anti-
depressant drugs (Blier, 2003). Cumulatively, these findings underscore the role of 
serotonergic transmission in regulating anxiety/depression behaviors.  
 Apart from its function in the adult brain as a neurotransmitter regulating various 





by acting as a potent neurotrophic factor during development and guiding the formation 
of the previously described cortico-limbic circuits underlying anxiety and depression 
behaviors. This unique role for serotonin is the focus of the current work and will be 











e.) Etiology  
Although there are several psychosocial and biological models that attempt to 
elucidate the origins of emotional disorders, all of them concede that there is both a 
genetic and environment component in the vulnerability to psychiatric conditions 
(Torgensen 1986; McGuffin et al. 1991; Kendler et al. 1993; Bierut et al. 1999; Sullivan 
et al. 2000; Levinson et al., 2006; Kendler et al., 2011; Hettema et al., 2001). Genetic 
factors contribute vulnerability towards the acquisition of affective disorders, but those 
with susceptibility genes do not necessarily develop frank anxiety or depression (Caspi et 
al., 2003; Levinson et al., 2006). Since an organism’s behavioral repertoire is guided by 
both the underlying genes that sculpt the circuits/systems modulating behavior, but also 
by the unique molecular and psychological terrain they encounter during their lifetime, it 
is unsurprising that models taking into account both these factors are the most 
comprehensive. One such paradigm is the stress-diathesis model which highlights the 
gene by environment (G x E) interaction in the manifestation of affective disorders 
(Monroe & Simons, 1991; Gross and Hen, 2004). A specific example of this interaction 
is found in epidemiological data of human carriers of the short or “s” allele of the 5-htt 
(slc6A4) gene, which results as a consequence of an insertion/deletion polymorphism in 
the promoter region of the 5-htt gene. Human “s” allele carriers display an underlying 
vulnerability to adult emotional dysfunction. However, this dysfunction manifests itself 
primarily with exposure to traumatic experiences, such as childhood maltreatment, with a 
demonstrable dose-response effect both in terms of number of “s” alleles (homozygotes 





also in terms of dosage of stress exposure (positive correlation between probability of 
depression/anxiety and number of stressful life events).  
An important question is how genetic and environmental factors influence 
vulnerability. One model suggests that they influence the formation and/or function of 
brain regions or neurosystems that modulate emotional behaviors (Ansorge et al., 2007; 
Leonardo and Hen, 2009; Daubert and Condron, 2010). Since circuitry is fundamentally 
set early in development (although some plasticity may be retained throughout life) it is 
conceivable that these factors, acting in development, could influence the maturation of 
circuits thereby permanently altering their function. Thus, a germane next question is 
when are these factors acting to influence vulnerability? This question is especially 
pertinent when considering the existence of sensitive or critical periods in brain 
development (Knudsen, 2004; Hensch, 2004). If, for instance, the impact of the genetic 
changes or environmental perturbations occur during these highly plastic critical time 
windows, it is possible for the developmental trajectory of the brain to be altered in a 
long-lasting and permanent fashion (Knudsen, 2004). These critical time windows have 
been thoroughly characterized in the development of sensory circuits such as those 
mediating auditory cue learning, filial recognition, and vision. Whether or not similar 
critical periods exist in the development of emotional circuits is unclear, however as the 
following section will depict, there is evidence that they do. This G x E x time 
interaction, as it relates to affective disorders, is best captured by the neurodevelopmental 







2.) Neurodevelopmental Origins 
Increasing evidence suggests that adult psychiatric conditions have their roots in 
developmental perturbations, with a particularly strong case for the presence of critical 
time windows in the development of circuits underlying depression and pathological 
anxiety (Gross et al., 2002; Gingrich et al., 2003; Ansorge et al., 2007; Leonardo and 
Hen, 2009).  Initial work in the field revealed that, in humans, early-life anxiety levels are 
strong predictors of vulnerability to both anxiety and depression later in life (Breslau et 
al., 1995; Parker et al., 1999; Weissman et al., 2005). Exposure to either enriched or 
adverse environmental factors in early life can, respectively, decrease or enhance an 
organism’s vulnerability to affective and fear-related disorders in adulthood (Kendler et 
al., 1992; Kessler et al., 1997; Bulik et al., 2001; Caspi et al., 2003; Moffitt et al., 2007). 
Moreover, many psychiatric disorders often have an early onset. For instance, according 
to the National Institute of Mental Health, almost 50% of lifetime cases of mental illness 
begin on average at age 14, with anxiety disorders having a median age of onset of 11 
(Kessler et al., 2005). Taken together, these findings suggest that the circuits regulating 
affective and fear behaviors are established early on and are highly sensitive to 
perturbations occurring during their formation.  
a.) Involvement of Serotonin  
Work investigating the neurotransmitter pathways regulating the formation of 
anxiety, depression and fear circuits has implicated the serotonin (5-HT) system. Insight 
into this idea has come from findings in humans with the previously mentioned lower-





dysfunction in adulthood, especially with exposure to adverse life-events (Lesch et al., 
1996; Caspi et al., 2003). This behavioral phenotype was also found in 5-htt -/-  mice, an 
extreme rodent model of the human “s” polymorphism, that underwent testing in 
pharmacologically validated behavioral paradigms used to gauge anxiety/depression 
behaviors in rodents (Lira et al., 2003; Holmes et al., 2003; Olivier et al., 2008; Muller et 
al., 2011). The behavioral profile of  human “s” allele carriers and 5-htt -/- mice was 
contrary to what was expected based on the fact that pharmacological inhibition of 5-
HTT (via treatment with SSRIs such as fluoxetine; FLX) has anti-depressant/anxiolytic 
effects (Gingrich et al., 2003; Ansorge et al., 2007;  Leonardo and Hen, 2009). One key 
difference between drug-induced 5-HTT inhibition during adulthood versus having 
reduced (or lacking) the 5-HTT protein throughout life, is that in the genetic conditions, 
5-HTT hypofunction is present during key developmental periods, whereas the 
pharmacological treatment circumvents the developmental period, and is instead applied 
to a mature substrate –the developed adult brain. A hypothesis that emerged to reconcile 
these paradoxical findings was that the dysregulation of the serotonin system that arises 
from genetic 5-HTT hypofunction likely precludes the proper development of brain 
circuits that underlie these behaviors (Gingrich et al., 2003; Ansorge et al., 2004; 
Ansorge et al., 2007; Homberg et al., 2010). This hypothesis is contingent on the potent 
neurotrophic properties of serotonin and its demonstrable impact on brain maturation 






Fig. A.2 In early life, 5-HT acts as a potent neurotrophic factor influencing various 
maturation processes that comprise brain development, in both humans and mice (based 
on Giedd et al., 1999; Gaspar et al., 2003; Tau and Peterson, 2010). 
 
The putative mechanism by which 5-HT influences brain development is 
presented in Fig. A.3. Briefly, serotonin interacts with, and can affect the expression of, 
various elements important in the highly orchestrated series of events comprising brain 
development (Gaspar et al., 2003). These elements include transcription factors in 
mitogenic pathways, signaling molecules, growth factors (such as brain-derived 
neurotrophic factor and S100β), axon-guidance molecules such as netrin-1, cytoskeletal 
proteins, synaptic proteins and various receptor types (Whitaker-Azmitia et al., 1996; 
Gaspar et al., 2003; Sodhi and Sanders-Bush, 2004; Homberg et al., 2010). Through these 
diverse relationships, 5-HT influences various maturation processes including neuronal 
proliferation, migration, axonal/dendritic arborization and synaptogenesis (Gaspar et al., 





developmental processes are underway in order to avoid aberrant maturation of brain 
circuits, such as those mediating affective behaviors. Complementarily, perturbations of 
serotonergic tone during these critical periods could permanently alter the formation of 
these circuits such that they impact adult emotional behaviors. As such, the paradoxical 
anxiety and depression-like behavioral phenotype of “s” allele carrier and 5-htt -/- mice 
may be due to the abnormal formation of affective circuitry, due to the altered 
serotonergic tone they experienced during key developmental windows. In line with this 
hypothesis, disrupting serotonergic tone strictly during a critical developmental time 
window would be sufficient to phenocopy the emotional phenotype of 5-htt -/- mice and 










b.) Testing the neurodevelopmental hypothesis: Post-natal FLX mouse model 
Part 1 
The preceding hypothesis was tested directly in our lab in two parts. First, we 
determined whether altering serotonergic tone during a critical developmental time 
window would be sufficient to yield abnormal adult emotional behaviors and reproduce 
the phenotype of 5-htt -/- mice and “s” allele carriers. To this end, we employed a 
pharmacological mouse model in which 5-HTT was inhibited via FLX treatment, during 
various temporally restricted periods in post-natal development (“PN-FLX mouse 
model), and the outcome of this blockade on adult behaviors was examined. The post-
natal period was selected as this epoch represents a time of major brain development in 
rodents and is thought to be analogous to the third trimester of gestation in humans 
(Gaspar et al., 2003; Ansorge et al., 2007; Leonardo and Hen, 2009; Homberg et al., 
2010). During this time, many of the systems and brain regions implicated in the 
pathophysiology of anxiety and depression disorders are rapidly evolving (Sodhi and 
Sanders-Bush, 2004; Homberg et al., 2010). For instance, in the first few weeks of life, 
the HC and mPFC undergo rapid and substantial changes in anatomy and volume 
(Whitaker-Azmitia et al., 1996; Zhang et al., 2006; Andersen et al., 2007), with data 
suggesting that between P0 and P7, the rate of cortical growth exceeds that of any other 
brain region (Zhang et al., 2006). Synaptic connections, axon tracts and dendritic arbors 
are also being sculpted at this time, fortifying the importance of this epoch in circuit 
formation (Gaspar et al., 2003). This post-natal period also corresponds to the time in 
which the 5-HT system itself is rapidly maturing. 5-HT levels gradually increase in this 





(Sodhi and Sanders-Bush, 2004; Sodhi; Whitaker-Azmitia, 2005). In rodents, only about 
30% of adult levels of serotonin receptors are present at birth and are thought to increase 
in expression during the first weeks of post-natal life (Azmitia and Whitaker-Azmitia, 
1997; Beique et al., 2004; Gaspar et al., 2003; Whitaker-Azmitia, 2005). For instance, the 
5-HT1A receptor is present at P0, but is dramatically upregulated within the first three 
weeks of life, with near adults levels of this receptor achieved around P21 (Gross et al., 
2002). Serotonergic innervation to behaviorally relevant areas is also developing during 
this time. In the mPFC, serotonergic innervation is present at birth but adult patterns are 
achieved only around the sixth week of life, implying that axonal arbors are being 
dramatically sculpted in the early post-natal period (Azmitia and Whitaker-Azmitia, 
1997). Interestingly, during this time, the mPFC and HC are also expressing 5-HTT and 
can thus take up, store and potentially release 5-HT, a feature which may be important in 
their functional development (Narboux-Neme et al., 2011).   
Based on the above data, we hypothesized that the critical period in which 
changes in serotonin impact adult anxiety and depression behaviors is captured in the 
early post-natal period. To experimentally test this hypothesis, wildtype mice were given 
daily intraperitoneal injections of either FLX (10mg/ml) or Vehicle (0.9% NaCl) during 
the following time windows: P4-21 (Ansorge et al., 2004), P2-21, P2-11, P12-P21, P22-
41 (Qinghui Yu, unpublished data). After post-natal treatment, animals were allowed to 
mature in standard facility conditions and behavioral testing was performed at P90 and 
above. We have previously shown that this treatment scheme results in therapeutic and 





without any overall effects on viability and growth (Ansorge et al., 2004 and 2008). A 
treatment naïve cohort was also included to control for injection and handling stress.  
c.) PN-FLX mouse phenotype 
The behavioral phenotype of PN-FLX treated mice was characterized using 
specific, pharmacologically validated tests for anxiety and depression-like behaviors 
(Figs. A.4 to A.6, methodology described in detail in Chapter 2). PN-FLX mice treated 
between P4-21, P2-21, or the narrower P2-11 window, displayed anxiety and depression-
like behaviors in adulthood. In particular, PN-FLX mice show decreased exploratory 
behavior (Fig A.4) and suppression of feeding in a novel, brightly lit and thereby 
anxiogenic, environment (Fig A.5).  
 
 Fig. A.4. Mice treated with FLX from either P2-21 or the narrower P2-11 display anxiety and 
depression-like behavior in the Open Field Test (A), as evidenced by significantly reduced 
vertical activity or “rearing”  (B) and decreased time engaging in exploratory activity (C). FLX 
treatment during any of the other windows had no effects relative to either controls, or naïve 
mice. Rearing activity is decreased in other mouse models of emotional dysfunction and can be 





Choleris et al., 2001; Holmes, 2003). Moreover, diminished ambulatory activity in a novel, 
brightly-lit environment is indicative of  reduced exploratory activity and is observed in other 
mouse models of anxiety/depression (Gross et al., 2002; Richardson-Jones et al., 2011). 
 
 
Fig. A.5. Only mice treated with FLX from either P2-21 or the narrower P2-11 display anxiety 
and depression-like behavior in the Novelty Suppressed Feeding (NSF) test (A), as evidenced by 
significantly longer latencies to feed (B). Feeding latency times are sensitive to chronic anti-
depressant and acute anxiolytic drug treatment and are elevated in other mouse models of anxiety 
and depression (Bodnoff et al., 1989; Gross et al., 2002; Santarelli et al., 2003; Lira et al., 2003).  
 
PN-FLX mice also displayed an innate helpless-like phenotype and ineffectual 






Fig. A.6. Only mice treated with FLX from either P2-21 or the narrower P2-11 display anxiety 
and depression-like behavior in the Shock Escape (SE) test (A), as evidenced by significantly 
increased latencies to escape (B), relative to controls. Increased escape latencies are found in 
other mouse models of anxiety and depression and are decreased with anti-depressant and 
anxiolytic agents (Seligman, 1972, Cryan et al., 2002; Lira et al., 2003; Muller et al., 2011). 
 
The critical time window was contained within the narrower P2-11 epoch as 
treatment schedules that did not include this window, did not produce abnormal 
emotional behaviors in adulthood (summarized in Fig A.7). Thus, we were able to show 
that 5-HTT inhibition solely during a key developmental period was sufficient to 
phenocopy the behavioral profile of constitutive 5-htt -/- mice. Moreover, these long-term 
behavioral effects were not specific to the use of FLX, as PN-treatment with other SSRIs 
and monoamine oxidase A (MAOA) inhibitors, also alter adult emotional behaviors 
(Vogel et al., 1990; Maciag et al., 2006a and 2006b; Ansorge et al., 2008, Qinghui Yu, 
unpublished results). Nor are these behavioral effects specific to manipulations of the 5-
HTT, as variations or loss of the inhibitory 5-HT1A receptor or MAOA also result in 





al., 1999; Gross et al., 2000; Tadic et al., 2003; Guitierrez et al., 2004; Savitz et al., 
2010). In line with our finding from the PN-FLX model, restoration of proper 5-HT1A R 
signaling in forebrain in the second to third post-natal week was sufficient to rescue the 
behavioral phenotype of constitutive 5-ht1a -/- mice (Gross et al., 2002). These data 
provide evidence for a strong correlative relationship between altered developmental 
serotonergic tone (irrespective of mechanism of disruption) and adult affective 
dysfunction. 
 
Fig. A.7. Summary of PN-FLX treatment phenotypes. P2-11 and P2-21 treatment with 
fluoxetine altered adult emotional behavior in a similar fashion. P12-21 and P22-41 treatments 
had no effect. Behavior was assessed in the open field test, the novelty suppressed feeding test 
and the shock escape test. The summary depicts treatment windows with (red boxes) and without 








The compelling next question relates to the mechanism by which early-life perturbations 
of 5-HT result in altered adult behaviors. Since behaviors are mediated by specific brain 
regions, and the connectivity between them, the serotonin-sensitive critical time windows 
for emotional behaviors likely represent epochs in which the circuits underlying these 
affective behaviors are developing (Gingrich et al., 2003; Gross and Hen, 2004b; 
Ansorge et al., 2007; Leonardo and Hen, 2009). Indeed, the crucial role of 5-HT in 
sculpting connectivity between brain regions has already been shown for sensory circuits. 
Specifically, serotonin signaling via the 5-HT1B and 5-HT1D receptors is essential in 
thalamocortical circuit maturation, which transmits sensory information from the 
whiskers to the somatosensory cortex (Rebsam et al., 2002; Gaspar et al., 2003; Bonnin et 
al., 2007). The axonal arbors of cortically projecting thalamic neurons are disrupted in 5-
htt -/- mice, which results in significantly impaired tactile sensation (Pang et al., 2011). 
These findings provide a convincing proof-of-principle that illustrates how abnormal 
serotonergic tone alters the maturation of circuits/brain areas resulting in altered 
behavior. Accordingly, serotonin may play a similar role in sculpting brain regions that 
underlie emotional behaviors, such as the mPFC and HC. Addressing this question has 












The overarching hypothesis of this body of work: 
 
During development serotonin influences the maturation of brain regions that underlie 
affective behaviors such as the mPFC and hippocampus. Thus perturbations of 
serotonergic tone in early development alter the developmental trajectory of these 
regions thereby enhancing the vulnerability to anxiety and depression-like disorders in 
later life.  
 













CHAPTER 2:  Serotonin modulates the structural, physiological and functional 
development of the medial prefrontal cortex 
 
Introduction 
In this chapter, we address the first part of our overarching hypothesis, by 
determining if early-life perturbations of 5-HT affect the maturation of the mPFC. 
Having identified changes in mPFC development, we next asked whether these 
alterations were causal to at least some component of the emotional phenotype of PN-
FLX mice.  
The mPFC is a key regulator of affective state, whose output modulates fear-
related behaviors, anxiety levels, stress responses and depressive states (Vertes, 2006; 
Milad et al., 2007). As such, variations in its proper development may impact its 
functional output, thereby resulting in a dysregulation of emotional behaviors. As 5-htt -/- 
and PN-FLX mice display an enhanced anxiety and depression-like phenotype, we 
hypothesize that they have abnormal mPFC function. Indeed, there is ample, although 
circumstantial, evidence indicating that 5-HT influences the developmental course of the 
mPFC. For example, humans with the lower-expressing “s” allele of the 5-htt gene, 
display a marked decrease in gray matter volume in the prefrontal cortex (Pezawas et al., 
2005). These changes are found in regions that are homologous, in terms of their 
connectivity and function, to sub-regions of the rodent mPFC, namely the infralimbic 
(IL) and prelimbic (PL) cortices (Uylings et al., 2003). Similar structural changes in the 
mPFC have also been characterized in 5-htt -/-  mice, an extreme model of the “s” 





due to alterations in dendritic branching and complexity in this region that we, and others, 
have characterized  (Appendix B, Fig. B.1-B.2; Wellman et al., 2007). Changes in mPFC 
volume have also been characterized in humans with anxiety and depression (Sheline et 
al., 1996; Vasic et al., 2008; Lorenzetti et al., 2009), both of which are pathologies 
associated with serotonergic dysfunction (Gingrich et al., 2003). Together, these data 
suggest a strong association between serotonergic tone, mPFC structure and affective 
dysfunction.  
5-HT also influences the physiological properties of the mPFC.  Dysregulation in 
5-HT signaling affects spine density (Nietzer et al., 2011), receptor expression (Mossner 
et al., 2003; Yuen et al., 2005; Englander et al., 2005; David et al., 2005; Guidotti et al., 
2011), receptor coupling (Manouri la Cour et al., 2001; Bhanshali et al., 2007; 
Stockmeier et al., 2009), afferent input (Maciag et al., 2006; Neil Gray, unpublished 
results) and electrophysiological responses (Iyer et al., 1996; Manouri la Cour et al., 
2001; Goodfellow et al., 2009;  Adhikari et al., 2010;) in the mPFC. Congruently, many 
of the above physiological parameters are abnormal in mice displaying both altered 
serotonergic tone, and dysregulated affective behaviors, such as 5-htt -/- and those 
lacking the 5-HT1A receptor (5-ht1a -/- mice), suggesting a correlation between these 
phenotypes  (Gobbi et al., 2001; Mannoury la Cour et al., 2001, Murphy et al., 2001; Li et 
al., 2003). Additionally, theta oscillations within the mPFC, which are generated by the 
synchronized rhythmic activity of neuronal electrical conductances in the 4-12 Hz range, 
are also influenced by 5-HT signaling (Gordon et al., 2005). This suggests that 5-HT 





influence of 5-HT on mPFC neuronal physiology, we hypothesize that mPFC neurons of 
PN-FLX mice display altered physiological properties.  
Furthermore, since mPFC output is essentially a composite of the firing and 
physiology of the individual neurons of which it is composed, changes in mPFC neuronal 
cytoarchitecture and physiology may impact its functional output. Functional probing of 
this structure using mPFC-dependent behavioral paradigms suggests mPFC output is 
indeed altered in 5-htt -/- mice (Wellman et al., 2007). Specifically, the mPFC, through 
its connections to other limbic structures such as the amygdala, modulates an organism’s 
ability to extinguish learned fear, termed fear extinction (Burgos-Robles et al., 2007; 
Milad et al., 2007; Quirk and Mueller, 2008). Lesion and microstimulation studies have 
shown that specific manipulations of mPFC output result in either enhanced or dampened 
fear extinction learning and memory (Lebrón et al., 2004; Sierra-Mercado et al., 2006; 
Santini et al., 2008; Farrell et al., 2010; Sierra-Mercado et al., 2011) . In line with their 
structural/physiological mPFC phenotype, 5-htt -/- mice display deficits in fear extinction 
learning and its subsequent recall (Wellman et al., 2007) signifying altered mPFC 
function. Congruently, this decreased corticolimbic connectivity, suggestive of altered 
mPFC output, has also been demonstrated in human “s” allele carriers. Functional 
magnetic resonance imaging (fMRI) studies revealed diminished functional connectivity 
between the mPFC and the amygdala in “s” allele carriers, in response to fearful stimuli 
known to recruit corticolimbic circuits (Heinz et al., 2004; Pezawas et al., 2005). 
Inclusively, these data indicate a strong correlation between abnormal serotonergic tone, 
altered maturation of the mPFC and affective dysfunction. To directly address whether 





investigated whether PN-FLX mice displayed structural, physiological and functional 
changes in the mPFC, by addressing the following aims: 
 
Aim 1a: Does development-specific disruption of serotonergic tone alter the maturation 
of the medial pre-frontal cortex (mPFC)? 
i. Are there structural alterations within the mPFC of PN-FLX mice? 
ii. Are there electrophysiological changes in mPFC neurons from PN-FLX 
mice? 
  iii. Is the functional output of the mPFC altered in PN-FLX mice? 
Next, we sought to determine whether there was a causal relationship between the 5-HT-
mediated changes in the mPFC and the emotional behaviors generated as a result of 
early-life modulation of 5-HT. As such, the following aim was addressed: 
Aim 1b: Are the structural/functional changes in the mPFC causal to the affective 













Drug preparation and Subjects 
Fluoxetine (FLX; ANAWA Trading SA, Wangen, Switzerland) was dissolved in 
0.9% NaCl to a final concentration of 2mg/ml. The solution was filtered using a 0.45um 
filter tip and filtrate was collected in a fresh tube and stored at 4º until ready to use. Prior 
to use, FLX solution was warmed to room temperature. Male and female WT 129SvEv 
mice pups were intraperitoneally injected with the 2mg/kg FLX (in 0.9% sodium 
chloride, NaCl) solution. Control mice received injections of vehicle (0.9% NaCl 
solution). For treatment, entire litters were removed from dams and placed into a bucket 
(10 cm diameter) containing shavings from the respective home cage. The bucket was 
resting on scales, to allow for weighing mice after picking them up using a subtractive 
technique. Mice were injected in random order, and an entire litter was injected within 2 
min. After injections, mice were placed back into the home cage and were observed for 
5mins to ensure mothers attended to them. For the morphological analyses mice were 
treated from P4-21 as this period yields an identical behavioral profile as mice treated 
form P2-11, as it contains the narrower critical time window (Ansorge et al., 2000). For 
all other experiments mice were treated from P2-P11. After weaning, which occurred on 
P28, mice were separated by sex, randomly mixed for treatment and group housed with 5 
mice per cage.  
 
Analysis of dendritic complexity 
Brains from adult (>P90), male PN-Veh and PN-FLX mice processed with the 





using a vibratome to generate 150µm sections which were mounted on 3% gelatin-
subbed slides. Pyramidal neurons (n = 6-9 cells per mouse; 3 mice per treatment group) 
in the infralimbic (IL) and prelimbic (PL) regions (layer 2/3 and 5) were visualized at 
100x magnification and identified based on their location (verified using the Comparative 
Cytoarchitectonic Atlas of the 129/Sv mouse brain by Hof et al., 2000) and characteristic 
morphology such as the pyramidal shape of their somas and the presence of a prominent 
apical dendrite. Cells that were in the middle of the z-plane and possessed intact dendritic 
arbors were marked as potential candidates for analysis. From this candidate pool, 7 to 10 
cells per brain were randomly selected and traced. Neurons were manually traced using 
Neurolucida software (MBF Bioscience, Williston, VT). Cells from both hemispheres 
were included in a balanced manner. Extent of dendritic arborization was determined via 
Sholl analysis (Sholl, 1953) using NeuroExplorer software (MBF Bioscience) with 10μm 
set as the radius parameter (Fig. 2.1). Dependent measures from the Sholl analysis output 
included number of nodes (branch points, both bifurcating and trifurcating nodes were 
included in analysis, however >95% of total nodes were bifurcating), intersections and 
total dendritic material. In addition to the Sholl parameters, the length of dendritic tree 
(distance between the soma and farthest point of dendritic tree) was also recorded using 
the maximum Sholl radius as the index of how far out the trees protruded from the soma. 
Brain sections were coded such that the experimenter was blind to treatment during the 






Fig 2.1. Schematic displaying the steps in analyzing dendritic complexity of mPFC 
neurons. Cells were visualized at 100x magnification (A), manually traced (B) and finally 
analyzed using Sholl analysis (C). Sholl analysis works by setting concentric spheres of a 
fixed radius (10µm) starting from the epicenter of the soma. In each sphere or “shell” the 
number of nodes (branch-points), intersections (number of branches crossing through a 
specified shell) and dendritic material is reported.  
 
Electrophysiology 
Experiments were performed at the University of Toronto (data acquisition and 
analysis was performed by Nathalie Goodfellow- laboratory of Dr. Eveyln Lambe) and 
approved by the University of Toronto Animal Care and Use Committee and conformed 
to the international guidelines on the ethical use of animals.  Male PN-FLX and PN-Veh 
mice aged P100-P120 were shipped to the University of Toronto Animal facility and 
were kept in quarantine and allowed to habituate to the new environment for a period of 
>6 weeks. The following methods have been modified from, and based on: Goodfellow et 





excised and immediately cooled by placement in 4°C oxygenated sucrose artificial CSF 
(sACSF; 254 mM sucrose, 10 mM D-glucose, 24 mM NaHCO3, 2 mM CaCl2, 2 mM 
MgSO4, 3 mM KCl,1.25 mM NaH2PO4; pH 7.4). The sACSF was specifically 
formulated such that it contained no NaCl in order to dampen any sodium ion-mediated 
firing activity that might occur during the processing of the tissue in preparation for 
recordings, thereby protecting the tissue from excitotoxicity. Brains were mounted on a 
vibratome and cut to generate 400μm thick slices of the medial prefrontal cortical region. 
Prefrontal slices were cut from anterior to posterior using the appearance of white matter 
and the corpus callosum as anterior and posterior guides (from approximately 1.4 to 2.3 
mm anterior to Bregma). Slices were cut on a Dosaka Linear Slicer (Sci-Media) and were 
transferred to 32°C oxygenated “regular” (including NaCl) ACSF (128 mM NaCl, 10 
mM D-glucose, 24 mM NaHCO3, 2 mM CaCl2, 2 mM MgSO4, 3 mM KCl,1.25 mM 
NaH2PO4; pH 7.4) in a pre-chamber and allowed to recover for at least 2 h before the 
beginning recordings. For whole cell recordings, slices were placed in a superfusion 
chamber (Warner Instruments) and mounted on the stage of an OlympusBX50WI 
microscope. Regular ACSF at 31 to 33 °C was bubbled with 95% oxygen and 5% carbon 
dioxide and flowed over the slice at a rate of 3–4 ml/min. The temperatures used during 
brain removal and recordings were found to be critical for maintaining healthy brain 
slices which was especially important given the advanced age of our mice. 
Whole cell recordings of neurons were performed as previously described 
(Goodfellow et al., 2009). Briefly, whole-cell recording electrodes (2–3 MΩ) contained 
120mM potassium gluconate, 5 mM KCl, 2 mM MgCl, 4 mM K2-ATP, 0.4 mM Na2-





KOH). Prefrontal cortex layer 2/3 pyramidal neurons in the IL and PL were visualized 
using infrared differential interference contrast microscopy. Neurons were identified 
based on their location, the pyramidal shape of their somas and presence of a prominent 
apical dendrite. Care was taken to select neurons in the central part of each region (IL and 
PL) so as to avoid any confusion of whether a cell belonged to either IL or PL. Under 
these conditions, and currents were recorded using continuous single electrode voltage-
clamp mode with a Multiclamp700b (Molecular Devices), acquired and low-pass filtered 
at 3 kHz using pClamp10.2/Digidata1440 software (Molecular Devices). For input-output 
curve generation, neurons were held at their resting membrane potentials, or at -75 mV, 
as indicated, and 50 pA current steps up to 450 pA were used and spike responses to 
current injections were measured (Fig 2.2). Statistical comparisons between treatment 
groups were analyzed using unpaired t-tests. Data is presented as means +/- standard 
error of the mean (S.E.M.). 
 
 
Fig. 2.2 Neurons in the mPFC were patched (A, yellow arrow indicates pipette) to make 
whole-cell recordings in responses to incremental 50 pA current steps (B). Spike 
responses (frequency of spikes) to current steps were measured (C). (Figures courtesy of 






Cued fear conditioning and extinction 
Mice were fear conditioned using equipment set up similarly to that described by 
Drew et al., 2010. On day 1, mice were placed into the conditioning chamber (“context 
A”; ENV010MD, Med Associates, St. Albans, VT), allowed to explore freely for 180 s 
and then received three tone-shock pairings, in which 20 s, 80 dB, 2000 Hz tone 
(conditioned stimulus, CS) co-terminated with 2 s, 0.75 mA scrambled foot shocks 
(unconditioned stimulus, US) delivered via the grid floor. Tone-shock pairings were 
delivered with variable inter-trial intervals. On day 2, mice received a second day of cued 
fear conditioning in context “A” in which they received two tone-shock pairings. Mice 
then went two days of fear extinction training (days 3 and 4) in novel context “B” which 
differed significantly from conditioning context “A” in several ways including odor cues, 
wall color/composition, floor composition (grid floor vs. bedding) and room/chamber 
lighting. On day 5, mice were placed back into the extinction training context “B” and 
their response to 5 tones were measured. When indicated, % freezing values were 
normalized to freezing levels at the start of the extinction session (D3 start). Mice were 
recorded using a video camera mounted above the conditioning chamber and movement 
was monitored using FreezeFrame software from Actimetrics (Evanston, IL). Percent 
freezing was automatically calculated using FreezeView software (Actimetrics). Freezing 
was defined as the cessation of all movement excluding respiration and the freezing bout 
duration was defined as 0.5s. One-way analysis of variance (ANOVA) was used to 







Fig 2.3 Cued fear conditioning and extinction protocol. Bars represent 20 s, 80 dB, 2000 
Hz tones. Jagged arrows represent 2 s, 0.75 mA scrambled foot shocks. During training 
days, 1 bar = one tone, while on extinction training days, 1 bar = 3 tones. Orange bar 
represents the tones used to determine freezing to CS cue after fear conditioning session.  
 
Infralimbic lesions 
Lesion studies and behavioral tests and were conducted in accordance with the 
Principles of Laboratory Animal Care guidelines from the National Institute of Health 
(NIH) and the Institutional Animal Care and Use Committee guidelines. Adult (> P90) 
Male and female PN-Veh and PN-FLX mice were assigned to  either sham- or IL-lesion 
groups. Post-natal treatments were carried out as previously described. Mice were 
anaesthetized using Isoflurane and underwent stereotactic surgery in which they received 
two bilateral injections of either ibotenic acid (0.25 µl of 5 mg/ml, 0.125 µl/min injection 





diameter of 12 μm (pulled from capillaries: 3-000-203-G/X, Drummond Scientific, 
Broomall, PA),  if they were in the IL lesion groups or with vehicle (0.9% NaCl, 0.25 μl, 
0.125 μl/min injection rate),  if they were in the sham lesion group. Injection coordinates 
were 1.6 and 2.1 mm anterior to bregma, 2.8 mm ventral from the brain surface and +/- 
0.3 mm lateral to the midline. After surgery, mice were returned to their cages and were 
monitored daily over the next week to ensure that they recovered without issue. Mice 
were given 2 to 4 weeks for recovery before the onset of behavioral testing. Behavioral 
testing on lesioned mice was conducted as previously described in this paper. 
 
Behavioral testing of lesioned mice 
Tests were administered in the following order: open field, novelty suppressed 
feeding, and shock avoidance with a minimum 7 day inter-test durations.  
 
Open Field 
Measurement of exploratory activity in response to a novel environment was 
assessed as described in Ansorge et al., 2008, using the open field test. Briefly, mice were 
allowed to explore brightly lit (800-900 lux) Plexiglass activity chambers (43.2 × 43.2 × 
30.5 cm, length × width × height; model ENV-520; Med Associates, Georgia, VT) 
equipped with infrared beams located 1.5 cm above the chamber floor and spaced 2.5 cm 
apart as well as beams 6 cm above the chamber floor, spaced 2.5 cm apart. Beams were 
positioned such that both horizontal and vertical activity was detectable. Mice were 
placed in the center of the chamber and were allowed to freely explore for 60 minutes. 





time in the center (defined as the central 15 ×15 cm region) and vertical activity (rearing) 
were measured as the dependent variables.  
 
Novelty-suppressed feeding  
The novelty-suppressed feeding test was performed similarly to previously 
described (Ansorge et al., 2008).  Briefly, food deprived mice (24 hours, with water 
available ad libitum) were placed in a brightly lit (800–900 lux) open arena (51 × 35 cm) 
containing clean wood chip bedding. A white filter paper 125 mm in diameter which was 
attached firmly to the center of the arena (embedded in the bedding). One familiar food 
pellet weighing ∼4 g was firmly attached to the paper such that the mice could not move 
the pellet from the center and thus the pellet remained in the center region throughout the 
experiment. Mice were removed from their home cage, placed in a holding cage for 30 
min before the test, and then released in the southwest corner of the arena. The latency to 
approach the pellet and begin a feeding episode was recorded. Mice were given a 
maximum of 15 mins to complete the task. Immediately after initiating a feeding episode, 
mice were removed from the arena and placed into their home cage containing a pre-
weighed food pellet and allowed to feed ad libitum for 5 min. Food consumption was 
determined by the difference in weight of the pellet. As a control, mice were weighed pre 
and post-24 hr food deprivation and percent weight loss was calculated. Latency to 
approach food, home-cage food consumption and % weight loss were used as the 








The shock escape test was performed as previously described (Ansorge et al., 
2008). Briefly, mice were tested in a Plexiglas box (model ENV 010MD; Med 
Associates, St. Albans, VT) located within a sound-attenuated chamber. The box was 
divided into two identical chambers (20 × 17 × 20 cm, length × width × height) and 
separated by an automated guillotine door. The apparatus was equipped with a grid floor 
made of stainless steel beams and connected to a shock generator and 8 infrared beams 
for detecting movement of the animal. Mice (one mouse per box) were placed into the 
chamber with the guillotine door raised and were allowed to freely explore both 
compartments for 5 min after which the guillotine door closed and the trials commenced. 
At the beginning of each trial, the door was raised and a mild scrambled foot shock (0.2 
mA; 10 s maximum duration) was delivered to the subject. The end of a trial was 
signaled by the closing of the guillotine door and was triggered either by a transition to 
the opposite chamber (“escape”) or after a lapse of 10 s. The test consisted of 30 trials 
each separated by a 30 s inter-trial interval. Latencies to escape for each trial were 
recorded. If the subject failed to make a transition during the 10 s duration of the foot 
shock, a maximum latency of 10 s was assigned. Locomotor activity was assessed during 
inter-shock intervals by counting total infrared beam interruptions during each session. 
 
Histology  
At the end of the study, mice were transcardially perfused with PBS followed by 
4% paraformaldehyde. Brains were excised and further fixed via incubation in 4% 





in 30% sucrose for 3 days. A freezing microtome (Leica Microsystems, Buffalo Grove, 
IL) was used to cut the entire anterior-posterior extent of the IL region in 35um sections, 
which were mounted onto 3% gelatin-subbed slides and allowed dry completely so as to 
ensure they were well adhered to the slides. Sections were then stained with cresyl violet. 
Briefly, slides were immersed in 50% ethanol for 1 min, dipped in water, and then placed 
in the Nissl stain solution  containing a 1:10 mixture of cresyl acetate (  9-Amino-5-
imino-5H-benzo[a]phenoxazine acetate salt)  and neutral red, both from Sigma-Aldrich, 
St. Louis, MO) for 3 mins to allow for impregnation. Slides were then re-dipped in water, 
and dehydrated by submersion in progressively higher percentages of alcohol solutions 
(50%, 70%, 95%, 100%, each for 1 min) followed by placement in xylene for a minimum 
of 30mins. Processed slides were then coverslipped using DPX mounting media (Sigma-
Aldrich, St. Louis, MO) and were allowed to dry for two days before being analyzed. To 
determine the location and extent of the lesion sections were visualized using light 
microscopy and by drawing out the regions of ibotenic-acid mediated neuronal loss that 
was visible on brain atlas figures (Comparative Cytoarchitectonic Atlas of the 129/Sv 
mouse brain by Hof et al., 2000). Animals with non-IL lesions were eliminated from the 
analysis.  
 
Statistical analysis  
Data were analyzed using Student’s t test or one-way analysis of variance 
(ANOVA), with repeated measures where appropriate and as indicated. Post-natal 
treatment and surgery type (sham vs. lesion) were assessed as independent variables. The 





0.1. Datasets containing male and female mice were analyzed for main effects and/or 
interactions of sex with the dependent variables under study. Since none were found, 
male and female data were combined. No interaction or main effects of treatment were 
found, so data from PN-Veh and PN-FLX mice were collapsed to measure effect of 
lesion (primary dependent variable). All data are presented as the mean +/- standard error 
























Aim 1a (i).    Altered neuronal cytoarchitecture in the infralimbic region of PN-FLX 
mice 
Dendritic morphology of Golgi-stained pyramidal neurons in two key subregions 
of the mPFC, the infralimbic (IL) and prelimbic (PL) cortices from adult PN-FLX and 
PN-Veh mice was examined. We found a decrease in the complexity of the apical 
dendritic arbors of layer 2/3 IL neurons from PN-FLX mice, relative to controls, as 
indicated by a significantly reduced number of nodes (F1, 22 = 7.376 ; p = 0.0126, Fig. 
2.4), intersections (F1, 24 = 10.272; p = 0.0038, Fig. 2.5) and total dendritic material (F1, 24 
= 7.599; p = 0.0110, Fig 2.6). The reduced complexity of the IL apical arbor is 
throughout the entire extent of the arbor up to 240µm from the soma (repeated measures 
ANOVA up to 240 µm: F1, 23 = 7.221; p = 0.0132; Fig 2.7). Furthermore, the decreased 
dendritic complexity of IL apical arbors is in absence of any overall shrinkage of the 
dendritic tree as the average distance that the apical arbor extended from the center of the 
soma was not significantly different between treatment groups (Fig. 2.8). The finding of 
decreased dendritic complexity was also limited to the apical arbor of IL neurons as no 
changes were detected in IL basilar trees (Fig. 2.9). Representative models of IL layer 2/3 
neurons from PN-Veh and PN-FLX mice are presented in Fig. 2.10. In the layer 2/3 of 
the PL cortex, we found no differences in morphology in neither the apical nor the basilar 
dendritic trees (Fig. 2.11, apical; Fig. 2.12, basilar). Additionally, no significant 
differences between PN-FLX mice and controls were observed in layer 5 pyramidal 





2.16, basilar) region. Thus, we find a specific ~20% decreased dendritic complexity in 
the IL layer 2/3 sub-region of the mPFC (Fig 2.17).  
 
 
Fig 2.4. Apical dendrites of IL layer 2/3 pyramidal neurons from PN-FLX mice have 
significantly less total number of nodes relative to controls. N = 3 mice/group, 6-9 
cells/mouse, * p<0.05. Data represent mean ± SEM 
 
Fig. 2.5. Apical dendrites of IL layer 2/3 pyramidal neurons from PN-FLX mice have 
significantly lower total number of intersections relative to controls. N = 3 mice/group, 6-





    
Fig. 2.6. Apical dendrites of IL layer 2/3 pyramidal neurons from PN-FLX mice have 
significantly less total dendritic material relative to controls. N = 3 mice/group, 6-9 
cells/mouse, * p<0.05.   
 
 
Fig. 2.7. The increased complexity (as captured by increased number of intersections) of 
PN-FLX apical layer 2/3 IL arbors are most prominent in the first 240μm proximal to the 






Fig. 2.8.  No significant differences detected in the average distance that apical dendrites 
of IL layer 2/3 neurons extend out from the soma, between PN-FLX and PN-Veh mice. N 
= 3 mice/group, 6-9 cells/mouse. 
 
Fig. 2.9. No differences in total number of nodes (A), intersections (B), dendritic material 
(C) and distance from soma (D), in basilar dendrites of IL 2/3 neurons from PN-FLX and 






Fig. 2.10. Models of representative IL layer 2/3 neurons from PN-Veh and PN-FLX 
mice, depicting the decreased complexity of the apical arbor in PN-FLX mice.  
 
Fig. 2.11 No differences in total number of nodes (A), intersections (B), dendritic 
material (C) and distance from soma (D), in apical dendrites of PL layer 2/3 neurons from 






Fig. 2.12. No differences in total number of nodes (A), intersections (B), dendritic 
material (C) and distance from soma (D), in basilar dendrites of PL layer 2/3 neurons 
from PN-FLX and PN-Veh mice. N = 3 mice/group, 6 cells/mouse. 
 
Fig. 2.13. No differences in total number of nodes (A), intersections (B), dendritic 
material (C) and distance from soma (D), in apical dendrites of IL layer 5 neurons from 






Fig. 2.14. No differences in total number of nodes (A), intersections (B), dendritic 
material (C) and distance from soma (D), in basilar dendrites of IL layer 5 neurons from 
PN-FLX and PN-Veh mice. N = 3 mice/group, 6-7 cells/mouse. 
 
Fig. 2.15. No differences in total number of nodes (A), intersections (B), dendritic 
material (C) and distance from soma (D), in apical dendrites of PL layer 5 neurons from 






Fig. 2.16. No differences in total number of nodes (A), intersections (B), dendritic 
material (C) and distance from soma (D), in basilar dendrites of PL layer 5 neurons from 
PN-FLX and PN-Veh mice. N = 3 mice/group, 5-6 cells/mouse. 
 
Fig. 2.17. Summary of morphological findings in mPFC region in PN-Veh and PN-FLX 
mice. The only region where changes (decreased complexity) were observed was in 






Aim 1a (ii).    Concurrent decrease in infralimbic, and increase in prelimbic 
excitability in neurons from PN-FLX 
 
To determine whether the morphological changes we found in the mPFC were 
accompanied by changes in electrophysiological properties of the IL and PL pyramidal 
neurons, we performed whole-cell patch clamp recordings in acute brain slices. We 
investigated changes in both intrinsic physiological properties of neurons and also in their 
excitability, as gauged by their responses to varying current injections. 
 We found no significant differences in the intrinsic properties (membrane 
potential, rheobase, spike amplitude, input resistance or capacitance) of IL pyramidal 
neurons between treatment groups (Table 2.1). However, when spike frequencies in 
response to current injections were measured for IL pyramidal neurons, from both resting 
membrane potential or when held at -75 mV, a main effect of post-natal treatment was 
found using a two-way ANOVA, dependent variables: current and spike frequency (from 
rest: p<0.0001, NPN-Veh =13; NPN-FLX = 19; from -75mV: p<0.0001, NPN-Veh =13; NPN-FLX 
= 19) indicating that PN-FLX mice display significantly fewer spikes to current 
injections. Surprisingly, neurons from the PL region of PN-FLX mice responded with 
significantly more spikes to current injections, relative to controls when held at rest (two 
way ANOVA: p < 0.01, NPN-Veh =10; NPN-FLX = 20) or at -75 mV (p < 0.05) . PL neurons 
also exhibited significantly reduced rheobase values (p = 0.04) and a decrease in mean 
spike amplitude (p =0.04). 
Our electrophysiological measurements were limited to the layer 2/3 where the 





significant changes in intrinsic properties or input-output curves of layer 5 pyramidal 
neurons in either the IL or PL. Inclusively, our electrophysiological data indicate a 
significant decrease in excitability of IL neurons, concomitant to an increase in PL 









Rin  (MΩ) Cm  (pF) Rheobase (pA) 




-85.5 ± 2.8 87.3 ± 1.5 165.0 ± 25.9 86.5 ± 5.0 134 ± 26 
 
PN-FLX 
 (n= 19) 
-83.6 ± 1.8 84.9 ± 1.2 130.9 ± 13.2 91.6 ± 9.0 
150 ± 16 
(n=17) 
 P 0.6 0.2 0.2 0.7 0.6 








-88.9 ± 1.6 83.7 ± 1.4 115.7 ± 13.7 87.1 ± 4.9 
173 ± 21 
(n=17) 
 P 0.4 0.04* 0.1 0.1 0.03* 
 
Table 2.1. Intrinsic properties of layer 2/3 pyramidal neurons in the IL and PL of adult PN-FLX 
and PN-Veh mice. Data are shown as mean ± SEM and includes p values for unpaired t-tests. N = 






Fig 2.18. Input-output curve depicting frequency of spikes fired in response to varying 
current steps, from resting membrane potential (left) or from -75mV (right) for IL layer 
2/3 neurons from PN-Veh and PN-FLX mice. PN-FLX mice fire significantly fewer 
spikes at higher currents (main effect of treatment, two-way ANOVA, for both panels: p 
< 0.0001). N = 3-6 mice/treatment group 10-20 cells/group. (Data courtesy of N. Goodfellow). 
 
Fig 2.19. Input-output curve depicting frequency of spikes fired in response to varying 
current steps, from resting membrane potential or from -75mV, for PL layer 2/3 neurons 





currents (main effect of treatment: from rest, p < 0.01; from -75 mV p < 0.05). N = 3-6 
mice/treatment group 10-20 cells/group. (Data courtesy of N. Goodfellow). 
 
Aim 1a (iii). PN-FLX mice display pronounced deficits in fear extinction learning 
and recall 
To gauge changes in mPFC output, PN-FLX mice underwent classical Pavlovian 
cued fear conditioning and subsequent extinction. During the conditioning phase, we 
detected no significant differences between post-natal treatment groups in either baseline 
freezing to training context “A” (2.20), in response to tone-shock pairings or post-training 
freezing levels (Fig. 2.21). On the following day, mice were placed in context “B”, where 
they received extinction training. No significant differences in baseline freezing to novel 
context “B” between post-natal treatment groups were observed (Fig. 2.22). However, in 
response to the first three tones on extinction day 1 (24 hours after cued fear 
conditioning), PN-FLX mice have significantly reduced % freezing relative to controls 
(F1,45 = 12.480; p = 0.0010, Fig 2.23). 
As visible in Fig. 2B, during the extinction training session (D1), PN-Veh controls 
exhibited a robust extinction learning phenotype as indicated by a progressive decrease in 
freezing over time (with exposure to each subsequent set of tones in absence of the 
noxious shock). PN-FLX  mice, on the other hand, exhibit a pronounced deficit in 
extinction learning  as indicated by the absence of a decrease in freezing levels over the 
extinction training session (post-natal treatment x time effect, repeated measures 
ANOVA: F5, 240 = 3.204; p <0.0001). Post-tone freezing is also significantly higher in PN-





To control for the differences in initial freezing to tone, % freezing  values for all 
bins were normalized to each post-natal treatment group’s respective initial freezing 
levels (at D1 start, Fig 2.25). As we previously saw in Fig. 2.24 (un-normalized data), 
PN-FLX mice display a deficit in extinction learning when compared to PN-Veh controls, 
even when % freezing is normalized to baseline response to tone (D1 start vs. end: 
treatment x time interaction p < 0.001). Between D1 and D2, neither PN-Veh nor PN-
FLX mice displayed extinction recall (D2 start versus D1 start not statistically 
significant). On D2, both PN-Veh and PN-FLX mice displayed pronounced and 
comparable levels of extinction learning (p < 0.001 for effect of time; no treatment effect 
or interaction). However, on D3, despite learning to extinguish the CS-US memory to the 
same extent on D2, only PN-Veh displayed extinction recall, whereas PN-FLX do not 
(D3 start versus D2 start statistically significant only for PN-Veh; p < 0.01).  
Overall, our findings suggest that mice experiencing increased serotonergic tone 
from P2-11 display deficits in both the learning and memory components of fear 
extinction and are congruent with our hypothesis that there exists a decrease in IL/PL 








Fig 2.20. PN-FLX and PN-Veh mice have comparably low levels of baseline freezing to 





mice exhibit comparable levels of freezing at baseline, in response to 
the first and last tones of the training session and in the post-training period, as PN-Veh 








Fig. 2.22  PN-FLX and PN-Veh mice have comparably low levels of baseline freezing to 
the novel training context. N = 23-24 mice per treatment group.  
 
 
Fig. 2.23 PN-FLX mice freeze significantly less to the first tone on extinction day 1, 







Fig. 2.24  PN-Veh mice exhibit a progressive decrease in freezing to tone over the entire 
extinction training session (day 1, D1) while PN-FLX  mice do not ( treatment x time 
interaction effect : p = 0.0081). PN-FLX  mice also exhibit significantly higher post-









Fig 2.25. Freezing levels of PN-FLX and PN-Veh mice, normalized to their starting 
freezing levels at the start of the first extinction training (day 1, D1). On D1 of extinction 
training, PN-FLX treated mice displayed a deficit in extinction learning, when compared 
to PN-Veh controls ( treatment x time interaction p < 0.001). Between D1 and D2, 
neither PN-Veh nor PN-FLX mice displayed extinction recall (D1 start versus D2 start 
not statistically significant). On D2, PN-Veh and PN-FLX mice displayed extinction 
learning (# effect of time: p < 0.001, no treatment or interaction effects). Between D2 and 
D3, only PN-Veh displayed extinction recall (* D2 start versus D3 start statistically 








Aim 1b.    IL lesions result in a partial phenocopy of the PN-FLX mouse behavioral 
phenotype 
Next we addressed the question of whether the changes in the mPFC were causal 
to the behavioral phenotype of PN-FLX mice (Figs. 1.2-1.4). To mimic the decreased 
IL/PL output of PN-FLX mice, mice underwent stereotactic surgery in which they 
received two bilateral injections of the neurotoxin, ibotenic acid, resulting in cell death 
and gliosis of the IL cortex. We histologically verified the location of the lesions and 
excluded subjects that had non-IL lesions. Figure 2.26 displays the location and extent of 
the lesions in control mice. After a minimum 2 week recovery period, mice underwent 
behavioral testing. In the open filed test, one-way ANOVA demonstrated a significant 
effect of surgery on % time in center in which IL-lesion mice spent a significantly 
reduced amount of time exploring the central, more anxiogenic region of the arena (F1,45 
= 4.722; p = 0.0351, Fig. 2.27), relative to sham lesion controls, suggesting an 
enhancement of anxiety-like behavior in IL-lesion animals. IL-lesion mice also spent 
significantly less time engaging in exploratory vertical activity, relative to sham-lesion 
controls (F1,42 = 4.154; p =0.0479, Fig. 2.28). Total ambulatory time and distance were 
not affected by surgery (Fig 2.29). IL lesions also resulted in an increase in the time to 
approach food (latency to feed) in the novelty suppressed feeding test in both PN-Veh 
and PN-FLX mice (F1,45 = 4.667. p = 0.0361, Fig. 2.30). In the familiar home-cage 
environment, PN-FLX mice do not differ from controls in amount of food consumed 
(Fig. 2.31A). Effects of 24hr food deprivation between groups was also not significantly 
different (Fig. 2.31B) In the shock escape test lesioning the IL was not sufficient to 





in latency to escape the shocks (Fig 2.32A) or baseline ambulatory activity during the 
habituation phase (Fig. 2.32B) between IL- and sham-lesion mice were detected. 
 
Fig 2.26. IL lesioned mice spend significantly less time engaging in vertical activity 
(time rearing) in the open field test, relative to Sham lesioned controls (* p = 0.0479). N = 
23-24 mice per treatment group.  
  
Fig 2.27. IL lesioned mice spend significantly less % time in center, relative to Sham 






        
Fig 2.28. No differences in total ambulatory time (A) or distance (B) between PN-Veh 
and PN-FLX mice in the open field test. N = 23-24 mice per treatment group.  
 
 
Fig 2.29. PN-FLX mice take significantly longer to approach the food pellet relative to 







     
Fig 2.30. No significant differences between Sham- and IL-lesion animals in home-cage 
food consumption (A) or % weight loss after 24hr food deprivation (B).  
 
Fig. 2.31. No significant differences between Sham- and IL-lesion animals in latency to 











Aim 1a (i).    Structural changes 
We have found pronounced cytoarchitectural changes in the mPFC of PN-FLX 
mice, suggesting that the structural development of the mPFC is sensitive to 5-HT levels 
in the early post-natal period (Figs. 2.4-2.7). Moreover, these changes are present 
specifically in the apical dendritic trees of layer 2/3 pyramidal neurons in the IL sub-field 
of the mPFC, a region in which volume reductions are also found in human “s” allele 
carriers (Pezawas et al., 2005). Thus, the altered volume in human “s” allele carriers may 
also have developmental roots. 5-htt -/- mice also display changes in the IL region of the 
mPFC, however, the layer-specificity and directionality of the changes do not exactly 
mirror those found in PN-FLX mice (Appendix B, Fig.B.1-B.2). This is unsurprising as 
the constitutive loss of 5-HTT may generate an arborization phenotype quite dissimilar 
from that of PN-FLX mice who experience elevated 5-HT strictly during development, 
due to compensatory changes or due to persistently elevated 5-HT in adulthood.  
 The fact that arborization changes are limited to the IL region, and not the PL, 
may suggest that IL arbors are particularly sensitive to 5-HT levels during development. 
The increased sensitivity of IL neurons could be due to an enhancement of specific 5-HT 
receptors that mediate the cytoskeletal changes that affect dendritic arborization. 
Interestingly, the regions in which structural and functional changes are observed in “s” 
allele carriers have been shown to have especially high levels of 5-HTT (Varnas et al., 
2004). A similar enrichment in 5-HTT may be present in the IL which could account for 
the most prominent effect of 5-HTT inhibition in this region. PL and IL arbors may also 





processes, such as node formation and branch elongation are underway in the IL, while 
these processes may occur at an earlier, or later, time window in the PL region. This in 
turn could explain the IL-specific arborization changes in PN-FLX mice.  
The enhanced sensitivity of the IL region is not limited to early-life FLX 
treatment as IL hypertrophy is also generated by other anxio- and depresso-genic 
paradigms. For instance, both chronic mild stress and brief uncontrollable stress, in 
adulthood, cause a retraction in the apical trees of IL pyramidal neurons, as evidenced by 
significantly reduced branch numbers and length, relative to unstressed animals (Radley 
et al., 2004; Cook and Wellman, 2004; & Radley et al., 2005; Liston et al., 2006; 
Izquierdo et al., 2006; Farrell et al., 2010). One study of the effects of chronic stress on 
IL arborization demonstrated a specific effect on neurons that projected to the entorhinal 
cortex and not in those projecting to the basolateral nucleus (BLA) of the amygdale 
(Shansky et al., 2009). It would be interesting to know whether similar dissociations exist 
in PN-FLX mice as it would provide insight into the specific corticolimbic circuits that 
are altered with early-life disruption of serotonergic tone. Together, these findings 
demonstrate that IL dendritic arbors are particularly sensitive to manipulations of either 
5-HT or to factors that elicit emotional dysfunction. Indeed, stress itself has been shown 
to increase 5-HT levels in various brain regions, including the mPFC (Mokler et al., 
2007; Mo et al., 2009). Thus the stress-induced and PN-FLX-generated hypotrophy of the 
IL may occur via similar mechanisms. Furthermore, while adult stress-induced changes 
in mPFC morphology are reversible (Radley et al., 2005; Goldwater et al., 2009), early-
life stress has long-term and stable consequences on mPFC dendritic arbors (Murmu et 





fortifies the existence of critical time windows in the development of the structural 
properties of neurons in the mPFC, during which manipulations affecting 5-HT can result 
in permanent changes to mPFC structure.  
 Why the structural changes are observed specifically in layer 2/3 is a question of 
note that may shed light into the putative mechanism by which 5-HT affects dendritic 
arbor formation in cortical neurons. Early-life 5-HT-mediated signaling via the 5-HT3A 
receptor (5-HT3AR) is extremely important in proper maturation of the dendritic arbors 
of cortical layer 2/3 neurons (Chameau et al., 2009, Smit-Ritger et al., 2011a). The 
mechanism by which this occurs is dependent on Cajal-Retzius (CR) cells that release the 
glycoprotein reelin in a 5-HT3AR-dependent fashion. Reelin in turn acts to inhibit the 
extent to which dendritic elaboration occurs. Thus, 5-HT3AR genetic loss, 
pharmacological inhibition or anti-reelin antibody administration, all result in 
hypercomplexity of cortical neurons in layer 2/3 (Chameau et al., 2009). Conversely, 
increased activation of the 5-HT3AR due to increased 5-HT levels, for instance, would 
result in reduced complexity of apical arbors, and would be congruent with the dendritic 
phenotype of PN-FLX mice, especially in light of the fact that CRs are present and active 
in the first two postnatal weeks. Indeed, it has been shown that the decreases in dendritic 
arborization of mice treated with FLX in early (embryonic) development, can be reversed 
by pharmacological inhibition of the 5-HT3AR, and this hypotrophy does not occur in 
FLX-treated 5-HT3AR-/- mice (Smit-Rigter et al., 2011). Since CR cells reside in the 
superficial layers of the cortex (marginal zone/layer 1) it is understandable why its 
dendritic effects, via soluble reelin release, are limited to the near-by layer 2/3 neurons. 





thought to mediate its effects on dendritic arborization (Chameau et al., 2009), may be 
higher in IL region. This too may account for the fact that changes in PN-FLX mice are 
limited to the IL layer 2/3 region.  
Taken together, our morphological data suggest that, as hypothesized, 5-HT acts 
during development to affect the maturation of mPFC structure. Furthermore, our 
findings underscore the neurotrophic properties of 5-HT, and demonstrate that the effects 
5-HT on dendritic growth cannot be generalized, but rather are dependent on various 
factors such as location (layer-specificity) of the neuron, type of arbor (basilar vs. apical), 
which are likely reflective of differences in receptor types and responsivity of each region 
to 5-HT mediated trophic effects.  
 
Aim 1a (ii).    Electrophysiological changes  
Concomitant to the changes in cytostructure, we find alterations in physiological 
properties of mPFC pyramidal neurons from PN-FLX mice. In the IL, for example, we 
see a marked reduction in the frequency of spikes generated in response to current 
injections (Fig. 2.18) indicating that IL neurons from PN-FLX mice are significantly less 
excitable than those of controls. Conversely, we find that PL pyramidal neurons from 
PN-FLX mice are more excitable, as they yield an increased number of spikes in 
response to current injections (Fig. 2.19). Thus, the electrophysiological footprint of early 
life perturbations of serotonergic tone is a change in the balance between IL and PL 
excitability resulting in a putative decrease in the IL/PL output ratio.  
The question that arises next is how does 5-HT, acting during development, lead 





understanding of the mechanisms underlying excitability are needed. Spike responses to 
current injections are influenced by passive electrical properties of neurons such as their 
resting membrane potential (RMP) and input resistance (Rin) (Kandel et al., 2000; Part II, 
Chapter 8). Thus, excitability changes in PN-FLX mice could be due to 5-HT-mediated 
changes in these parameters. However, in IL neurons we find no differences in any of the 
intrinsic properties measured [RMP, Rin, membrane capacitance (Cm), spike amplitude 
and rheobase] (Table 2.1). Whereas in the PL we find a reduction in rheobase values 
signifying that PL neurons from PN-FLX mice have lower thresholds for spike 
generation, which is congruent with their enhanced excitability. The spike amplitude of 
PL neurons of PN-FLX mice is also significantly reduced and likely reflect changes in 
the cellular mechanisms underlying the currents that generate spikes, such as variations in 
number of VG sodium channels or receptor activation/inactivation properties (Kandel et 
al., 2000; Part II, Ch. 9), which may be influenced by 5-HT.                                                                   
The lack of difference in Rin and Cm in both IL and PL neurons is particularly 
interesting as it may reveal the relationship between the morphological and physiological 
changes in PN-FLX mice. The morphological properties of a neuron can potentially 
influence its physiology, by affecting surface-area (SA) dependent intrinsic properties 
such as Rin and Cm, which in turn can affect the neuronal responses to current pulses 
(Kandel et al., 2000; Part II, Ch. 7-9). The lack of changes in these SA-dependent 
parameters, may suggest that the cytoarchitectural changes caused by early-life 
perturbations to 5-HT may be concomitant, but not causal, to the physiological phenotype 
of PN-FLX mice. A major caveat to this interpretation is that the technique we employed 





unable to capture changes in dendritic area, despite them being prominent in the region 
proximal to the soma (Fig. 2.7). Moreover, the effect of morphological changes on 
physiology, may not be related to changes in intrinsic properties, but may impact the SA 
over which synapses, receptors and channels are expressed. This in turn could affect 
firing properties of a neuron and could be addressed experimentally by measuring spine 
density and channel/receptor expression via staining studies. An alternate means by 
which 5-HT could influence mPFC physiology is by affecting the repertoire of receptors 
and channels expressed at the surface of IL neurons later in adulthood. Variations in the 
balance between voltage-gated (VG) sodium, potassium and chloride channels on IL 
neurons could affect their excitability, without affecting resting neuronal properties such 
as Rin and RMP. For instance, various receptors, such as the metabotropic glutamate 
receptor 5 (mGluR5), N-methyl-D-Aspartate (NMDA) receptors, M-type potassium (K+) 
channel or the β-adrenergic receptor (β-AR) influence the intrinsic properties and/or 
excitability of mPFC neurons (Burgos-Robles et al., 2007; Mueller et al., 2008; Santini 
and Porter, 2010; Fontanez-Nuin et al., 2011). Although this has not been addressed 
experimentally, early-life 5-HT levels may impact the expression of these receptors in a 
stable and long-lasting manner such that their adult levels are altered, thereby affecting IL 
and PL neuronal physiology. Indeed, there is evidence that PN-FLX may in fact have 
such long-lasting effects on the expression of specific receptors and signaling molecules 
in adult neurons in the dorsal raphe nucleus (Neil Gray, unpublished results). Thus it is 
plausible it may similarly change affect receptor expression in the mPFC. 
Indeed, the ability of circumscribed changes in 5-HT levels during development 





has been shown that modulating 5-HT levels in embryonic development, alters receptor 
expression and ligand-binding well after birth (Azmitia, 1987). Early life stress, which 
has been shown to alter 5-HT levels in various limbic structures, also has long term 
effects on receptor mRNA editing and expression of intracellular signaling molecules 
such as G-proteins (Englander et al., 2005; Bhansali et al., 2007). Moreover, the impact 
of early-life changes in 5-HT is not limited to cells in the mPFC, as neurons in other 
regions, such as in the dorsal raphe nucleus, also have altered physiology after PN-FLX 
treatment (Emanuela Morelli, unpublished results). These data support the idea that 
physiological properties of neurons in the mPFC, and other regions, are under the 
influence of 5-HT during the early post-natal period.  
Preliminary data reveals that a similar IL and PL physiological phenotype is 
found in 5-htt -/- mice (Goodfellow et al., unpublished data). Although such 
comprehensive physiological studies have not been conducted in humans, imaging 
studies have revealed similar alterations in the activity of the mPFC in “s” allele carriers 
and depressed/anxious patients. For instance, diminished activity, as measured by glucose 
metabolism, cerebral blood flow and blood oxygen level dependence (BOLD) based 
fMRI studies suggest that there indeed are activity and physiological changes in the 
human PFC in patients with emotional dysfunction (Price and Drevets 2010). 
Additionally, post-mortem studies in depressed patients show reductions in mPFC 
neuronal activation as evidenced by reduced expression of immediate early genes such as 
sif268, egr1, c-fos and arc in regions analogous to the IL in rodents (Covington III et al., 
2010). Thus, altered mPFC physiology may be an endophenotype of depression and 





structural and functional changes in the mPFC with the 5-htt -/-  and “s” allele carriers, 
but who only experience altered 5-HT in development, it is likely that the physiological 
changes observed in the animals/humans experiencing constitutive 5-HTT hypofunction 
result as a consequence of developmental changes.  
An important caveat is that although we see differences in intrinsic excitability of 
mPFC neurons, our experiments do not assess network effects or extent of input onto 
these neurons, which would influence their in-vivo physiology. For example, although IL 
neurons may display blunted intrinsic excitability, they may receive enhanced excitatory 
input which may compensate for their diminished firing propensity. Thus, the extent of 
excitatory and inhibitory input on these cells is also an important consideration when 
characterizing their physiological phenotype. This excitatory/inhibitory balance could be 
gauged experimentally, by measuring the number of mini excitatory vs. inhibitory post-
synaptic potentials (mEPSPs and mIPSPs) in these neurons. Moreover, although we 
know that given a certain input, IL and PL neurons from PN-FLX mice have blunted and 
enhanced responses, respectively, our experiments to do not directly address the afferent 
projections that recruit these regions during specific behavioral paradigms. For instance, 
afferent input from the hippocampus (Farinelli et al., 2006; Garcia et al., 2008) and 
medio-dorsal thalamus (Herry et al., 1999; Li et al., 2004; Hugues and Garcia, 2007) are 
recruited during fear learning and extinction, and the extent to which these afferents 
communicate with the mPFC may predict how well an animal learns to extinguish 
learned fear. As an example, long-term potentiation at HC-mPFC synapses and BDNF 
release from hippocampal afferents in the mPFC are both important in acquisition of fear 





may be changes in afferent input that could compensate for, or perhaps enhance, the 
effect of the physiological changes in the mPFC of PN-FLX mice.  
Finally, the directionality of the changes in mPFC neuron firing are also revealing 
and provide a putative mechanism for the etiology of the affective and fear-related 
phenotypes of PN-FLX. The importance of mPFC neuronal firing in fear-related 
behaviors, particularly in the fear extinction learning and recall has been well-
characterized (summarized in Table 2.1). Extinction recall, for example, is associated 
with a pronounced increase in burst firing in the IL region of the mPFC (Milad and 
Quirk, 2002; Santini et al., 2008; Rabinak et al., 2008; Santini and Porter, 2010). As such, 
manipulations that that dampen IL excitability produce fear extinction deficits (Sierra-
Mercado et al., 2006; Farrell et al., 2010; Santini and Porter, 2010; Sierra-Mercado et al., 
2011). Conversely, enhanced PL excitability is associated with deficits in fear extinction, 
and in order for successful extinction learning to take place the PL needs to be silenced 
(Vidal-Gonzalez et al., 2006; Santini et al., 2008; Burgos-Robles et al., 2009; Sierra-
Mercado et al., 2011).  
These data suggest that IL recruitment and PL suppression is required for 
suppression of the fear-conditioning memory, and for recall of the extinction training. 
This fact is congruent with the known connectivity of these mPFC subregions to the 
amygdala—another region whose output is shown to modulate fear-related behaviors 
(Phillips and LeDoux, 1992; LeDoux, 2003). The IL sends excitatory projections to 
inhibitory GABAergic neurons that reside in the intercalated cell layer and to the 
basolateral amygdala (BLA) itself (Fig 2.33). Thus, enhanced IL output increases 





hypothalamus, bed nucleus of the stria terminals (BNST) and periacqueductal gray 
(PAG) mediates the physiological effects of fear such stress-hormone release, autonomic 
changes and freezing responses. Conversely, PL output increased excitation of key nuclei 
within the nucleus, such as the BLA and the central nucleus, which in turn enhance fear 
responses. Thus, this change in IL/PL excitability, would affect the mPFC-amygdala 
circuitry in a manner that would enhance fear-related behaviors in PN-FLX mice. This 
hypothesis was directly tested in the subsequent section. 
 
 
Table 2.2. Summary of work in the field that demonstrates the opposite influence of 
infra- and pre-limbic regions on activation of the amygdala on fear behaviors (Quirk et 
al., 2000; Santini et al., 2003; Vidal-Gonzalez et al., 2006, Farrell et al., 2010; Sierra-
Mercado et al., 2010).  
 
Aim 1a (iii).    mPFC functional output 
Although PN-FLX mice display pronounced structural and physiological changes 
in the IL and PL, these changes may not necessarily affect mPFC output, if, for instance, 
there are compensatory changes in afferent input or local network activity in this region. 
To address this, we directly probed mPFC function by using a well-characterized mPFC-





2006). We found that PN-FLX mice display pronounced deficits in both fear extinction 
learning and its subsequent recall (Figs. 2.24, 2,25), demonstrating that the 
structural/physiological changes in the mPFC are associated with altered mPFC function, 
as hypothesized. Based on our electrophysiological findings and the circuitry presented in 
Fig. 2.33, the blunted extinction learning and recall phenotype of PN-FLX mice is 
consistent with a decreased IL/PL output. For instance, pharmacological inactivation and 
anatomical lesions of the IL, which essentially replicate, in an extreme manner, the IL 
hypofunction observed in PN-FLX, phenocopy the PN-FLX fear extinction deficits 
(Sierra-Mercado et al., 2006; Farrell et al., 2010; Santini and Porter, 2010; Sierra-
Mercado et al., 2011) . Likewise, norepinephrine, via the β-adrenergic receptor (β-AR), 
enhances IL intrinsic excitability, thus, inhibition of β-ARs in the IL decreases its output 
and consequently results in pronounced extinction deficits (Mueller et al., 2008). It was 
also shown that IL excitability is positively correlated with extinction recall (Santini et 
al., 2008). Interestingly, the retraction of the IL apical arbors that occurs with chronic 
stress is also associated with extinction deficits (Miracle et al., 2006; Izquierdo et al., 
2006) and a negative correlation between extent of IL hypertrophy and extinction 
learning/memory was found   (Izquierdo et al., 2006). Enhancements of PL activity, via 
microstimulation, which mimic the hyperfunction of the PL neurons from in PN-FLX 
mice result in extinction recall deficits (Vidal-Gonzalez et al., 2006; Sierra-Mercado et 
al., 2011). Administering the M-type K+ channel agonist, flupirtine, directly into the IL 
region, reduces its intrinsic excitability, mimicking the PN-FLX phenotype and also 
phenocopies the extinction recall deficits of PN-FLX mice (Santini and Porter, 2010). 





of FLX mice are causal to their fear-extinction phenotype and indicated changes in mPFC 
output resulting from the morphological/physiological changes in this region. 
Congruently, deficits in fear recall have also been characterized in 5-htt -/-  mice 
that share both the morphological and physiological mPFC phenotypes of PN-FLX mice 
(Wellman et al., 2007) and also exhibit blunted fear extinction behaviors. A similar 
correlation exists between changes in mPFC structure/function has been described in 
human “s” allele carriers and a higher vulnerability to developing PTSD ( Lee et al., 
2005; Kilpatrick et al., 2007) an anxiety disorder in which the prominent characteristic is 
the inability to extinguish traumatic memories. Our data suggest that the diminished 
ability to quench traumatic memories may be due to dysfunctional mPFC output due to 
altered serotonergic tone during development. Thus, drugs that may correct the putative 
imbalance in output ratio of specific substructures of the mPFC may provide benefits as 
therapeutic agents or adjuncts, in treatment of PTSD.  
An important consideration is that other brain regions also play a role in 
extinction learning and recall, although their involvement have not been as thoroughly, 
nor reliably, characterized. For instance, the HC has been shown to affect extinction and 
learning behaviors (Corcoran et al., 2005; Milad et al., 2007; Peters et al., 2010). Thus, 
although we are using this behavioral paradigm to test for changes in mPFC function, we 
cannot rule out that the deficits in extinction behaviors we see are also due to other brain 
regions. Indeed, the crosstalk between regions such as the mPFC and HC will be 
discussed in detail in the last chapter of this thesis. 
Interestingly, PN-FLX mice also show deficits in fear expression itself, as 





following cued fear conditioning (Fig.2.24). The expression of fear in response to the cue 
is classically thought to be dependent on amygdala function (Phillips and LeDoux, 1992), 
which suggests that PN-FLX mice may also have alterations in amygdala activity. 
Indeed, structural and imaging findings in 5-htt -/-  and “s” allele carriers suggest that the 
amygdala might be another locus of dysfunction in mice and humans that experienced 
altered serotonergic tone during development  (Hariri et al., 2002; Pezawas et al., 2005; 
Wellman et al., 2007). Although this hypothesis merits further investigation, we have not 
addressed these question directly in the current body of work for several reasons. First, 
the deficits in freezing to cue lack replicability, as they were not present in a subsequent 
cohort tested while the pronounced extinction deficit phenotype were still observed 
(Appendix C, Fig. C.1-C.2). Secondly, cued freezing deficits may not necessarily indicate 
amygdala dysfunction. For instance, it was shown that altering the excitation/inhibition 
(E/I) balance in the mPFC results in potent deficits in freezing to cue (Yizhar et al., 
2011). Thus, the changes in IL/PL output, or rather as yet uninvestigated changes in the 
excitation vs. inhibitory input into these regions, could potentially result in the cued 
deficits that are observed independent of any changes in the amygdala. Similarly, 
microstimulation studies have shown that enhancing output from the IL or PL can 
differentially modulate the expression of conditioned freezing to cue (Milad et al., 2004; 
Vidal-Gonzalez et al., 2006) and tetradotoxin mediated inhibition of the ventral HC also 
produces cued freezing deficits (Bast et al., 2001). To address these questions one could 
better characterize the E/I ratio in mPFC neurons of PN-FLX mice, by, for instance 
quantifying the frequency and number of mini excitatory and inhibitory post-synaptic 





and physiology in the amygdala to determine whether early-life 5-HT alterations also 
affect the functional development of this region is also warranted.  
In this section, we have shown that the structural and morphological properties of 
mPFC neurons are set during a critical time window in post-natal development, and are 
under direct influence of 5-HT. As such, perturbing normal serotonergic tone during 
these critical time windows, permanently alters their structure/morphology which in turn 
affects mPFC output resulting in changes in mPFC-mediated behaviors such as extinction 
learning and recall. As the mPFC is involved in emotional regulation, in the next section 
we test whether the change in mPFC output we have characterized can also account for 
the affective phenotype of PN-FLX mice.  
 
Aim 1b.    Testing the link between the mPFC and behavioral changes 
In the final part of our work, we investigated whether the changes in the mPFC 
are causal to the anxiety and depression-like phenotype of PN-FLX mice. There is 
copious correlative data implicating the mPFC in anxiety and mood regulation (Manji et 
al., 2001; Davidson 2002; Krishnan and Nestler, 2008; Price and Drevets, 2010). Altered 
volume, activity, and connectivity of this region have been characterized in patients with 
anxiety and/or depression and in mouse models of these conditions (Mayberg et al., 2003; 
Hariri et al., 2006; Wellman et al., 2007; Adhikari et al., 2010; Price and Drevets, 2010; 
Sotres-Bayon and Quirk, 2010). Despite their high correlative value, these data leave 
several questions unanswered. For instance, are the mPFC changes observed in 
depressed/anxious patients merely endophenotypes of the emotional dysfunction? Or do 





emotional behaviors? A substantial amount of data indicate that the mPFC is a primary 
locus of dysfunction in humans and rodents with emotional disorders and may be causal 
to their affective dysfunction. For instance, prevention of components of the mPFC 
morphological and/or physiological phenotype precludes the affective dysregulation in 
mouse models of anxiety/depression (Zoladz et al., 2008; Smit-Rigter et al., 2011). 
Moreover, therapeutic regimes used to treat affective dysfunction alter some of the mPFC 
phenotypes of depressed/anxious patients (Mayberg et al., 2003; Drevets et al., 2008; 
Moore et al., 2009; Covington III et al., 2011). Treatment with the SSRI class of anti-
depressant/anxiolytic drugs, for example, can reverse the structural/physiological changes 
in the mPFC (Mayberg et al., 2000; Seminowicz, 2004; Bessa et al., 2009). Whereas 
DBS, a technique that has been shown to have efficacy in patients with treatment-
resistant depression, suppresses the pathological activity within the mPFC network 
(Mayberg et al., 2003; Mayberg et al., 2005; Lozano et al., 2008; McNeely et al., 2008, 
Hariri et al., 2006). Additionally, the extent of mPFC volume reduction and physiological 
responses has predictive value in risk for anxiety and depression in humans and mice 
(Coryell et al., 2005; Izquierdo et al., 2006; Boes et al., 2010; Farb et al., 2011). 
Inclusively, these data indicate that the mPFC changes are likely causal to 
anxiety/depressive phenotypes. 
Relating these findings back to the PN-FLX mice, who also display similar 
structural, physiological and functional changes in the mPFC, we asked whether their 
affective phenotype occurred as a result of focal mPFC alterations. Since the prime 
footprint of PN-FLX treatment is a decrease in the IL/PL output ratio, we recapitulated 





changing this IL/PL balance in control mice is sufficient to phenocopy several (enhanced 
anxiety in novel open field, Fig 2.28; and suppressed feeding behavior in NSF test, Fig 
2.30), but not all aspects (no change in helplessness behavior in SE test, Fig. 2.32) of 
their anxiety and depression-like behavior. In a somewhat complementary experiment, it 
was shown that optogenetic stimulation of the mPFC results in improvement in some 
depression-like behaviors in a rodent stress-model of enhanced anxiety/depression 
(Covington III et al., 2010). In particular, stimulation of the mPFC prevented the stress-
induced reduction in anhedonic responses and social exploration, both of which are 
components of the depression. The fact that we cannot exactly replicate the phenotype of 
the PN-FLX mice, suggests that there are other brain regions, whose developmental 
trajectories are influenced by 5-HT, that may also be altered in PN-FLX mice, and may 
also contribute to the emotional phenotype of PN-FLX mice. 
Inclusively, our data suggest that the structural/physiological changes in the 
mPFC of PN-FLX mice arise as a consequence of early-life manipulations of 5-HT 
levels. These changes in turn alter corticolimbic circuits such as those between the mPFC 
and amygdala and possibly other behaviorally relevant structures such as the 
hippocampus (discussed in next chapter). As corticolimbic circuits mediate affective 
behaviors, their dysregulation result in an enhancement in anxiety and depression in PN-
FLX mice. This model is presented in Fig 2.33, which an emphasis on amygdala 







Fig. 2.32. Model depicting how changes in connectivity between mPFC the amygdala 
and other brain regions may result in the enhanced fear, anxiety and depressive behaviors 
in PN-FLX mice.  
 
Concluding remarks 
To return to our initial hypothesis, we have found that 5-HT affects the 
development of both structural and physiological properties of the mPFC and that this 
region is a major locus of dysfunction in mice that have experienced altered serotonergic 
tone during development. Moreover, we have demonstrated that the altered maturation of 
the mPFC is directly associated with its dysfunctional output, and thus provides a 
mechanism by which early-life alterations in serotonergic tone impact adult behaviors. 
Our data can be related to findings in “s” allele carriers, who display similar structural 
and functional changes in the mPFC. The altered function of the mPFC may act as a 
liability and may interact with further environmental stressors to enhance the 





model by which genetic or environmental factors that alter serotonergic tone during 

























CHAPTER 3: Serotonin modulates the structural and functional development of the 
hippocampus 
Introduction  
In this chapter we explore the second part of our principal hypothesis, by 
investigating whether early-life manipulations of 5-HT levels yield changes in the 
structure and function of the hippocampus (HC).  
Although best known for its effects on cognitive processes (Scoville and Milner, 
1957; Moser and Moser, 1998; Burgess et al., 2002; Bannerman et al., 2004; Bars and 
Gage, 2007), the HC has been well-characterized as a modulator of affective state and is 
a major locus of change in humans and rodents displaying anxiety and depression-like 
behaviors (Moser and Moser, 1998; Pothuizen and Feldon, 2004; McHugh et al., 2004; 
Andersen et al., 2006; Fanselow and Dong, 2010). Data in support of this dual role of the 
HC comes from lesions studies that indicate a functional dichotomy along the septo-
temporal axis of the HC. Cognitive behaviors are primarily affected by dorsal HC lesions 
(Moser et al., 1993; Hock and Bunsey, 1998; Matus-Amat et al., 2004; Hunsaker and 
Kesner, 2008) while ventral lesions affect emotional behaviors (Kjelstrup et al., 2004; 
Bannerman et al., 2004; Nascimento and Carobrez, 2007; Yoon and Otto, 2007; Trivedi 
and Cooper, 2009). As such, HC-dysfunction can result in both the affective and 
cognitive phenotypes of anxiety and mood-disorders. Indeed, changes in the HC are 
observed in human patients and mouse models displaying dysregulated affective 
behaviors. Such changes occur at the level of gene expression (neurotransmitters, stress-





neurogenesis and cellular viability (Gould et al., 1992; Boldrini et al., 2009; Yau et al., 
2001; McKittrick et al., 2000; van der Hart et al. 2002; Alfonso et al., 2004; Czeh and 
Lucassen, 2007; Cai et al., 2008; Molteni et al., 2010; Weaver et al., 2010; Ivy et al., 
2010; Andrus et al., 2010). 
Although there are diverse changes in the HC, the most replicable and robust 
findings correlated with emotional dysregulation, to date, are alterations in HC structure. 
In particular, significant reductions in HC volume have been characterized in human 
patients, non-human primates and rodent models exhibiting depression and anxiety-like 
behavior (McEwen et al., 1997; Margarinos et al., 1996; Sheline et al., 1996; Sapolsky, 
2001; Rusch et al., 2001; Bremner et al., 2006; Lee et al., 2009) and the degree of these 
changes are directly correlated with severity of symptoms and/or illness duration (Sheline 
et al., 1996; MacQueen et al., 2003; Bremner et al., 2006; Taylor Tavares et al., 2007). A 
prime contributor to the reduced volume is thought to be a retraction in neuropil (Reagen 
and McEwen, 1997; Stockmeier et al., 2004; Czeh and Lucassen, 2007) as dendritic 
material of HC neurons is reduced in patients and mouse models with affective disorders 
(Stockmeier et al., 2004; McEwen et al., 1997; Magarinos et al., 1995; Soetanto et al., 
2010). For instance, 5htt -/- mice and those lacking the brain derived neurotrophic factor 
(BDNF), display altered dendritic complexity of HC neurons (Appendix B, Fig. B.3, B.4 
& B.7; Chen et al., 2006), fortifying the correlation between structural changes in the HC 
and emotional dysregulation. In 5-htt -/- mice, changes are found in the cornu ammonis 3 
(CA3) and dentate gyrus (DG) sub-regions of the HC (Appendix B, Fig. B.3, B.4 & B.7). 
A recent immunohistological study on human post-mortem brain slices showed an 





depression scores, suggesting a similar correlation between HC structure and emotional 
dysfunction exists in humans (Soetanto et al., 2010). Congruently, pro-depressive and 
anxiogenic factors, such as stress-exposure cause dramatic reductions in the complexity 
of the dendritic arbors of HC neurons (Watanabe et al., 1992; Magarinos et al., 1995; 
Vyas et al., 2002; McLaughlin et al., 2007; Martinez-Tellez et al., 2009). Conversely, 
interventions that protect against depression/anxiety, such as environmental enrichment, 
antidepressant agents and anxiolytic drugs prevent/reverse these structural alterations, 
and concurrently preclude the associated negative impact on emotional behaviors 
(Watanabe et al., 1992; McEwen et al., 1997a; Magarinos et al., 1999; van der Hart et al., 
2002; Czeh et al., 2001; Czeh et al., 2002; Santarelli et al., 2003; Hutchinson et al., 2010; 
Price and Drevets, 2010).  
In conjunction to the changes in dendritic architecture, altered density of dendritic 
spines (regions of synaptic input) are also associated with pro-depressive/anxiogenic 
interventions such as restraint stress, learned helplessness (inescapable shock exposure) 
and social defeat stress (Sunanda et al., 1995; Magarinos et al., 1997; Sousa et al., 2000; 
Kole et al., 2004; Hajszan et al., 2009; Magariños et al., 2011). Congruently, 
interventions that protect against emotional dysfunction, such as antidepressant treatment, 
often reverse/prevent these changes in spine density (Watanabe et al., 1992; Hajszan et 
al., 2010), bolstering the correlative relationship between the structural changes in the HC 
and affective and cognitive dysfunction. Given the demonstrable impact of the HC in 
regulating affective state, and since PN-FLX mice have robustly dysregulated affective 
behaviors, we hypothesized that they display alterations in HC dendritic architecture and 





During the early post-natal period, development of the HC is highly influenced by 
5-HT. Most of HC development occurs post-natally in rodents, at a time when 
serotonergic innervation to this structure is already present (Swann et al., 1989; Segal et 
al., 1990; Tansey et al., 2002; Gaspar et al. 2003; Andersen et al., 2006). Additionally, 
many 5-HT receptors are greatly up-regulated during this period suggesting that in the 
first few weeks of life, the ability of the HC to sense, and be influence by, 5-HT is both 
prominent and growing (Grove and Tole, 1999; Gross et al., 2002; Sodhi and Sanders-
Bush, 2004). Indeed, early-life modulation of 5-HT has been shown to alter the 
expression of key genes know to regulate development and growth of HC neurons, such 
as those regulating the expression of growth factors, including BDNF (Molteni et al., 
2010; Zhou et al., 2008), receptors (Sibille et al., 2000; Sodhi and Sanders-Bush, 2004), 
synapses (Gaspar et al., 2003; Wellman et al., 2007) and cytoskeleton-associated proteins  
(Yuen et al., 2005; Bonnin et al., 2007; Chameau et al., 2007). In summary, as the HC is 
a modulator of emotional state and because its development is influenced by 5-HT, we 
hypothesized that the early-life dysregulation of serotonergic tone in PN-FLX mice 
would impact the proper development of the HC, resulting in altered dendritic complexity 
and spine densities. In this regard, we addressed the following aims: 
Aim 2: Does development-specific disruption of serotonergic tone alter the maturation of 
the hippocampus? 
i. Are there structural alterations within the hippocampus? 
a. Are there changes in dendritic arborization? 






Furthermore, to probe whether the potential structural changes in the HC would impact 
its output, we used HC-sensitive behavioral tests, specifically those that probe cognitive 
functioning in PN-FLX mice. The use of these tests was contingent on the fact that apart 
from its validated role in the regulation of the affective component of depression and 
anxiety, the HC has also been implicated in the cognitive phenotypes of these psychiatric 
disorders (Sapolsky 2001; Fanselow and Dong, 2010;). For instance, the deficits in 
learning, memory, and spatial cognition described in humans with anxiety, depression, or 
those experiencing prolonged stress, can be generated via HC manipulations (Moser et 
al., 1993; Phillips and LeDoux, 1992; Burgess et al., 2002). HC lesions or altering HC-
output via external inhibition/stimulation have a direct impact on learning and memory, 
especially those requiring the acquisition and recall of contextual and spatial information 
(Moser et al., 1993; Phillips and LeDoux, 1992). Similar deficits in learning and memory 
are well-characterized in human patients under chronic stress and those that have 
depressive symptoms and pathological levels of anxiety (Austin et al., 2001; Lupien et 
al., 2007; Bossini et al., 2008; Withall et al., 2010). Patients with mood disorders also 
often display altered spatial cognition. For instance, patients with unipolar depression 
fare worse in tasks that require spatial recognition (Gould et al., 2007; Taylor Tavares et 
al., 2007). Interestingly, the aforementioned changes in volume, dendritic complexity and 
spine density in the HC are correlated to the cognitive deficits in some humans and 
rodent studies (Bremner et al., 2007; Sheline et al. 2003, O’Brien et al., 2004), suggesting 
that changes in HC structure can affect HC function and, thus, may be probed using 





sensitive cognitive tests to probe both HC function and to characterize potential changes 
in PN-FLX cognitive function. Specifically, we asked: 
Aim 2  ii. Is the functional output of the hippocampus altered? 
a. Are there changes in spatial learning and memory? 




Three male mice from each post-natal treatment group were anaesthetized and 
sacrificed in adulthood (P90-P100).  Brains were excised and processed with the Golgi 
stain as previously described (Rosoklija et al., 2003). Golgi-stained sections were 
visualized using light microscopy. Pyramidal neurons in the CA3(ventral CA3c) and DG 
granule cells, whose cell bodies were in the stratum granulosum (ventral DG, both inner 
and outer blades) and were identified based on morphology and location using the 
“Comparative Cytoarchitectonic Atlas of the C57BL/6 and 129/Sv Mouse Brains” (Hof 
et al., 2000) as a guide. Fully impregnated cells with intact arbors that lay in the middle 
of the z-plane were selected as candidates for analysis. From this candidate pool, 6-10 
cells per region/mouse were manually traced using Neurolucida (MBF Bioscience, 
Williston, VT).  Neuroexplorer software (MBF Bioscience) was used to perform Sholl 
analysis on the tracings to determine dendritic complexity, in which number of nodes, 
intersections and total dendritic material were designated as the dependent measures. To 





the soma was measured using the maximum Sholl radius as a measure of the length of 
dendritic trees. One-way analysis of variance (factorial or repeated measures, as 
indicated) was used to analyze data.  
Dendritic spine analysis 
A subset of cells used in the dendritic complexity study were chosen for analysis 
of spine number and density (n = 2-5 cells/mouse; 3 mice per treatment group). 
Neurolucida software was used to trace the apical dendrites of neurons and to manually 
specify the location of spines. Spines of all major classes (mushroom, thin and stubby and 
thorny excrescences) were included in the analysis and not distinguished from each other. 
Neuroexplorer was used to analyze traces and determine total number of spines. Total 
spine density was calculated by dividing total number of spines by total amount of 
dendritic material present. Only the first 200 μm of the apical trees were analyzed as past 
this point spines were increasingly harder to visualize which made the tracings and 
designation of spines above 200 μm unreliable.  This proximal region was also of special 
interest as it receives input from the DG via the main processing circuit in the HC, the 
trisynaptic pathway.  
Morris Water Maze 
Male PN-FLX and PN-Veh mice were tested in a water maze procedure 
consisting of the following stages: 1.) habituation 2.) visible platform training 3.) hidden 
platform training and 4.) probe trials.  





The habituation phase consisted of two days, with mice undergoing two trials per 
day. On day 1, behaviorally naïve mice were placed into a bucket (38 x 35 x 26 cm) that 
contained a clear, plexiglass platform in its center (height: 20 cm), and was filled with 
water to about 0.5 cm above the platform. Water temperature was maintained between 
23-25 °C. Mice were placed, one at a time, into the corner of the bucket (trial 1 = 
southeast corner; trial 2 = northwest corner) and allowed to freely swim and explore 
within the bucket in order to find, and mount, the platform. The trial was designated as 
over when a mouse had remained on the platform for 30 consecutive seconds. The clock 
was reset whenever the mouse jumped off the platform. Day 2 of habituation was the 
same as day 1 except that the bucket was filled with water that was made opaque using 
non-toxic white gesso, and in that the criteria used to end a trial was that the mouse had 
been on the platform for 20 consecutive seconds.  
Stage 2: Visible platform training 
After habituation mice were tested to determine their ability to find a platform in a 
larger water maze which consisted of a circular, white plastic reservoir (1.7 m diameter, 
approximately 2 feet high) filled to a depth of approximately 20 cm (1 cm above 
platform) with water that was maintained between 21-25 °C. The water was made opaque 
using white, non-toxic gesso. Water was stirred at the start and middle of the day, to 
prevent settling of the gesso and to ensure opacity of the water.  Black curtains 
surrounded the pool and each curtain panel had distinct patterns placed on them to act as 
visual (extra-maze) cues. The cues included: 1.) green stripes across the wall 2.) fuchsia 
squares in a symmetrical pattern 3.) a large pink cross with curlicues drawn on it 4.) blue 





mounted digital camera was positioned directly above the pool and the focus/zoom was 
adjusted to ensure the entirety of the pool was captured. Images from the camera were 
captured and stored by a tracking computer, hidden behind the curtains. The pool was 
divided into four quadrants (North, West, South and East). A clear plexiglass platform 
(14.6 cm in diameter) was placed in the NW quadrant (15cm away from the pool edge) of 
the pool and whose location was indicated by a tall visible, multi-colored flag. The 
location of the platform was fixed for the entire experiment. Each mouse underwent three 
trials per day for two days. During a trial, a mouse was placed into the water (with their 
heads facing the pool wall) at one of the four designated release sites each roughly 
equidistant from the platform location. All mice were released at the same start location 
for a given trial, but release sites were different between trials. Mice were allowed to 
swim and find the location of the submerged platform. If a mouse found, and remained 
on the platform for a 15 consecutive seconds, the trial was considered over and the mouse 
was retrieved. Each trial lasted for a maximum of 120s. If mice were unable to find the 
location of the visible platform in that time, they were gently guided towards it by the 
experimenter. After each trial, mice were directly placed into a warmed cage containing 
tissue paper, to help dry them off and to keep them warm. After an entire cage of mice 
was run, all mice were transferred from the warming cage to their home cage. During the 
trials, mice were recorded and tracked using the AnyMaze video tracking system from 
Stoelting (Wood Dale, IL). AnyMaze was also used to analyze video files and determine 
the latency to find the platform and swim speed. Heat-maps generated from AnyMaze 
were also obtained to visualize the swim trajectory of mice during a trial. 





This stage was performed using the same experimental set up as for visible 
platform training. In this case, however, the location of the platform was not indicated by 
any visible marker and was thus was hidden from view as it was fully submerged under 
opaque, white water. Mice underwent 3 trials per day for a period of eight days with 
about a 60 minute inter-trial interval. At the start of each new trial/session, pool water 
was stirred using a squeegee to ensure homogenous opacity of the water. Mouse release 
sites were selected in a random manner and were different for each trial within a day; 
however, all mice had the same start location within a session. 
Mice were recorded for a maximum of 120 s after which data collection terminated.  
However, if mice were unable to find the platform in that time, they were given an 
additional two minutes of unrecorded time to search for the platform. If a mouse was still 
not able to find the platform in the additional 2min period, the experimenter manually 
guided the mice towards the platform. In order to end a trial, a mouse had to remain on 
the platform for 15 consecutive seconds. Mice swim trajectories were tracked and 








Fig. 3.1  Cartoon of Morris Water Maze set up. Platform is represented by the smaller 
grey circle in the NW (green) quadrant. Distinct extra-maze cues were placed on the 
walls surrounding the pool. Modified image from Lynn Talton©, UCLA behavioral 
testing facility.  
Stage 4: Probe trials 
During probe trials, the platform was removed and mice were released into the 
pool and allowed to search for the platform for 90 s. Probe trial 1 was done on the 
morning of day 10, 24 hours after the last day of training, and all extra-maze cues used 
during the training session were left intact (P1, “full-cue” probe). After completion of P1, 
the platform was replaced in its initial position and mice were given three more hidden 
platform trials so that they would retain their memory of the platform’s location. On day 
11, the 2nd probe trial (P2, “partial-cue” probe) was conducted, in which 3 out of 5 of the 
extra-maze cues were removed from the wall/curtain, leaving only two (blue nitrile 
gloves and the fuchsia squares in the NE and SE quadrants, respectively). On day 12, all 





AnyMaze software was used to calculate the percent of time spent in the target (NW) 
quadrant, in which the platform was located during the training sessions. 
 
Contextual fear conditioning 
Conditioning was performed on male and female PN-Veh and PN-FLX mice 
between the ages of PN90-PN100, using equipment set up similarly to that previously 
described by Drew et al., 2010. Briefly, the conditioning context or context “A” consisted 
of conditioning chambers (ENV010MD, Med Associates, and St. Albans, VT) in which 
the metal grid floors and metal chamber walls were left exposed and unaltered, the 
interior chamber fan and house lights were turned on. Three drops of lemon scent 
(oil/essence) were applied to the interior of chambers using a cotton Q-tip at the start of 
each round. Mice were habituated for 5-10 mins in a separate room (a distance away from 
the room housing the conditioning chambers so as to prevent auditory or olfactory cues 
emanating from the shocking chambers from reaching the mice that were to be 
subsequently run). Habituation took place in plastic cages containing familiar corn 
bedding (same as that in the home cage). On the conditioning day (day 1), mice were 
placed into context “A” and allowed to explore freely for 180 s after which they received 
three scrambled foot shocks (duration: 2 s, intensity: 0.75 mA) delivered via the grid 
floors of the chambers. As depicted below, shocks were delivered with variable inter-trial 
intervals and mice remained in the chamber for an additional 30seconds before being 
removed and placed back in their home cage.  On day 2, mice were placed back into 







Fig 3.2 Contextual fear conditioning protocol. Red, jagged arrows represent 2ms, 0.75 
mA scrambled foot shocks delivered via the grid floor of conditioning chamber. “A” 
represents training context. 
 
Results 
Aim 2 i a.  Pronounced changes in dendritic structure of CA3 neurons from PN-FLX 
mice 
In the CA3, we found that, relative to PN-Veh controls, PN-FLX mice have 
significantly more condensed apical dendritic trees (F1, 43 = 7.359; p = 0.0096, Fig. 3.3) 
suggesting early-life exposure to FLX results in a retraction of the dendritic arbor. 
Despite having arbors that do not extend out as far as those of PN-Veh mice, the apical 
dendritic trees from PN-FLX mice are more branched as evidenced by their significantly 
higher total number of nodes, relative to controls (F1, 40 = 6.111; p = 0.0178, Fig. 3.4). To 
determine whether this increased branching was uniformly present throughout the extent 
of the arbor, or whether it was limited to a specific region along the tree, we plotted spine 





number of nodes in PN-FLX mice is present specifically in the region proximal to the 
soma, within the first 100μm from the soma (repeated measures one-way ANOVA: F1,31= 
4.669; p = 0.0385, Fig. 3.5). The increased branching of CA3 apical trees in the proximal 
arbor, was accompanied by increased number of intersections (trend effect: F1, 43 = 4.030; 
p = 0.0510, Fig. 3.6) and dendritic material (F1,41 = 6.120; p = 0.0176, fig. 3.7).  
However, when the total number of intersections and dendritic material (over the entire 
extent of the arbor) were measured, we found no significant differences between 
treatment groups (Figs. 3.8 and 3.9).  The lack of an overall difference in total number of 
intersections and dendritic material despite there being a significantly higher number of 
total branch points in PN-FLX mice suggests that either i.) the mean length of the apical 
branches of PN-FLX mice are shorter or that ii.) there is a higher frequency of shorter 
length branches in the apical arbors of CA3 neurons from PN-FLX mice. To broach this 
question directly, we looked at the mean length of the branches and found no significant 
differences between PN-Veh and PN-FLX mice (Fig. 3.10). However, when we look at 
the % of short (<500µm) vs. long branches (>500μm), we find that PN-FLX mice have a 
significantly higher number of shorter branches and a significantly lower number of long 
branches (F1,46 = 6.733; p = 0.0127, Fig. 3.11). Thus, our morphological data indicate that 
the PN-FLX mice have more compact, but bushier CA3 apical arbors relative to their PN-
Veh counterparts.  
Unlike the apical arbors, the basilar CA3 dendritic trees of PN-FLX mice do not 
differ in how far they extend out from the soma, relative to controls (Fig 3.12). However, 
the basilar CA3 arbors of PN-FLX are more branched than controls, as indicated by their 





number of branching seems to be higher specifically within the first 150 μm of dendritic 
tree proximal to the soma (60 μm to 150 μm, effect of treatment: p = 0.0092, Fig. 3.14). 
This increased branching is also accompanied by significantly higher total intersections 
(F1,26 = 5.413; p = 0.0280, Fig.3.15) and total dendritic material (F1,27 = 3.719; p = 
0.0644, Fig.3.16). The increase in intersections is uniform throughout the entire extent of 
the dendritic arbor (Figs 3.17). These data suggest that unlike the apical trees that are 
stubbier, the basilar arbors of CA3 neurons from PN-FLX mice are more branched and 
more expansive than those of PN-Veh mice. This fact is corroborated by the finding that 
the mean branch length of CA3 basilar arbors from PN-FLX mice are significantly larger 
relative to PN-Veh mice (F1,35 = 6.094; p = 0.0186, Fig. 3.19). A model encapsulating the 
changes in both the apical and basilar CA3 arbor in PN-FLX mice is presented in Fig 
3.20.  
A second region in which we detected alterations in dendritic complexity in SERT 
KO mice was the DG. Thus, we sought to determine whether similar changes were 
observable in PN-FLX mice. In the DG we looked at alterations in dendritic complexity 
in the primary DG cell type, the granule cells, which solely possess apical arbors. We 
found no significant differences in dendritic complexity of the apical arbors of granule 
cells between PN-FLX and PN-Veh mice, as they had comparable number of nodes (Fig. 
3.21), intersections (Fig. 3.22) and total amount of dendritic material (Fig. 3.23). The 
mean distance to which DG arbors extended from the soma were also comparable 
between treatment groups (Fig. 3.24).   
Informed from the morphological analysis of 5-htt -/- mice, who do not display changes 





CA1 region in PN-FLX mice, and thus our analysis was focused exclusively on the CA3 
and DG regions. Morphological findings in the HC are summarized in Fig. 3.25. 
 
 
Fig. 3.3. PN-FLX mice have significantly reduced length of CA3 apical dendritic trees, 
indicating that their arbors do not extend out as far as those of controls (** p = 0.0096). N 
= 22-23 cells/treatment, 3 mice/group.  
  
Fig. 3.4. PN-F LX mice have significantly higher number of nodes in the CA3 apical 






Fig. 3.5. The increased number of nodes in CA3 apical arbors of PN-FLX mice is 
primarily within the first 100µm proximal to the soma (*p = 0.0385). N = 19-20 
cells/treatment, 3 mice/group.  
 
 
Fig. 3.6. Despite no overall differences in intersection number, PN-FLX mice display 
significantly higher number of intersections in the first 100µm proximal to the soma, the 
same region in which the pronounced increase in number of nodes is observed. (# p = 






Fig. 3.7. Despite no overall differences in dendritic material, PN-FLX mice display 
significantly higher number of intersections in the first 100µm proximal to the soma, the 
same region in which the pronounced increase in number of nodes and intersections is 
observed. (*p =.0176)N = 19-20 cells/treatment, 3 mice/group.  
 
 
Fig. 3.8. No differences in the total number of intersections between PN-FLX and PN-








Fig. 3.9. No differences in the total dendritic material between PN-FLX and PN-Veh 
mice. N = 19-20 cells/treatment, 3 mice/group.  
 
 
Fig. 3.10. Mean dendritic length in the apical CA3 arbor is not significantly different 







Fig. 3.11. Histogram displaying percentages of each branch type (categorized by length) 
in CA3 apical arbor. PN-FLX mice have a significantly higher % of medium length 
branches and a significantly lower % of long branches relative to controls. (* p = 0.0127) 
N = 19-20 cells/treatment, 3 mice/group.  
 
 
Fig. 3.12. No differences in how far arbors extend from the soma are observed between 







Fig. 3.13. PN-FLX mice have significantly higher total number of nodes relative to PN-
Veh controls. (*p = 0.0337). N = 11-13 cells/treatment, 3 mice/group.  
 
 
Fig. 3.14. The changes in total number of nodes in PN-FLX mice start in the proximal to 
medial region of the basilar CA3 dendritic tree. (**p < 0.001). N = 11-13 cells/treatment, 







Fig. 3.15.  PN-FLX mice have significantly higher total number of intersections relative 




Fig. 3.16.  PN-FLX mice have a trend increase (p = 0.0644) in total dendritic material 







Fig. 3.17. PN-FLX have higher number of intersections from the proximal (starting at 
50µm) to the very distal aspect of the basilar arbors. N = 19-20 cells/treatment, 3 
mice/group.  
 
Fig 3.18. Branches in the CA3 basilar trees of PN-FLX mice are significantly longer than 







Fig 3.19. Model depicting the differences in both the apical and basilar arbors of CA3 
neurons from each treatment group. 
   
 
Fig. 3.20. No effect of treatment on total number of nodes (A) in DG granule cell arbors 
and no treatment effects on number of nodes at any point along the arbor (B). N = 18 







Fig. 3.21. No effect of treatment on total number of intersections in DG arbors (A) and   
no treatment effects on number of intersections at any point along the arbor (B). N = 18 
cells/treatment, 3 mice/group.  
 
 
Fig. 3.22. No effect of treatment on total dendritic material of DG arbors (A) and no 
treatment effect on total dendritic material at any point along the arbor (B). N = 18 







Fig. 3.23. The average distance that the apical arbors of DG granule cells extend from the 
soma, is not different between PN-FLX and PN-Veh mice. N = 18 cells/treatment, 3 
mice/group.  
 
Fig. 3.24. Summary of morphological findings in the HC. Changes in dendritic 
complexity are found in the CA3 of PN-FLX mice, and not in the DG and likely not in 







Aim 2 i b. PN-FLX mice have fewer spines and reduced spine density in CA3 apical 
arbors 
As a preliminary readout for the extent of input to the CA3 region we examined 
the number and density of spines on the apical dendritic arbors. We limited our analysis 
to the CA3 region as this was the area in which we identified the most pronounced 
changes in dendritic arborization. In this initial 200μm segment of the apical arbor, we 
find that PN-FLX mice have a reduced total number of spines, relative to controls 
(overall trend effect: F1,20 = 3.681; p = 0.0694, Figs. 3.26 and 3.27), with a significant 
reduction 130 to 150 µm from the soma (F1,20 = 5.409; p = 0.0307). PN-FLX mice also 
display significantly reduced spine density (total number of spines/total amount of 
dendritic material) relative to PN-Veh controls (F1,19 = 15.266; p = 0.0009, Fig. 3.28 and 
3.29). As is visible from the spine number or density vs. distance from soma graphs 
(Figs. 3.27 and 3.29), the decreased number and density of spines observed in CA3 
neurons from PN-FLX mice is uniform throughout the entire extent of the 200μm 
segment analyzed. 
 
Fig. 3.25. PN-FLX mice have a decrease in the total number of spines in the CA3 apical 






Fig. 3.26. The decrease in spine number in PN-FLX mice is throughout the 200µm region 




Fig. 3.27. PN-FLX mice have a significantly lower spine density in the CA3 apical arbor, 







Fig. 3.28. The pronounced decrease in spine density in PN-FLX mice is throughout the 
extent of the 200µm region analyzed. (**p = 0.0009). N = 10-12 cells/treatment, 3 
mice/group.  
 
Aim 2 ii a.  PN-FLX mice display pronounced deficits in spatial learning and 
memory 
To determine whether the structural changes in the HC of PN-FLX mice affect its 
functional output, we utilized the HC-sensitive Morris Water Maze paradigm. During the 
habituation phase both PN-Veh and PN-FLX mice were able to find the location of the 
central platform and successfully mount it within 10s +/- 5s. Mice required a maximum 
of three attempts to remain on the platform for 20 consecutive seconds, and based on 
experimenter observations, no obvious differences in any of the aforementioned 





In the visible training phase, the location of the platform, which was situated in 
the NW quadrant of the pool, was indicated by a tall, multi-colored flag. On day 1 of 
visible training, mice took an average of 62.036 +/- 5.078 seconds (averaged over two 
trials) to find the location of the platform and to mount it successfully, with no detectable 
effect of post-natal treatment on this parameter (Fig. 3.30). On day 2 of the visible 
platform task, the mean latency to find the platform was again comparable between 
groups and was significantly decreased relative to day 1 (effect of time: F1,24 =  92.366; p 
< 0.0001, Fig. 3.30) suggesting that mice learned and recalled the position of the platform 
from day 1’s training session and/or established a faster swim trajectory to the platform. 
No differences in average swim speeds between groups on either day of visible training 
were observed (Fig. 3.31).  
During the hidden platform training stage, the flag was removed such that mice 
could solely rely on extra-maze cues to navigate and determine the platform’s location. 
On day 1 of hidden training, mice from both treatment groups took an average of 40.789s 
+/- 4.515s to find the platform, which was significantly more time relative to the second 
day of visible training (effect of flag removal: F1,25 = 38.153; p < 0.0001), suggesting that 
the removal of the flag made the task more challenging. Although a noticeable decrease 
in latency with each consecutive training day was observed in both groups (effect of time: 
F1,15 = 6.627; p < 0.0001), PN-FLX mice took significantly longer overall to locate the 
platform, compared to controls, over the first 8 days of the hidden training session (F1, 15 
= 6.697; p = 0.0206, Fig 3.32). On the final (9th) day of training, however, PN-FLX mice 





hidden training session, PN-FLX mice had significantly increased swim speeds relative to 
controls (F1,21 = 15.113; p = 0.008, Fig. 3.33). 
We next looked at long term retention of the platform location by conducting a 
probe trial on day 10 (P1, full-cue probe). Despite being trained to the same degree on 
day 9, PN-FLX mice spent significantly less time searching for the platform in the target 
(NW) quadrant, relative to controls (F1, 25 = 8.705; p = 0.0068, Fig. 3.34A and B). 
However, both groups did show a preference for the target region over the other 3 
quadrants, spending significantly more that 25% of their time in this area (one tailed t-
test, hypothesized mean ≤ 25: PN-Veh: t12 = 8.139; p < 0.0001; PN-FLX: t12 = 4.407; p = 
0.0004, Fig. 3.34C). 
To increase the difficulty of the task in order to determine if this would further 
separate the two groups in their ability to locate the platform, we removed three of the 
extra-maze cues, leaving solely the cues in the NE and SE corners of the room housing 
the pool. In this partial-cue probe trial (P2), a significant and comparable drop in % time 
spent in the target quadrant was observable in both treatment groups (effect of partial cue 
removal: F1,24 = 49.648; p < 0.0001). A treatment effect on this parameter was also  
detected with PN-FLX mice spending significantly less time in the target region relative 
to controls (F1,24 =5.748; p = 0.0246, Fig. 3.35A and B). With the removal of some of the 
extra-maze cues, the preference that both groups of mice previously showed for the target 
quadrant was no longer present as they did not spend more than 25% of their time in this 
region (Fig. 3.35C). Upon closer examination, we determined that PN-FLX mice seemed 
to have a selective preference for the two other quadrants in which the cues were still 





regions (one tailed t-test, hypothesized mean ≤ 25. NE quadrant: t12 = 2.807; p = 0.0079, 
Fig. 3.35C; SE quadrant: t12 = 4.107; p = 0.0007, Fig. 3.35C). PN-Veh mice did not show 
a preference for any quadrant, spending ~25% in each of the 4 regions. 
On the final day of testing, mice were given a so-called “no-cue” probe trial (P3) 
in which all extra-maze cues were removed. With no cues present, both PN-Veh and PN-
FLX mice do not show a preference for the target quadrant, spending only 19.897% +/- 
2.066 of their time in this region (Fig. 3.36A and B). Instead, both groups of mice show a 
preference for the NE quadrant which contained a non-salient extra-maze cue (computer 
wire) spending significantly more than 25% of their time in this region (one tailed t-test, 
hypothesized mean ≤ 25. both groups combined: t28 = 6.274; p < 0.0001, Fig 3.36C). No 
significant differences in swim speeds were detected between PN-FLX and PN-Veh mice 
in any of the three probe trials (Fig. 3.37). 
Thigmotactic behavior (as measured by percent time spent in the outer 10 cm 
periphery of the water maze) of both groups of mice, during each of the probe trials 
describe above, was measured. PN-FLX mice displayed a trend effect of higher levels of 
thigmotaxis during the full- and partial cue probe trials (effect of treatment: p = 0.0790). 
An increase in thigmotaxis was also observable in both treatment groups with increasing 
removal of extra-maze cues (effect of cue removal: p <0.0001) suggesting that the 
periphery was the “default” region in the case when animals had difficulty locating the 







Fig. 3.29. No differences between groups in latency to platform during visible training 
session (in which platform is marked with a flag) on either day 1 or day 2 of training. 
Significant effect of time (p < 0.001) indicates that both treatment groups learn to find the 
visible platform faster on day 2. N = 11-12 mice per group. 
 
 
Fig. 3.30. No differences in latency to platform during visible training session (in which 
platform is marked with a flag) on either day 1 or day 2 of training. Significant effect of 
time indicates that both treatment groups learn to find the visible platform faster on day 2 






Fig. 3.31. PN-FLX mice have significantly longer latencies to locate the hidden platform 
over all 9 days of the training session. (* p = 0.0206). N = 7-8 mice/treatment.  
 
Fig. 3.32. PN-FLX mice have significantly higher swim speeds during the 9 day hidden 







Fig. 3.33. Full-cue probe trial. (A) PN-FLX spend significantly less time in the target 
quadrant, relative to PN-Veh mice, when all extra-maze cues remain present (**p = 
0.0068). (B) Heat maps displaying representative tracts of PN-Veh and PN-FLX mice 
swim tracts. Red circle within target (NW) quadrant indicates platform. (C) % time spent 
in each of the four quadrants. N = 12-13 mice/group.  
 
Fig. 3.34. Partial-cue probe trial. (A) PN-FLX spend significantly less time in the target 
quadrant, relative to PN-Veh mice, when all extra-maze cues remain present (*p = 





swim tracts. (C)  Graph displaying % time spent in each of the quadrants, indicating a 
preference for the NE and SW quadrants. N = 13 mice/group. (C) Graph displaying % 
time spent in each of the quadrants.  PN-FLX mice spend significantly more than 25% of 
time in the NE and SE quadrant (# p < 0.01 for one-tailed t-test). N = 12-13 mice/group.  
 
 
Fig. 3.35. No-cue probe trail. (A) PN-FLX and PN-Veh mice spend comparably little 
time in the target quadrant. (B) heat maps displaying representative swim tracts of PN-
Veh and PN-FLX mice. (C) Graph displaying % time spent in each of the quadrants. 
Both PN-Veh and PN-FLX mice spend significantly more than 25% of time in the NE 








Fig. 3.36. No differences in swimming speed between treatment groups during all three probe 
trials. N = 12-13 mice/group.  
 
Fig. 3.37. Thigmotactic behavior during the three probe trials, PN-FLX vs. PN-Veh mice. Effect 






Aim 2 ii b.  PN-FLX mice have deficits in contextual fear conditioning 
To verify the changes in HC-mediated we behaviors PN-FLX mice underwent contextual 
fear conditioning. A specific HC-dependent version of this test, which involves adequate pre-
exposure to the training context (180 s) was employed (Drew et al., 2010). PN-FLX mice display 
no significant differences, relative to PN-Veh controls, in either baseline freezing (Fig. 3.38) or 
in acute responses to the three shocks during the conditioning phase of the protocol (Fig. 3.39). 
An incremental rise in % freezing to each subsequent shock was observed for both groups (F1, 2 = 
188.319; p < 0.0001), with no main or interaction effects of/with treatment. However, 24 hours 
after conditioning, when mice were returned to the training context in which they received the 
shocks, PN-FLX mice have significantly reduced freezing relative to controls (F1,48 = 32.488; p < 
0.0001, Fig. 3.40) throughout the entire 180s session (Fig. 3.41).  
 
Fig. 3.38. PN-FLX and PN-Veh mice have comparably low levels of baseline freezing to the 








Fig. 3.39. No differences in acute freezing responses to shocks during fear conditioning session 
between treatment groups. N = 24-16 mice/group. (**effect of shocks: p < 0. 0001) 
 
Fig. 3.40. PN-FLX mice have significantly lower % freezing to context 24 hours after fear 







Fig. 3.41. PN-FLX mice have significantly lower % freezing to context 24 hours after fear 





CA3 apical dendrites 
We have found that early-life perturbation of serotonergic tone significantly impacts the 
cytoarchitectural development of HC neurons suggesting that, as hypothesized, the structural 
maturation of the HC is influenced by 5-HT levels in development. Specifically, mice that 
experienced elevated serotonergic tone in early post-natal life display altered dendritic 
complexity of both CA3 apical and basilar arbors (Fig. 3.20). Apical dendrites of PN-FLX mice 
do not extend out as far as those of PN-Veh mice (Fig. 3.3) but have increased branching in the 





3.11). This region of the CA3 apical arbor is well-characterized as it receives the most 
pronounced afferent input from the DG via the mossy-fiber (MF) pathway (Amaral and Witter, 
1989; Andersen et al., 2006), which comprises the first segment of the trisynaptic pathway 
(TSP), a term used to describe the serial connections from the DGCA3CA1 regions of the 
HC (Andersen et al., 2006). Thus, any changes in the complexity of dendrites in this proximal, 
apical segment of CA3 neurons could signify changes in the TSP connectivity, which in turn 
could influence HC function as the TSP is the primary processing circuit within the HC 
(Andersen et al., 2006). It is possible however, that despite there being more dendritic material in 
this region, MF input may itself be altered which could either compensate for, or potentiate, the 
PN-FLX dendritic phenotype. To address this question, we assessed dendritic spine number and 
density in this region proximal, apical region. Although we included all spine types in our 
studies, the primary class in this region had a thick and large morphology, characteristic of the 
so-called “thorny excrescences” which represent the post-synaptic aspect of mossy fiber (DG)-
CA3 synapses (Gonzales et al., 2001; Andersen et al., 2006). We find that PN-FLX mice have a 
reduced number and density of spines in this region (Fig. 3.26-3.29), suggesting that DG input 
into the CA3, and thus TSP connectivity, has been diminished. The decreased spine number and 
density are likely due to synaptic-scaling, in which the enhanced branching of apical arbors 
elicits a compensatory decrease in number of synapses in order to maintain input equilibrium 
(Turrigiano, 2010). This finding also suggests that the number and density of spines along the 
dendritic arbor of HC neurons is under the influence of 5-HT in early development. Most likely, 
the dendritic arborization changes occur as a direct consequence of altered 5-HT signaling, 





 The loss of synaptic input into the CA3 can potentially affect its electrophysiological properties, 
as it may reflect a shift in the excitatory/inhibitory balance within the CA3. In particular, the 
neurotransmitter released at mossy-fiber-CA3 terminals is glutamate, which, via primarily its 
ionotropic kainate receptors, results in an excitation of CA3 neurons (Contractor et al., 2000; 
Kamiya et al., 2002). Thus, decreased MF input into the CA3 would likely result in reduced 
excitation of CA3 neurons which could subsequently dampen their output. Thus, an important 
next step would be to fully characterize the effects of the morphological/synaptic change on the 
physiological properties of CA3 neurons from PN-FLX mice. These physiological experiments 
would inform us of whether structural changes in the CA3 have ramifications on the 
physiological properties of these neurons and whether they represent a loss- or gain of function 
phenotype.  
In line with the above findings, 5-htt-/- mice display a similar CA3 apical dendritic 
phenotype, but in their case the increase in total number of nodes is accompanied by significant 
changes in total intersections and dendritic material (Appendix B, Fig. B.3), implying that 5-htt-
/- mice have a higher number of branches with greater mean length than controls. 
Mechanistically, it may be that 5-HT during early post-natal development is important in setting 
the number of nodes (our data suggest it increases node number), but prolonged elevation in 5-
HT levels, such as those present in 5-htt -/- mice, may be responsible for continued branch 
elongation. This would explain why PN-FLX mice have a higher node number, but less extended 
branches. These data also suggest that certain morphological parameters, such as node number, 
are less plastic and set primarily during the early-post natal critical period, while changes in 





Changes in CA3 arbors have also been described in post-mortem studies in humans with 
emotional dysfunction. For example, depressive symptoms were correlated with decreases in 
CA3 dendritic and synaptic proteins such as microtubule-associated protein 2 (MAP-2), 
synaptopodin and spinophilin in mood-disorder patients (Law et al., 2004; Soetanto et al., 2010). 
These findings emphasize the strong association between the morphological/synaptic properties 
of the CA3 and affective dysfunction. 
The apical CA3 dendritic arbor, is also particularly sensitive to pro-depressive and 
anxiogenic manipulations. For instance, chronic stress paradigms produce a pronounced 
retraction of CA3 apical dendrites and a decrease in CA3 spine density, similar to what we 
observe in PN-FLX mice (Watanabe et al., 1992; Magarinos et al., 1997; Sousa et al., 2000; Kole 
et al., 2004; McLaughlin et al., 2007; Magariños et al., 2011). In this regard, the PN-FLX 
phenotype, is identical to that of chronically stressed mice, who also display a stress-induced 
enhancement of depression and anxiety-like behaviors and cognitive deficits (Bowman et al., 
2002; Conrad et al., 2003; Gregus et al., 2005; McLaughlin et al., 2007; Luine et al., 2007). This 
fortifies the idea that changes in the CA3 are strongly associated with affective dysfunction and 
suggests there is a causal relationship between them.  
 
CA3 Basilar dendrites 
The basilar arbors of PN-FLX mice are more complex than those of controls, as 
evidenced by the significantly higher number of nodes, intersections and dendritic length (Figs. 
3.12-3.18). These findings imply that, during the post-natal development of these arbors, 5-HT 





CA3 basilar phenotype of PN-FLX mice is identical to that of 5-htt-/- mice, who also display 
bushier, more expansive arbors (Appendix B, Fig. B.5). Additionally, our analysis was done on 
pyramidal neurons in the CA3c region, the area within the blades of the DG. Tracing and 
immunohistological studies have shown that the basilar arbors of CA3c neurons receive 
significant input form the mossy-fiber pathway (Andersen et al., 2006). This finding further 
fortifies the idea that TSP connectivity and function may be altered in PN-FLX mice. Along with 
mossy-fiber afferents, basilar arbors also receive input from other CA3 neurons in both the ipsi- 
and contra-lateral HC, in a fiber path termed the associational-commisural (A/C) pathway 
(Andersen et al., 2006). This fiber pathway composed of the recurrent collaterals from CA3 
neurons is thought to form an autoassociative network regulating the retrieval of memories, 
based solely on a small part or single feature of that memory (Gold and Kesner, 2005; Cravens et 
al., 2006). In particular, the (A/C)-recurrent collateral network has been shown to be important in 
cognitive tasks such as pattern completion and encoding of place/space (“spatial mapping”) 
(Leutgeb and Leutgeb, 2007; Nakashiba et al., 2008; Fellini et al., 2009). As such, this pathway 
is implicated in the acquisition of contextual and spatial information (Nakazawa et al. 2002). 
Thus, structural changes in the basilar CA3 arbors, may reflect disruptions in A/C connectivity 
and potentially alter the behavioral functions mediated by this pathway, such as spatial and 
contextual cognition (discussed in subsequent section).  
 
Dentate Gyrus 
PN-FLX mice do not exhibit any changes in morphology of granule cells within the DG 





significantly less complex granule cell arbors relative to WT controls (Appendix B, Fig. B.7). 
This suggests that the affective phenotype shared by both PN-FLX and 5-htt-/- mice is not likely 
due to changes in the DG as they do not share the granule cell structural phenotype. Since 5-htt-/- 
mice exhibit altered DG neuronal morphology, it is clear that the development and/or 
maintenance of the dendritic arbors of DG neurons is dependent on 5-HT. However, the lack of 
changes in the DG of PN-FLX mice implies that DG neurons may mature at a different period in 
development (outside the P2-P11 time window), relative to the CA3. Alternatively, the 5-HT 
receptor(s) that mediated the effects of 5-HT on dendritic arborization may not be expressed (or 
have limited expression) on the DG during the post-natal period in which we have 
pharmacologically altered 5-HT levels in PN-FLX mice, which would explain the lack of 
changes in the DG of PN-FLX mice, relative to controls.  
 
HC-mediated behaviors 
Next we asked whether the structural changes within the HC of PN-FLX mice affect its 
function using HC-sensitive behavioral paradigms including the Morris Water Maze (MWM) 
test and an associative contextual learning task (contextual fear conditioning). The MWM test 
requires mice to locate a hidden platform within a pool (“the maze”) using extra-maze cues. 
Lesions of the HC, especially those affecting the dorsal HC, result in pronounced deficits in this 
task as evidenced by longer latencies to find the platform (Moser et al., 1995; Cho et al., 1999; 
Broadbent et al., 2006). This is true only when mice are released at different locations along the 
pool edge, as was done in our protocol, which prevents the use of an egocentric strategy (in 





dependent strategies (Rudy and Sutherland, 1989). Instead, when salient extra-maze cues are 
present, and when mice are released at varying locations within the maze, they are forced to 
make complex configural representations of space in order to locate the platform (“allocentric” 
or configural strategy), which is contingent on HC-output (Rudy and Sutherland, 1989; Arns et 
al., 1999). In this specific task, we find that PN-FLX mice display pronounced deficits in 
learning the location of a hidden platform as evidenced by significantly longer latencies to find 
the platform, relative to controls (Fig. 3.32). As loss-of-function manipulations of the HC, such 
as lesions and pharmacological inhibition, result in similar spatial learning deficits, it is likely 
that the PN-FLX mice have diminished HC output, and that increasing 5-HT levels in early-life 
result in a hypofunction of the HC. 
Genetic inhibition of specifically the CA3 region, where we find the structural changes in 
PN-FLX mice, is sufficient to yield deficits in spatial cognition in the MWM test, despite the DG 
and CA1 regions being intact. For instance, mice with genetically silenced CA3 regions, due to 
conditional loss of the NR1 subunit of the excitatory glutamatergic NMDA-R (CA3-NR1-KO 
mice), have deficits in the MWM task (Nakazawa et al., 2002). Moreover, in these CA3-NR1-
KO mice, signaling in the DG-CA3 and CA3-CA1 synapses is intact, but the associational-
commisural (A/C) fibers representing the recurrent collateral CA3-CA3 connections have 
diminished signaling. This indicates a specific role of the A/C pathway in meditation of spatial 
cognitive behavior in the partial-cue probe trial of the MWM task. As previously mentioned, the 
dendritic changes in PN-FLX mice include regions that receive input form the A/C pathway. 
Thus our morphological and behavioral data indicate that early-life 5-HT levels are important in 
the maturation of the A/C circuit. This hypothesis could be directly addressed 





al., by stimulating the stratum radiatum of the CA3 region (that contains the A/C fibers) and 
recording in CA3 neurons in the stratum pyramidale. Taken together, these findings suggest that 
the structural changes in the CA3 of PN-FLX may be causal to their spatial cognitive deficits.  
To verify that the prolonged latencies in PN-FLX mice were indeed due to altered ability to 
make configural representations of space, and not due to changes in sensory acuity, motivation or 
swimming ability, we performed a non-HC version of the MWM, in which the platform’s 
location is clearly indicated by a large flag. In this visible platform version of the MWM test, 
PN-FLX mice performed as well as PN-Veh controls, as indicated by comparable latencies to 
find the platform and similar swim speeds (Fig. 3.30-3.31). The lack of difference in the visible 
training segment of the MWM test, suggests that PN-FLX mice do not differ from controls in 
their visual acuity or in comprehension of the task. Moreover, PN-FLX mice have significantly 
higher swim speeds and cover more distance during the hidden platform training phase (Fig. 
3.33), suggesting that their motivation to escape from the maze and onto the platform is intact, 
and may even be enhanced relative to PN-Veh controls. Despite this enhanced searching, 
however, PN-FLX mice still have longer latencies to find the hidden platform, validating the 
deficit in their ability to create spatial representations of the maze context in order to find the 
platform, using an allocentric strategy.  
In line with their spatial learning deficits, during the full-cue probe trial, PN-FLX mice 
display pronounced spatial memory deficits as evidenced by significantly less time in the 
target/platform quadrant, relative to controls (Fig. 3.34). When the spatial configuration 
surrounding the maze was altered by partial removal of extra-maze cues PN-FLX mice again 
spend significantly less time in target quadrant relative to controls (Fig. 3.35). Locating the 





memory in which a single or few elements of the spatial context are sufficient to recall the entire 
spatial context (Nakazawa et al., 2002; Leutgeb and Leutgeb, 2007; Nakashiba et al., 2008). The 
CA3 region has been shown to play a major role in pattern completion (Gold and Kesner, 2005; 
Cravens et al., 2006; Nakashiba et al., 2008; Fellini et al., 2009), and its A/C fibers composed of 
the recurrent collaterals of CA3 neurons are thought to form a network, in which positive 
feedback loops and Hebbian mechanisms, can support such complex processes as pattern 
completion (Gold and Kesner, 2005; Kesner, 2007; Gilbert and Brushfield, 2009; Myers and 
Scharfman, 2011). Indeed, the aforementioned CA3-NR1-KO mice have been shown to have 
specific defects in pattern completion that may underlie their deficits in ability to perform on the 
MWM task, especially under partial-cue conditions (Nakazawa et al., 2002). Thus, the poorer 
performance of PN-FLX mice, relative to controls, in the partial-cue trial, indicates diminished 
pattern-completion ability, likely related to the structural changes in their CA3 regions. Finally, 
in the “no-cue” trial, in which all extra-maze cues were removed, neither treatment group 
showed a preference for the target quadrant (Fig. 3.36), indicating that the extra-maze cues were 
necessary for the mice to correctly locate the target region which validates the hippocampal-
dependent nature of our protocol.  
Our behavioral findings suggest that PN-FLX mice display changes in HC-output as 
evidenced by their deficient spatial learning and recall abilities. Congruently, PN-FLX mice also 
display pronounced deficits in the ability to form rapid representations of space and context in an 
associative contextual conditioning task. Specifically, PN-FLX mice display deficits in freezing 
to the training context after a fear conditioning paradigm (Figs. 3.40-3.41) suggesting that they 
have difficulties in making rapid (with 180 s of context pre-exposure) configurations of novel 





to context (Phillips and LeDoux 1992; Chen et al., 1996; Corcoran and Maren, 2001; Bast et al., 
2001; Anagnostaras et al., 2001; Bast et al., 2003). The importance of specifically the CA3 
region in contextual freezing is also established, since mice with genetically inhibited CA3 
regions (CA3 TetX mice), display pronounced deficits in contextual freezing (Nakashiba et al., 
2008). The genetic technique used in the study by Nakazawa et al., allowed for reversibility of 
CA3 inhibition, and it was shown that restoring CA3 output rescued contextual deficits, 
suggesting a causal relationship between CA3 function and acquisition of contextual 
information. Similar deficits in contextual learning have been characterized in 5-htt-/- mice, who 
share the structural changes in the CA3 region observed in PN-FLX mice (Muller et al., 2011).  
Thus, the context deficits observed in both 5-htt-/- and PN-FLX mice likely result from the 
cytoarchitectural/synaptic changes in their CA3 regions.  
Although freezing to context is primarily attributable to altered HC-function, other 
structures such as the mPFC, amygdala and periacqueductal gray also affect contextual freezing 
(Philips and LeDoux, 1992; Morgan and LeDoux, 1995; Amorapanth et al., 1998; Ponnusamy et 
al., 2007; Yizhar et al., 2011). Thus, one cannot rule out the involvement of other regions in the 
contextual freezing deficits of PN-FLX mice. However, given their poor performance in the 
MWM test, which is more specific to HC-manipulations, it is likely that the decreased contextual 
freezing of PN-FLX mice is truly reflective of altered HC function, though changes in the 
aforementioned brain regions may exacerbate their deficits.  
A final point regarding the contextual fear deficits of PN-FLX mice is that they are 
somewhat hard to reconcile with the well-characterized enhancement in anxiety and depression 
behaviors displayed by these mice. If the response to freezing is solely dependent of emotional 





conditioning due to a putative increased reactivity to the stressful context-shock association. 
However, given the MWM data, the contextual deficits in PN-FLX mice are likely due to a 
diminished ability to learn spatial/contextual information, and are not as reflective of their 
emotional dysfunction. The dissociability of the affective and cognitive components of 
contextual fear conditioning have been established (Fanselow and Dong, 2010) and other mouse 
models of anxiety and depression similarly have diminished freezing to context (Muller et al., 
2011). 
 Conclusions and future directions 
In line with our main hypothesis, we have shown that modulation of serotonergic tone in 
early post-natal life impacts the maturation of the structural properties of the HC and these 
changes are directly correlated with altered HC output. In particular, we find that the 
development of the dendritic arbors and the density of spines in the CA3 sub-field of the HC are 
directly under the influence of post-natal 5-HT levels. Our findings also demonstrate that that the 
circuits underlying spatial/contextual cognition develop early on and are influenced by 
serotonergic tone. Indeed, given the high co-morbidity of cognitive and affective symptoms in 
mood disorder patients (Zakzanis et al. 1998; Hasler et al., 2004;; Ludewig et al., 2005; Gualtieri 
et al., 2008; Gohier et al., 2009), it is likely that the circuits mediating these two realms of 
behavior greatly overlap in the HC. Thus alterations to HC structure/function could account for 
both the affective and cognitive deficits in PN-FLX mice, and potentially in 5-htt -/- mice and 
“s” allele carriers as well. As PN-FLX mice display both anxiety/depression behavior and 
learning/memory dysfunction, this mouse model encapsulates both the affective and cognitive 





The data presented in this chapter suggest that the altered maturation of the CA3 in PN-
FLX mice likely contribute to their cognitive deficits. An important question that remains, 
however, is whether the altered structural/synaptic changes in the CA3, of PN-FLX mice are 
causal to (at least some component) of their affective phenotype? And,if so, by what mechanism? 
These questions will be the focus of future experiments in our laboratory, and some of the 
previously described mouse models could serve as useful tools in this regard. For instance, if the 
focal, loss-of-function changes in the CA3 are causal to the affective phenotype of PN-FLX 
mice, it is likely that CA3-TeTX and/or CA3-NR1-KO mice display similar anxiety and 
depression-like behaviors. This can be experimentally addressed using the same battery of tests 
employed in the characterization of the PN-FLX mice behavioral profile (OF, NSF, SE tests). 
Investigating the behavioral profile of CA3-TeTX or CA3-NR1 KO mice that were treated post-
natally with FLX or Veh would also prove informative. Specifically, if the changes in the CA3 
are causal to the emotional dysfunction observed in PN-FLX mice, it is likely that mice that 
already have genetically silenced CA3 regions may be immune to the effects of further PN-FLX-
mediated dysregulation of this region.  
Several lines of evidence suggest the CA3-specific changes would indeed impact the 
emotional behaviors of PN-FLX mice. First, the CA3 subfield, via its ubiquitous connections to 
other HC sub-regions, is an important modulator of the oscillatory theta activity in the HC 
(Vertes and Kocsis, 1997; Buzsaki, 2002; Villarreal et al., 2007; Yamaguchi et al., 2007). As 
mentioned in previous chapters, theta oscillations represent synchronized neuronal firing, 
indicative of network activity, and play an important role in the modulation of emotional 
behaviors. For instance, mice with enhanced anxiety and depression-like behaviors display 





2005). The synchrony between theta oscillations in two different regions, or theta coherence, 
between the HC and mPFC is also enhanced in anxiogenic conditions, and dysregulated 
connectivity between these regions is observed in mice displaying emotional and cognitive 
deficits (Sigurdsson et al., 2010; Adhikari et al., 2010). Thus, changes in the CA3 of PN-FLX 
mice may affect theta rhythms and/or coherence and may provide a mechanism by which the 
morphological (and potential physiological/connectivity) changes in the CA3 result in altered 
anxiety-like behavior of PN-FLX mice. 
Furthermore, the CA3 can be considered a central unit in the HC as it communicates with 
the CA1 via Schaffer collateral fibers, has back-projections to the DG, and also receives direct, 
monosynaptic input from the superficial layers of the entorhinal cortex via the temporoammonic 
pathway (Andersen et al., 2006; Scharfman, 2007). In addition, it also sends ubiquitous 
collaterals to other CA3 neurons on the both the ipsi- and contra-lateral sides via the A/C 
pathway and is part of the main processing circuit in the HC, the trisynaptic pathway (Andersen 
et al., 2006). Alterations in the CA3 could potentially affect many, or all, of these pathways, and 
thus a focal change in the CA3 can theoretically affect a great many behavioral processes 
mediated by these various circuits, including those that involve regulation of affective state. The 
ubiquitous connectivity of the CA3 with other regions may also explain why a seemingly small 
and limited change in one sub-field of the HC can result in a profound effect on behavior.   
Finally, if the changes in the CA3 are common to “s” allele carriers and other patients 
with affective/cognitive dysfunction observed in depression and anxiety, this information could 
potentially inform clinical interventions. For instance, drugs that target specifically the CA3 
region of the HC may have value in the treatment of some symptoms of depression and anxiety. 





Thus, despite the post-natal period being a critical period in the development of CA3 arbors, it is 
likely that this window may be re-opened in adulthood and any pathological 
structural/physiological changes in this region could be corrected with adult interventions. Thus, 
pharmacological agents that increase CA3 plasticity may prove beneficial in reversing the CA3-
mediated effects on anxiety, depression and cognitive behaviors. Indeed diminished plasticity of 
the brain is implicated in affective disorders, and agents that enhance plasticity have therapeutic 

















CHAPTER 4: Discussion 
Our data demonstrate that the structural and functional maturation of brain regions and 
corticolimbic circuits that underlie affective and cognitive behaviors are influenced by 5-HT 
signaling during a critical developmental epoch. Specifically, we find that increased 5-HT 
signaling from P2-11leads to morphological and physiological changes in the adult mPFC and 
HC that correlate with anxiety/depression-like behaviors, and cognitive impairment, in later life.  
 
Our model 
Our findings support the idea that emotional and cognitive components of anxiety and 
depression disorders, which manifest in adulthood, may have neurodevelopmental origins and 
their ontogeny is dependent on abnormal serotonergic tone during development.  
According to our model (Fig. D.1), factors that alter 5-HT signaling from P2-11 in mice, 
or equivalent species-specific critical periods, whether genetic (mutations or functional 
polymorphisms in 5-htt, tph, maoa, 5-ht1a receptor etc.) or environmental (stress, exposure to 
serotonin-modulating agents such as SSRIs), permanently alter corticolimbic circuits that 
mediate adult affective and cognitive behaviors. Thus, if individual, or combinations of, 
modulatory factors lead to increased serotonergic tone during the critical period, they 
subsequently augment the vulnerability to anxiety and depression disorders later in life. Thus, the 
paradoxical enhancement in depression and anxiety behaviors displayed by 5-htt -/- mice and 
human “s” allele carriers are likely caused by increased serotonin signaling during P2-11 and the 
third trimester of gestation (comparable to the P2-11 period in mice, in terms of developmental 











In the mPFC, the fingerprint of increased serotonergic tone during the critical post-natal 
epoch, is a decrease in IL/PL output ratio, which when mimicked in control mice, is sufficient to 
phenocopy some, but not all, of the anxiety and depression-like phenotype of PN-FLX mice. In 
the HC, augmentation of serotonin levels during development generate a CA3-hypofunction 
phenotype. Although we have not addressed this directly, we predict that the structural/synaptic 
changes in the CA3 of PN-FLX mice are also causal to some components of their emotional 
dysfunction and cognitive deficits. The fact that neither the mPFC of HC would contribute to the 
entirety of the PN-FLX phenotype, underscores the synergy between these two regions in the 
etiology of the anxiety and depression behaviors observed in PN-FLX mice. Indeed, 
corticolimbic connectivity has been shown to be paramount in behavioral responses during 
anxiety, and is dysregulated in mice models of emotional dysfunction (Price and Drevets, 2010; 
Adhikari et al., 2010). Thus, future work will investigate how mPFC-HC connectivity is affected 
by increased developmental serotonin signaling, and how potential changes in communication 
between these regions, act in concert to alter behavior.  
 
Additional alterations 
Although our focus has been primarily on the mPFC and HC, other behaviorally relevant 
structures may also be altered and warrant further investigation. For instance, our findings 
suggest that the structural and physiological alterations in the mPFC of PN-FLX mice, impact 
amygdala activity through altered top-down control. This is supported by our fear extinction data 
and is reviewed in the connectivity model presented in Chapter 2, Fig. 2.33. Our model may thus 





Heinz et al., 2005; Price and Drevets, 2010). However, we have not directly assessed amygdala 
morphology and physiology and thus cannot exclude that developmental serotonin signaling also 
modulates the maturation of this region. Thus, future work will close this gap in knowledge and 
investigate the consequences of increased serotonin signaling during P2-11 on amygdala 
maturation. 
Additionally, the mPFC and HC project to other brain structures which are also important 
in regulation of emotional state, and the physiological responses to stress and fear, such as the 
hypothalamus, nucleus accumbens and the ventral tegmental regions (Antoniadis et al., 2001; 
Davidson et al., 2002; Seidenbecher et al., 2003; Vertes, 2004; Quirk et al., 2006; Price and 
Drevets 2010). As such, it is imaginable that a primary dysfunction in the mPFC and HC may 
elicit secondary changes in these brain systems, thereby contributing to symptoms observed in 
patients with mood and anxiety disorders, such as dysregulated stress response, blunted affect 
and anhedonia.  
Finally, the maturation of the 5-HT system itself is altered in mice that experienced 
disrupted serotonergic tone in development (Kinney et al., 1997; Maciag et al., 2006a and 2006b; 
Neil Gray, Emanuela Morelli and Tessa Hirschfeld-Stoler, unpublished results). This finding 
emphasizes the known auto-trophic properties of 5-HT (Gaspar et al., 2003; Sodhi and Sanders-
Bush, 2004). For instance, PN-FLX mice display a hypotrophic serotonergic system with 
reduced serotonergic input into the mPFC and HC (Neil Gray, unpublished results). Thus, to 
fully understand the etiology of the affective and cognitive behaviors of mice or humans that 
experienced altered serotonergic tone during development, the contributions of both the 
presynaptic (5-HT) and post-synaptic (areas receiving 5-HT input, such as the mPFC and HC) 





in the adult brain, in the modulation of anxiety, depression and cognitive behaviors.  It is likely 
that the pre- and post- synaptic changes work collaboratively to generate the enhanced 




Although our approach to disrupt normal serotonergic tone during development is to 
increase it via FLX administration, others in the field have used depletion methods to address the 
role of serotonin in affective/cognitive circuit formation (Yan et al., 1997; Popa et al., 2008; 
Hohmann et al., 2007; Zhou et al., 2008; Hamon et al., 2011; Fernandez and Gaspar, 2012). 
Evidently, both increasing and dampening 5-HT tone during development have deleterious 
effects on brain maturation and function. This suggests, that there is a normal range of serotonin 
that is required during development in order to ensure proper maturation of brain structures such 
as the mPFC and HC, and either abnormally high or low levels of serotonin during critical time 
windows in development may alter the structural and functional maturation of 
emotional/cognitive circuits in the brain. 
 Furthermore, the role of 5-HT in circuit formation does not seem to be limited to those 
mediating emotional behaviors, as a similar requirement for proper 5-HT signaling has been 
demonstrated for the circuits underlying sensorimotor gating, sexual and aggressive behaviors 
and sensory perception (Rebsam et al., 2002; Gaspar et al., 2003; Maciag et al. 2006a; Nakamura 
et al., 2006; Qinghui Yu, unpublished results), with differing critical time windows for each 
behavior type. These findings underscore the general neurotrophic properties of 5-HT in circuit 





contingent on the specific epochs in which they are altered (Ansorge et al., 2007; Leonardo and 
Hen, 2009).   
 
Future directions 
Although we have shown that serotonin modulates the development of mPFC and HC 
neurons the exact mechanism by which this occurs remains to be investigated. Further 
characterization of the specific serotonin receptors and intracellular signaling pathways that 
mediate the effects of serotonin on dendritic morphology, synaptogenesis and receptor 
expression, and ultimately behavior, require further characterization.  
Finally, an important question with clinical significance is whether we can reverse or 
rescue the changes in the mPFC-HC circuits that arise from early-life disruption of serotonin 
tone. If the focal changes in the mPFC and HC are causal to their affective phenotype, then by 
enhancing IL activity, dampening PL activity or increasing CA3 output (or perhaps a 
combination of these), we may be able to correct the emotional phenotype of mice and humans 















Adhikari A, Topiwala MA, Gordon JA. (2010) Synchronized activity between the ventral 
hippocampus and the medial prefrontal cortex during anxiety. Neuron. 65(2):257-69. 
Adhikari A, Topiwala MA, Gordon JA. (2011). Single units in the medial prefrontal cortex with 
anxiety-related firing patterns are preferentially influenced by ventral hippocampal activity. 
Neuron. Sep 8;71(5):898-910. 
Alfonso J, Frasch AC, Flugge G. (2005). Chronic stress, depression and antidepressants: effects 
on gene transcription in the hippocampus.Rev Neurosci. 16(1):43-56. Review. 
Altamura C., ML Dell'Acqua, R Moessner, DL Murphy, KP Lesch, and A.M. Persico. (2007). 
Altered Neocortical Cell Density and Layer Thickness in Serotonin Transporter Knockout Mice: 
A Quantitation Study Cereb. Cortex. 17(6): 1394-1401. 
Alves SE, Hoskin E, Lee SJ, Brake WG, Ferguson D, Luine V, Allen PB, Greengard P, McEwen 
BS. (2002). Serotonin mediates CA1 spine density but is not crucial for ovarian steroid 
regulation of synaptic plasticity in the adult rat dorsal hippocampus. Synapse. 45(2):143-51. 
Amaral DG, Witter MP. (1989). The three-dimensional organization of the hippocampal 
formation: a review of anatomical data. Neuroscience. 31(3):571-91. Review. 
Amorapanth P, Nader K, LeDoux JE. (1999). Lesions of periaqueductal gray dissociate-
conditioned freezing from conditioned suppression behavior in rats. Learn Mem. 6(5):491-9. 
Anagnostaras SG, Gale GD, Fanselow MS. (2002). The hippocampus and Pavlovian fear 
conditioning: reply to Bast et al. Hippocampus. 12(4):561-5. Review. No abstract available.  
Andersen P., Morris R., Amaral D., Bliss T., O'Keefe J. (2006). The hippocampus book, Oxford 
University Press. 
Andrade R. (2011) Serotonergic regulation of neuronal excitability in the prefrontal cortex. 
Neuropharmacology. 61(3):382-6. Epub 2011 Jan 18. Review. 
Andrus BM, Blizinsky K, Vedell PT, Dennis K, Shukla PK, Schaffer DJ, Radulovic J, Churchill 
GA, Redei EE.(2010). Gene expression patterns in the hippocampus and amygdala of 
endogenous depression and chronic stress models. Mol Psychiatry.  
Angrini M, Leslie JC, Shephard RA. (1998). Effects of propranolol, buspirone, pCPA, reserpine, 
and chlordiazepoxide on open-field behavior. Pharmacol Biochem Behav. 59(2):387-97. 
Ansorge MS, Hen R, Gingrich JA. (2007). Neurodevelopmental origins of depressive disorders. 
Curr Opin Pharmacol. 7(1):8-17. Epub 2006 Dec 21. Review. Erratum in: Curr Opin Pharmacol. 





Ansorge MS, Morelli E, Gingrich JA. (2008) Inhibition of serotonin but not norepinephrine 
transport during development produces delayed, persistent perturbations of emotional behaviors 
in mice. J Neurosci. 28(1):199-207. 
Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA. (2004) Early-life blockade of the 5-HT 
transporter alters emotional behavior in adult mice. Science. 306(5697):879-81. 
Antoniadis EA, McDonald RJ. (2001). Amygdala, hippocampus, and unconditioned fear. Exp 
Brain Res. 138(2):200-9. 
Arns M, Sauvage M, Steckler T. (1999). Excitotoxic hippocampal lesions disrupt allocentric 
spatial learning in mice: effects of strain and task demands.Behav Brain Res. 106(1-2):151-64. 
Austin MP, Mitchell P, Goodwin GM. (2001). Cognitive deficits in depression: possible 
implications for functional neuropathology.Br J Psychiatry. 178:200-6. Review. 
Azmitia EC, Whitaker-Azmitia PM (1997) Development and adult plasticity of serotoninergic 
neurons and their target cells. In: Serotoninergic neurons and 5-HT receptors in the CNS 
(Baumgarten HG, Gothert M, eds), pp 1-40. Berlin: Springer.  
Baars and N. Gage. (2007). Cognition, Brain, and Consciousness: Introduction to Cognitive 
Neuroscience (eBook) By B. Academic Press.  
Bannerman D. M., Rawlins J. N., McHugh S. B., Deacon R. M., Yee B. K., Bast T., Zhang 
W.N., Pothuizen H. H., Feldon J. (2004). Regional dissociations within the hippocampus – 
memory and anxiety. Neurosci. Biobehav. Rev. 28, 273–283. doi: 
10.1016/j.neubiorev.2004.03.004. 
Bannerman DM, Grubb M, Deacon RM, Yee BK, Feldon J, Rawlins JN (2003). Ventral 
hippocampal lesions affect anxiety but not spatial learning. Behav Brain Res 139: 197-213 
Bartolomucci A, Carola V, Pascucci T, Puglisi-Allegra S, Cabib S, Lesch KP, Parmigiani S, 
Palanza P, Gross C. (2010). Increased vulnerability to psychosocial stress in heterozygous 
serotonin transporter knockout mice. Dis Model Mech. 3(7-8):459-70 
Bast T, Zhang WN, Feldon J. (2001). Different anterograde amnesias of fear after tetrodotoxin 
inactivation and infusion of the GABA(A) agonist muscimol. Exp Brain Res. 139(1):39-52. 
Bast T, Zhang WN, Feldon J.(2003). Dorsal hippocampus and classical fear conditioning to tone 
and context in rats: effects of local NMDA-receptor blockade and stimulation. Hippocampus. 
13(6):657-75. 
Béïque JC, Campbell B, Perring P, Hamblin MW, Walker P, Mladenovic L, Andrade R. (2004). 
Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated 






Benekareddy M, Goodfellow NM, Lambe EK, Vaidya VA. (2010). Enhanced function of 
prefrontal serotonin 5-HT(2) receptors in a rat model of psychiatric vulnerability.J 
Neurosci.30(36):12138-50. 
Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA, Almeida OF, Sousa N (2009) 
The mood-improving actions of antidepressants do not depend on neurogenesis but are 
associated with neuronal remodeling. Mol Psychiatry 14:764–773, 739. 
Bhansali P, Dunning J, Singer SE, David L, Schmauss C. (2007). Early life stress alters adult 
serotonin 2C receptor pre-mRNA editing and expression of the alpha subunit of the 
heterotrimeric G-protein G q. J Neurosci. 27(6):1467-73. 
Bierut, A.C. Heath, K.K. Bucholz, S.H. Dinwiddie, P.A.F. Madden and D.J. Statham, et al. 
(1999). Major depressive disorder in a community-based twin sample. Are there different genetic 
and environmental contributions for men and women?. Arch Gen Psychiatry. 56, pp. 557–563. 
Bland ST, Hargrave D, Pepin JL, Amat J, Watkins LR, Maier SF. (2003). Stressor controllability 
modulates stress-induced dopamine and serotonin efflux and morphine-induced serotonin efflux 
in the medial prefrontal cortex. Neuropsychopharmacology. 28(9):1589-96. Epub 2003 May 28. 
Blier P. (2003). The pharmacology of putative early-onset antidepressant strategies. Eur 
Neuropsychopharmacol. 13(2):57-66. Review. 
Bock J, Murmu MS, Biala Y, Weinstock M, Braun K. (2011). Prenatal stress and neonatal 
handling induce sex-specific changes in dendritic complexity and dendritic spine density in 
hippocampal subregions of prepubertal rats. Neuroscience. 193:34-43. Epub 2011 Jul 27. 
Bodnoff S. R., Humphreys A. G., Lehman J. C., Diamond D. M., Rose G. M., Meaney M. J. 
(1995). Enduring effects of chronic corticosterone treatment on spatial learning, synaptic 
plasticity, and hippocampal neuropathology in young and mid-aged rats. J. Neurosci. 15, 61–69. 
Boes AD, McCormick LM, Coryell WH, Nopoulos P. (2008). Rostral anterior cingulate cortex 
volume correlates with depressed mood in normal healthy children. Biol Psychiatry. 63(4):391-7.  
Boldrini M, Underwood MD, Hen R, Rosoklija GB, Dwork AJ, John Mann J et al. (2009). 
Antidepressants increase neural progenitor cells in the human hippocampus. 
Neuropsychopharmacology 34: 2376–2389.  
Bonnin A, Torii M, Wang L, Rakic P, Levitt P. (2007). Serotonin modulates the response of 
embryonic thalamocortical axons to netrin-1. Nat Neurosci. 10(5):588-97.  
Bossini L, Tavanti M, Calossi S, Lombardelli A, Polizzotto NR, Galli R, Vatti G, Pieraccini F, 
Castrogiovanni P. (2008). Magnetic resonance imaging volumes of the hippocampus in drug-
naïve patients with post-traumatic stress disorder without comorbidity conditions. J Psychiatr 





Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS. (2000). Hippocampal 
volume reduction in major depression. Am J Psychiatry. 157(1):115-8. 
Breslau N, Schultz L, Peterson E. (1995). Sex differences in depression: a role for preexisting 
anxiety. Psychiatry Res. 58(1):1-12. 
Brown SM, Henning S, Wellman CL. (2005). Mild, short-term stress alters dendritic morphology 
in rat medial prefrontal cortex. Cereb Cortex. 15(11):1714-22.  
Bulik CM, Prescott CA, Kendler KS. (2001). Features of childhood sexual abuse and the 
development of psychiatric and substance use disorders. Br J Psychiatry.179:444-9. 
Burgess N, Maguire EA, O'Keefe J. (2002). The human hippocampus and spatial and episodic 
memory. Neuron. 35(4):625-41. Review. 
Burgos-Robles A, Vidal-Gonzalez I, Santini E, Quirk GJ. (2007). Consolidation of fear 
extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex. 
Neuron. 53(6):871-80. 
Burman MA, Murawski NJ, Schiffino FL, Rosen JB, Stanton ME. (2009). Factors governing 
single-trial contextual fear conditioning in the weanling rat. Behav Neurosci. 123(5):1148-52. 
Burwell RD, Saddoris MP, Bucci DJ, Wiig KA. (2004). Corticohippocampal contributions to 
spatial and contextual learning. J Neurosci. 24(15):3826-36. 
Buzsáki G. (2002). Theta oscillations in the hippocampus. Neuron. 33(3):325-40. Review. 
Cai Q, Huang S, Zhu Z, Li H, Li Q, Jia N, Liu J. (2008). The effects of prenatal stress on 
expression of p38 MAPK in offspring hippocampus. Int J Dev Neurosci. 26(6):535-40. Epub 
2008 Jun 13. 
Cai Q, Zhu Z, Li H, Fan X, Jia N, Bai Z, Song L, Li X, Liu J. (2007). Prenatal stress on the 
kinetic properties of Ca2+ and K+ channels in offspring hippocampal CA3 pyramidal neurons. 
Life Sci. 80(7):681-9.  
Campbell, S., Marriott, M., Nahmias, C. & MacQueen, G.M. (2004). Lower hippocampal 
volume in patients suffering from depression: a meta-analysis. Am. J. Psychiatry 161, 598–607. 
Carola V, Frazzetto G, Pascucci T, Audero E, Puglisi-Allegra S, Cabib S, Lesch KP, Gross C. 
(2008). Identifying molecular substrates in a mouse model of the serotonin transporter x 
environment risk factor for anxiety and depression. Biol Psychiatry. 63(9):840-6. Epub 2007 Oct 
22. 
Carola V, Pascucci T, Puglisi-Allegra S, Cabib S, Gross C. (2011). Effect of the interaction 
between the serotonin transporter gene and maternal environment on developing mouse brain. 





Carroll JC, Boyce-Rustay JM, Millstein R, Yang R, Wiedholz LM, Murphy DL, Holmes A. 
(2007). Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT 
knockout mice. Behav Genet. 37(1):214-22. 
Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al. (2003). Influence of life 
stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301: 386–389. 
Castaneda AE, Tuulio-Henriksson A, Marttunen M, Suvisaari J, Lönnqvist J. (2008). A review 
on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J 
Affect Disord. 106(1-2):1-27. Epub 2007 Aug 20. Review. 
Chameau P, Inta D, Vitalis T, Monyer H, Wadman WJ, van Hooft JA. (2009). The N-terminal 
region of reelin regulates postnatal dendritic maturation of cortical pyramidal neurons. Proc Natl 
Acad Sci U S A. 106(17):7227-32. Epub 2009 Apr 6. 
Chaouloff F. (1993). Physiopharmacological interactions between stress hormones and central 
serotonergic systems. Brain Res Brain Res Rev. 18(1):1-32. Review. 
Chen C, Kim JJ, Thompson RF, Tonegawa S. (1996). Hippocampal lesions impair contextual 
fear conditioning in two strains of mice. Behav Neurosci. 110(5):1177-80. 
Chen H, Pandey GN, Dwivedi Y. (2006). Hippocampal cell proliferation regulation by repeated 
stress and antidepressants. Neuroreport. 17(9):863-7. 
Chen Y, Dubé CM, Rice CJ, Baram TZ. (2008). Rapid loss of dendritic spines after stress 
involves derangement of spine dynamics by corticotropin-releasing hormone. J Neurosci. 
12;28(11):2903-11. 
Chen Y, Rex CS, Rice CJ, Dubé CM, Gall CM, Lynch G, Baram TZ. (2010). Correlated memory 
defects and hippocampal dendritic spine loss after acute stress involve corticotropin-releasing 
hormone signaling. Proc Natl Acad Sci U S A. 107(29):13123-8.  
Cherian SB, Bairy KL, Rao MS. (2009). Chronic prenatal restraint stress induced memory 
impairment in passive avoidance task in post weaned male and female Wistar rats. Indian J Exp 
Biol. 47(11):893-9. 
Cho YH, Friedman E, Silva AJ. (1999). Ibotenate lesions of the hippocampus impair spatial 
learning but not contextual fear conditioning in mice. Behav Brain Res. 98(1):77-87. 
Choleris E, Thomas AW, Kavaliers M, Prato FS. (2001). A detailed ethological analysis of the 
mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency 
pulsed magnetic field. Neurosci Biobehav Rev. 25(3):235-60. 
Christian KM, Miracle AD, Wellman CL, Nakazawa K. (2011). Chronic stress-induced 





Chrousos GP (1998). Stressors, stress, and neuroendocrine integration of the adaptive response. 
The 1997 Hans Selye Memorial Lecture. Ann NY Acad Sci U S A. 851: 311–335. 
Conrad CD, LeDoux JE, Magariños AM, McEwen BS. (1999). Repeated restraint stress 
facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. 
Behav Neurosci. 113(5):902-13. 
Contractor A, Swanson GT, Sailer A, O'Gorman S, Heinemann SF. (2000). Identification of the 
kainate receptor subunits underlying modulation of excitatory synaptic transmission in the CA3 
region of the hippocampus. J Neurosci. 20(22):8269-78. 
Cook S. C., Wellman C. L. (2004). Chronic stress alters dendritic morphology in rat medial 
prefrontal cortex. J. Neurobiol. 60, 236–248.  
Cooper JR, Bloom FE, Roth RH (2003). The Biochemical Basis of Neuropharmacology, 8th edn. 
Oxford University Press: Oxford, New York, 7: 40 pp. 
Corcoran KA, Desmond TJ, Frey KA, Maren S. (2005). Hippocampal inactivation disrupts the 
acquisition and contextual encoding of fear extinction. J Neurosci. 2005 Sep 28;25(39):8978-87. 
Erratum in: J Neurosci. 25(42):9821 
Corcoran KA, Maren S. (2001).  Hippocampal inactivation disrupts contextual retrieval of fear 
memory after extinction. J Neurosci. 21(5):1720-6. 
Coryell W, Nopoulos P, Drevets W, Wilson T, Andreasen NC (2005). Subgenual prefrontal 
cortex volumes in major depressive disorder and schizophrenia: diagnostic specificity and 
prognostic implications. Am J Psychiatry 162: 1706–1712. 
Covington HE 3rd, Lobo MK, Maze I, Vialou V, Hyman JM, Zaman S, LaPlant Q, Mouzon E, 
Ghose S, Tamminga CA, Neve RL, Deisseroth K, Nestler EJ. (2010). Antidepressant effect of 
optogenetic stimulation of the medial prefrontal cortex. J Neurosci. 30(48):16082-90. 
Cravens CJ, Vargas-Pinto N, Christian KM, Nakazawa K. (2006). CA3 NMDA receptors are 
crucial for rapid and automatic representation of context memory. Eur J Neurosci. 24(6):1771-
80. 
Cryan JF, Markou A, and Lucki I (2002) Assessing antidepressant activity in rodents: recent 
developments and future needs. Trends Pharmacol Sci 23: 238-245. 
Czéh B, Welt T, Fischer AK, Erhardt A, Schmitt W, Müller MB, Toschi N, Fuchs E, Keck ME. 
(2002). Chronic psychosocial stress and concomitant repetitive transcranial magnetic 
stimulation: effects on stress hormone levels and adult hippocampal neurogenesis.Biol 
Psychiatry. 52(11):1057-65.ef 
Czéh B., Lucassen P. J. (2007). What causes the hippocampal volume decrease in depression? 
Are neurogenesis, glial changes and apoptosis implicated? Eur. Arch. Gen. Psychiatry Clin. 





Czéh B., Michaelis T., Watanabe T., Frahm J., de Biurrun G., van Kampen M., Bartolomucci A., 
Fuchs E. (2001). Stress-induced changes in cerebral metabolites, hippocampal volume, and cell 
proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl. Acad. Sci. 
U.S.A. 98, 12796–12801. doi: 10.1073/pnas.211427898 
Daubert EA, Condron BG. (2010). Serotonin: a regulator of neuronal morphology and circuitry. 
Trends Neurosci. 33(9):424-34.  
David SP, Murthy NV, Rabiner EA, Munafó MR, Johnstone EC, Jacob R, Walton RT, Grasby 
PM. (2005). A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A 
receptor binding in humans. J Neurosci. 2005 Mar 9;25(10):2586-90. 
Davidson RJ. (2002). Anxiety and affective style: role of prefrontal cortex and amygdala. Biol 
Psychiatry. 51(1):68-80. Review. 
Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, 4th edn. (2000). American 
Psychiatric Association: American Psychiatric Association, American Psychiatric Association. 
Task Force on DSM-IV.  Washington, DC.  Retrieved from: 
http://allpsych.com/disorders/dsm.html 
Díaz-Ríos M, Dombeck DA, Webb WW, Harris-Warrick RM. (2007). Serotonin modulates 
dendritic calcium influx in commissural interneurons in the mouse spinal locomotor network. J 
Neurophysiol. 98(4):2157-67. Epub 2007 Jun 20. 
Drevets WC, Price JL, Furey ML. (2008). Brain structural and functional abnormalities in mood 
disorders: implications for neurocircuitry models of depression. Brain Struct Funct. 213(1-2):93-
118.  
Drew MR, Denny CA, Hen R. (2010). Arrest of adult hippocampal neurogenesis in mice impairs 
single- but not multiple-trial contextual fear conditioning. Behav Neurosci. 124(4):446-54. 
Duman RS. (2002). Pathophysiology of depression: the concept of synaptic plasticity. Eur 
Psychiatry. 17 Suppl 3:306-10. Review. 
Durand M, Sarrieau A, Aguerre S, Mormède P, Chaouloff F. (1998). Differential effects of 
neonatal handling on anxiety, corticosterone response to stress, and hippocampal glucocorticoid 
and serotonin (5-HT)2A receptors in Lewis rats. Psychoneuroendocrinology. 23(4):323-35. 
Eiland L, Ramroop J, Hill MN, Manley J, McEwen BS. (2012). Chronic juvenile stress produces 
corticolimbic dendritic architectural remodeling and modulates emotional behavior in male and 
female rats. Psychoneuroendocrinology. 37(1):39-47.  
Englander MT, Dulawa SC, Bhansali P, Schmauss C. (2005).  How stress and fluoxetine 
modulate serotonin 2C receptor pre-mRNA editing. J Neurosci. 25(3):648-51. 
Fanselow MS, Dong HW. (2010). Are the dorsal and ventral hippocampus functionally distinct 





Fanselow MS. (2000). Contextual fear, gestalt memories, and the hippocampus. Behav Brain 
Res. 110(1-2):73-81. Review. 
Farb NA, Anderson AK, Bloch RT, Segal ZV. (2011). Mood-linked responses in medial 
prefrontal cortex predict relapse in patients with recurrent unipolar depression. Biol Psychiatry. 
70(4):366-72.  
Farinelli M, Deschaux O, Hugues S, Thevenet A, Garcia R. (2006). Hippocampal train 
stimulation modulates recall of fear extinction independently of prefrontal cortex synaptic 
plasticity and lesions. Learn Mem. 13(3):329-34. 
Farrell MR, Sayed JA, Underwood AR, Wellman CL. (2010). Lesion of infralimbic cortex 
occludes stress effects on retrieval of extinction but not fear conditioning. Neurobiol Learn Mem. 
94(2):240-6.  
Fellini L, Florian C, Courtey J, Roullet P. (2009). Pharmacological intervention of hippocampal 
CA3 NMDA receptors impairs acquisition and long-term memory retrieval of spatial pattern 
completion task. Learn Mem. 16(6):387-94.  
Fernandez SP, Gaspar P. (2012). Investigating anxiety and depressive-like phenotypes in genetic 
mouse models of serotonin depletion. Neuropharmacology. 62(1):144-54.  
Ferreira TA, Iacono LL, Gross CT. (2010). Serotonin receptor 1A modulates actin dynamics and 
restricts dendritic growth in hippocampal neurons. Eur J Neurosci. 32(1):18-26.  
Fontanez-Nuin DE, Santini E, Quirk GJ, Porter JT. Memory for fear extinction requires 
mGluR5-mediated activation of infralimbic neurons. Cereb Cortex. 2011 Mar;21(3):727-35. 
Epub 2010 Aug 12. 
Freund TF. (1992). GABAergic septal and serotonergic median raphe afferents preferentially 
innervate inhibitory interneurons in the hippocampus and dentate gyrus. Epilepsy Res Suppl. 
7:79-91. 
Frodl T, Koutsouleris N, Bottlender R, Born C, Jäger M, Mörgenthaler M, Scheuerecker J, Zill 
P, Baghai T, Schüle C, Rupprecht R, Bondy B, Reiser M, Möller HJ, Meisenzahl EM. (2008). 
Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene 
in major depression. Mol Psychiatry.13(12):1093-101.  
Frodl T, Meisenzahl EM, Zill P, Baghai T, Rujescu D, Leinsinger G, Bottlender R, Schüle C, 
Zwanzger P, Engel RR, Rupprecht R, Bondy B, Reiser M, Möller HJ. (2004). Reduced 
hippocampal volumes associated with the long variant of the serotonin transporter polymorphism 
in major depression. Arch Gen Psychiatry. 61(2):177-83. 
Garcia R, Spennato G, Nilsson-Todd L, Moreau JL, Deschaux O. (2008). Hippocampal low-
frequency stimulation and chronic mild stress similarly disrupt fear extinction memory in rats. 





Gaspar P, Cases O, Maroteaux L. (2003). The developmental role of serotonin: news from mouse 
molecular genetics. Nat Rev Neurosci. 4(12):1002-12. Review. 
Giedd J. (1999). Brain development, IX: human brain growth. Am J Psychiatry 156: 4. 
Gilad VH, Rabey JM, Eliyayev Y, Gilad GM. (2000).  Different effects of acute neonatal 
stressors and long-term postnatal handling on stress-induced changes in behavior and in ornithine 
decarboxylase activity of adult rats. Brain Res Dev Brain Res. 120(2):255-9. 
Gilbert PE, Brushfield AM. (2009). The role of the CA3 hippocampal subregion in spatial 
memory: a process oriented behavioral assessment. Prog Neuropsychopharmacol Biol 
Psychiatry. 33(5):774-81. Review. 
Gilbert PE, Kesner RP. (2003). Localization of function within the dorsal hippocampus: the role 
of the CA3 subregion in paired-associate learning. Behav Neurosci. 117(6):1385-94. 
Gingrich JA, Ansorge MS, Merker R, Weisstaub N, Zhou M. (2003). New lessons from 
knockout mice: The role of serotonin during development and its possible contribution to the 
origins of neuropsychiatric disorders. CNS Spectr. 8(8):572-7. Review. 
Gobbi G, Murphy DL, Lesch K, Blier P. (2001). Modifications of the serotonergic system in 
mice lacking serotonin transporters: an in vivo electrophysiological study. J Pharmacol Exp 
Ther. Mar;296(3):987-95. 
Gohier B, Ferracci L, Surguladze SA, Lawrence E, El Hage W, Kefi MZ, Allain P, Garre JB, Le 
Gall D. (2009). Cognitive inhibition and working memory in unipolar depression. Affect Disord. 
116(1-2):100-5.  
Gold AE, Kesner RP. (2005). The role of the CA3 subregion of the dorsal hippocampus in 
spatial pattern completion in the rat.Hippocampus. 15(6):808-14. 
Goldwater DS, Pavlides C, (2009). Hunter RG, Bloss EB, Hof PR, McEwen BS, Morrison JH. 
Structural and functional alterations to rat medial prefrontal cortex following chronic restraint 
stress and recovery. Neuroscience. 164(2):798-808. 
Gonzales RB, DeLeon Galvan CJ, Rangel YM, Claiborne BJ. (2001). Distribution of thorny 
excrescences on CA3 pyramidal neurons in the rat hippocampus. J Comp Neurol. 430(3):357-68. 
Good M, Honey RC. (1997). Dissociable effects of selective lesions to hippocampal subsystems 
on exploratory behavior, contextual learning, and spatial learning. Behav Neurosci. 111(3):487-
93. 
Goodfellow NM, Benekareddy M, Vaidya VA, Lambe EK (2009) Layer II/III of the prefrontal 
cortex: Inhibition by the serotonin 5-HT1A receptor in development and stress. J Neurosci 
29:10094–10103. 
Gordon JA, Lacefield CO, Kentros CG, Hen R. (2005). State-dependent alterations in 





Gould E, Cameron HA, Daniels DC, Wooley CS, McEwen BS (1992). Adrenal hormones 
suppress cell division in the adult rat dentate gyrus. J Neurosci 12: 3642–3650. 
Gould NF, Holmes MK, Fantie BD, Luckenbaugh DA, Pine DS, Gould TD, Burgess N, Manji 
HK, Zarate CA Jr. (2007). Performance on a virtual reality spatial memory navigation task in 
depressed patients. Am J Psychiatry. 164(3):516-9. 
Gray JA, McNaughton N (2000). The Neuropsychology of Anxiety: An Enquiry into The 
Functions of The Septo-Hippocampal System, 2nd edn. Oxford University Press: Oxford, New 
York, 16: 424 pp. 
Gross C, Hen R. (2004a). Genetic and environmental factors interact to influence anxiety. 
Neurotox Res. 6(6):493-501. Review. 
Gross C, Hen R. (2004b). The developmental origins of anxiety. Nat Rev Neurosci. 5(7):545-52. 
Review.  
Gross C, Santarelli L, Brunner D, Zhuang X, Hen R. (2000). Altered fear circuits in 5-HT(1A) 
receptor KO mice.Biol Psychiatry. 2000 Dec 15;48(12):1157-63. Review. 
Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, Santarelli L, Beck S, Hen R. 
(2002). Serotonin1A receptor acts during development to establish normal anxiety-like 
behaviour in the adult. Nature. 416(6879):396-400. 
Grove EA, Tole S. (1999). Patterning events and specification signals in the developing 
hippocampus. Cereb Cortex. 9(6):551-61. 
Gualtieri CT, Morgan DW. (2008). The frequency of cognitive impairment in patients with 
anxiety, depression, and bipolar disorder: an unaccounted source of variance in clinical trials. J 
Clin Psychiatry. 69(7):1122-30. 
Guidotti G, Calabrese F, Auletta F, Olivier J, Racagni G, Homberg J, Riva MA. (2012). 
Developmental Influence of the Serotonin Transporter on the Expression of Npas4 and 
GABAergic Markers: Modulation by Antidepressant Treatment. Neuropsychopharmacology. 
37(3):746-58. doi: 10.1038/npp.2011.252. Erratum in: Neuropsychopharmacology. 2012 
Apr;37(5):1322.  
Gutiérrez B, Arias B, Gastó C, Catalán R, Papiol S, Pintor L, Fañanás L. (2004). Association 
analysis between a functional polymorphism in the monoamine oxidase A gene promoter and 
severe mood disorders. Psychiatr Genet. 14(4):203-8. 
Hajós M, Hoffmann WE, Robinson DD, Yu JH, Hajós-Korcsok E. (2003). Norepinephrine but 
not serotonin reuptake inhibitors enhance theta and gamma activity of the septo-hippocampal 





Hajszan T, Dow A, Warner-Schmidt JL, Szigeti-Buck K, Sallam NL, Parducz A, Leranth C, 
Duman RS. (2009). Remodeling of hippocampal spine synapses in the rat learned helplessness 
model of depression. Biol Psychiatry. 65(5):392-400. 
Hajszan T, Szigeti-Buck K, Sallam NL, Bober J, Parducz A, Maclusky NJ, Leranth C, Duman 
RS. (2010). Effects of estradiol on learned helplessness and associated remodeling of 
hippocampal spine synapses in female rats. Biol Psychiatry. 67(2):168-74.  
Hansen HH, Sanchez C, Meier E (1997). Neonatal administration of the selective serotonin 
reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats: a 
putative animal model of depression? J Pharmacol Exp Ther 283: 1333–1341. 
Hariri AR, Drabant EM, Weinberger DR. (2006). Imaging genetics: perspectives from studies of 
genetically driven variation in serotonin function and corticolimbic affective processing. Biol 
Psychiatry. 59(10):888-97. Review. 
Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger 
DR. (2002). Serotonin transporter genetic variation and the response of the human amygdala. 
Science. 2002 Jul 19;297(5580):400-3. 
Harris KM (1999) Structure, development, and plasticity of dendritic spines. Curr Opin 
Neurobiol 9: 343-348 
Hasler G, Drevets WC, Manji HK, Charney DS (2004). Discovering endophenotypes for major 
depression. Neuropsychopharmacology 29: 1765–1781.  
Hayashi, A. Nagaoka, M. Yamada, K. Ichitani, Y. Miake, Y. Okado, N. (1998). Maternal stress 
induces synaptic loss and developmental disabilities of offspring. Int. J. Dev. Neurosci. 16, 209-
16. 
Haydon, D.P. McCobb and S.B. Kater, (1984). Serotonin selectively inhibits growth cone 
motility and synaptogenesis of specific identified neurons. Science. 226 pp. 561–564 
Heim C, Nemeroff CB. (2009). Neurobiology of posttraumatic stress disorder.CNS Spectr. 14(1 
Suppl 1):13-24. Review. 
Heinz A, Braus DF, Smolka MN, Wrase J, Puls I, Hermann D, Klein S, Grüsser SM, Flor H, 
Schumann G, Mann K, Büchel C. (2005). Amygdala-prefrontal coupling depends on a genetic 
variation of the serotonin transporter. Nat Neurosci. 8(1):20-1.  
Hensch TK (2004). Critical period regulation. Annu Rev Neurosci 27: 549–579. 
Herry C, Vouimba RM, Garcia R. (1999). Plasticity in the mediodorsal thalamo-prefrontal 





Hettema JM, Kuhn JW, Prescott CA, Kendler KS. (2006). The impact of generalized anxiety 
disorder and stressful life events on risk for major depressive episodes. Psychol Med. 36(6):789-
95.  
Hettema JM, Neale MC, Kendler KS (2001). A review and meta-analysis of the genetic 
epidemiology of anxiety disorders. Am J Psychiatry 158: 1568–1578. 
Hill MN, Hillard CJ, McEwen BS. (2011). Alterations in corticolimbic dendritic morphology and 
emotional behavior in cannabinoid CB1 receptor-deficient mice parallel the effects of chronic 
stress. Cereb Cortex. 21(9):2056-64. 
Hirschfeld RM. (2000). History and evolution of the monoamine hypothesis of depression. J Clin 
Psychiatry. 61 Suppl 6:4-6. Review. 
Hock BJ Jr, Bunsey MD. (1998). Differential effects of dorsal and ventral hippocampal lesions. J 
Neurosci. 18(17):7027-32. 
Hof P.R., W.G. Young, F.E. Bloom, P.V. Belichenko and M.R. Celio. (2000). Comparative 
Cytoarchitectonic Atlas of the C57BL/6 and 129/Sv Mouse Brains. New York, Elsevier.  
Hoffman AN, Krigbaum A, Ortiz JB, Mika A, Hutchinson KM, Bimonte-Nelson HA, Conrad 
CD. (2011).  Recovery after chronic stress within spatial reference and working memory 
domains: correspondence with hippocampal morphology. Eur J Neurosci. 34(6):1023-30. doi: 
10.1111/j.1460-9568.2011.07820.x.  
Hohmann CF, Richardson C, Pitts E, Berger-Sweeney J. (2000). Neonatal 5,7-DHT lesions cause 
sex-specific changes in mouse cortical morphogenesis. Neural Plast. 7(4):213-32. 
Hohmann CF, Walker EM, Boylan CB, Blue ME. (2007). Neonatal serotonin depletion alters 
behavioral responses to spatial change and novelty. Brain Res. 1139:163-77.  
Holloway RL. (1966). Dendritic branching:some preliminary results of training and complexity 
in rat visual cortex. Brain Res 2:393–396. 
Holmes A, Murphy DL, Crawley JN. (2003). Abnormal behavioral phenotypes of serotonin 
transporter knockout mice: parallels with human anxiety and depression. Biol Psychiatry. 
15;54(10):953-9. 
Holmes MC, French KL, Seckl JR. (1995). Modulation of serotonin and corticosteroid receptor 
gene expression in the rat hippocampus with circadian rhythm and stress. Brain Res Mol Brain 
Res. 28(2):186-92. 
Homberg JR, Schubert D, Gaspar P. (2010). New perspectives on the neurodevelopmental 
effects of SSRIs. Trends Pharmacol Sci. 31(2):60-5.  
Homberg, J.D. Olivier, B.M. Smits, J.D. Mul, J. Mudde, M. Verheul, O.F. Nieuwenhuizen, A.R. 





Characterization of the serotonin transporter knockout rat: a selective change in the functioning 
of the serotonergic system. Neuroscience. 146, pp. 1662–1676. Article  
Hosseini-Sharifabad M, Hadinedoushan H. (2007). Prenatal stress induces learning deficits and 
is associated with a decrease in granules and CA3 cell dendritic tree size in rat hippocampus. 
Anat Sci Int. 82(4):211-7. 
Huff NC, Frank M, Wright-Hardesty K, Sprunger D, Matus-Amat P, Higgins E, Rudy JW. 
(2006). Amygdala regulation of immediate-early gene expression in the hippocampus induced by 
contextual fear conditioning. J Neurosci. 26(5):1616-23. 
Hughes RN. (1993). Effects on open-field behavior of diazepam and buspirone alone and in 
combination with chronic caffeine. Life Sci. 1993;53(15):1217-25. 
Hugues S, Garcia R. (2007). Reorganization of learning-associated prefrontal synaptic plasticity 
between the recall of recent and remote fear extinction memory. Learn Mem. 1;14(8):520-4.  
Hunsaker MR, Kesner RP. (2008). Dissociations across the dorsal-ventral axis of CA3 and CA1 
for encoding and retrieval of contextual and auditory-cued fear. Neurobiol Learn Mem. 89(1):61-
9.  
Hutchinson K.M., McLaughlin K.J., Wright R.L., Anouti D.P., Ortiz J.B., Mika A., Huynh T.N., 
Hanna J.J., Diamond D.M., Conrad C.D. (2010). Protective effects of environmental enrichment, 
initiated before or during chronic stress, on cognitive and morphological measures of 
hippocampal integrity . Abstracts from the Society for Neuroscience, 2010; Poster: FL HHH16. 
Inoue T, Tsuchiya K, Koyama T. (1994). Regional changes in dopamine and serotonin activation 
with various intensity of physical and psychological stress in the rat brain. Pharmacol Biochem 
Behav. 49(4):911-20. 
Izquierdo A., Wellman C. L., Holmes A. (2006). Brief uncontrollable stress causes dendritic 
retraction in infralimbic cortex and resistance to fear extinction in mice. J. Neurosci. 26, 5733–
5738. 
Jia N, Yang K, Sun Q, Cai Q, Li H, Cheng D, Fan X, Zhu Z. (2010). Prenatal stress causes 
dendritic atrophy of pyramidal neurons in hippocampal CA3 region by glutamate in offspring 
rats. Dev Neurobiol. 70(2):114-25. 
Kalueff AV, Tuohimaa P. (2004). Experimental modeling of anxiety and depression. Acta 
Neurobiol Exp (Wars). 64(4):439-48. Review. 
Kamiya H, Ozawa S, Manabe T. (2002). Kainate receptor-dependent short-term plasticity of 
presynaptic Ca2+ influx at the hippocampal mossy fiber synapses. J Neurosci. 22(21):9237-43. 
Kandel, E., Schwarz J. and Jessell T. (2000). Principles of Neural Science, Fourth edition. 





Kaufman J, Charney D  (2000). Comorbidity of mood and anxiety disorders. Depress Anxiety. 
12 Suppl 1:69-76. Review. 
Kendler KS, Eaves LJ, Loken EK, Pedersen NL, Middeldorp CM, Reynolds C, Boomsma D, 
Lichtenstein P, Silberg J, Gardner CO. (2011). The impact of environmental experiences on 
symptoms of anxiety and depression across the life span. Psychol Sci. 22(10):1343-52. 
Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ (1992). Major depression and 
generalized anxiety disorder. Same genes, (partly) different environments? Arch Gen Psychiatry 
49: 716–722. 
Kendler KS, Prescott CA, Myers J, Neale MC (2003). The structure of genetic and 
environmental risk factors for common psychiatric and substance use disorders in men and 
women. Arch Gen Psychiatry 60: 929–937. 
Kendler, M.C. Neale, R.C. Kessler, (1993). A.C. Heath and L.J. Eaves, The lifetime history of 
major depression in women. Reliability of diagnosis and heritability. Arch Gen Psychiatry. 50, 
pp. 863–870. 
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005).  Survey 
Replication. Arc Gen Psychiatry 62: 593–602. 
Khan AA, Jacobson KC, Gardner CO, Prescott CA, Kendler KS. (2005). Personality and 
comorbidity of common psychiatric disorders. Br J Psychiatry. 186:190-6. 
Kilpatrick DG, Koenen KC, Ruggiero KJ, Acierno R, Galea S, Resnick HS, Roitzsch J, Boyle J, 
Gelernter J. (2007). The serotonin transporter genotype and social support and moderation of 
posttraumatic stress disorder and depression in hurricane-exposed adults. Am J Psychiatry. 
164(11):1693-9. 
Kinney GG, Vogel GW, Feng P. (1997). Decreased dorsal raphe nucleus neuronal activity in 
adult chloral hydrate anesthetized rats following neonatal clomipramine treatment: implications 
for endogenous depression. Brain Res. 756(1-2):68-75. 
Kjelstrup KG, Tuvnes FA, Steffenach HA, Murison R, Moser EI, Moser MB. (2002). Reduced 
fear expression after lesions of the ventral hippocampus. Proc Natl Acad Sci. U S A.  
99(16):10825-30.  
Knudsen EI (2004). Sensitive periods in the development of the brain and behavior. J Cogn 
Neurosci 16: 1412–1425. 
Koch C, Zador A (1993) The function of dendritic spines: devices subserving biochemical rather 
than electrical compartmentalization. J Neurosci 13: 413-422 
Kole MH, Costoli T, Koolhaas JM, Fuchs E. (2004). Bidirectional shift in the cornu ammonis 3 





Krishnan V, Nestler EJ. (2008). Nature. 455(7215):894-902. The molecular neurobiology of 
depression.Review. 
Laplante P, Diorio J, Meaney MJ. (2002). Serotonin regulates hippocampal glucocorticoid 
receptor expression via a 5-HT7 receptor..Brain Res Dev Brain Res. 139(2):199-203. 
Law AJ, Weickert CS, Hyde TM, Kleinman JE, Harrison PJ. (2004). Reduced spinophilin but 
not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia 
and mood disorders: molecular evidence for a pathology of dendritic spines. Am J Psychiatry. 
161(10):1848-55. 
Lebrón K, Milad MR, Quirk GJ. (2004). Delayed recall of fear extinction in rats with lesions of 
ventral medial prefrontal cortex. Learn Mem. 11(5):544-8. 
LeDoux J. (2003). The emotional brain, fear, and the amygdala. Cell Mol Neurobiol. 23(4-
5):727-38. Review. 
LeDoux J.E., Iwata J., Cicchetti P., Reis D.J. (1988). Different projections of the central 
amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J. 
Neurosci. 8:2517–2529. 
Lee HJ, Lee MS, Kang RH, Kim H, Kim SD, Kee BS, Kim YH, Kim YK, Kim JB, Yeon BK, 
Oh KS, Oh BH, Yoon JS, Lee C, Jung HY, Chee IS, Paik IH. (2005). Influence of the serotonin  
transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. 
Depress Anxiety. 21(3):135-9. 
Lee T, Jarome T, Li SJ, Kim JJ, Helmstetter FJ. (2009). Chronic stress selectively reduces 
hippocampal volume in rats: a longitudinal magnetic resonance imaging study. Neuroreport. 
20(17):1554-8. 
Lemaire V, Lamarque S, Le Moal M, Piazza PV, Abrous DN. (2006). Postnatal stimulation of 
the pups counteracts prenatal stress-induced deficits in hippocampal neurogenesis. Biol 
Psychiatry. 59(9):786-92. 
Leonard B.E. (1997). The role of noradrenaline in depression: a review.. J Psychopharmacol. 
11(4 Suppl):S39-47. Review. 
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer 
DH, Murphy DL (1996). Association of anxiety-related traits with a polymorphism in the 
serotonin transporter gene regulatory region. Science 274:1527-1531 
Leuner B, Gould E. (2010). Structural plasticity and hippocampal function. Annu Rev Psychol. 
61:111-40, C1-3. Review. 
Leutgeb S, Leutgeb JK. (2007). Pattern separation, pattern completion, and new neuronal codes 





Levinson DF. (2006). The genetics of depression: a review. Biol Psychiatry. 60(2):84-92. 
Review. 
Li Q., C. Wichems, L. Ma, L.D. Van de Kar, F. Garcia, D.L. Murphy (2003). Brain-region 
specific alterations of 5-HT2A and 5-HT2C receptors in 5-HT transporter knockout mice J 
Neurochem. 84, pp. 1256–1265 
Li X.B., Inoue T., Nakagawa S., Koyama T. (2004). Effect of mediodorsal thalamic nucleus 
lesion on contextual fear conditioning in rats  Original Research Article. Brain Research, 
Volume 1008, Issue 2, 22 May 2004, Pages 261-272 
Linthorst AC, Peñalva RG, Flachskamm C, Holsboer F, Reul JM. (2002). Forced swim stress 
activates rat hippocampal serotonergic neurotransmission involving a corticotropin-releasing 
hormone receptor-dependent mechanism. Eur J Neurosci. 16(12):2441-52. 
Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH, Bradley-Moore M, Lira J, 
Underwood MD, Arango V, Kung HF, Hofer MA, Hen R, Gingrich JA. (2003). Altered 
depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin 
transporter-deficient mice. Biol Psychiatry. 54(10):960-71. 
Liston C., M.M. Miller, D.S. Goldwater, J.J. Radley, A.B. Rocher, P.R. Hof, J.H. Morrison, B.S. 
McEwen. Stress-induced alterations in prefrontal cortical dendritic morphology predict selective 
impairments in perceptual attentional set-shifting. J. Neurosci., 26 (30) (2006), pp. 7870–7874 
López JF, Chalmers DT, Little KY, Watson SJ. (1998). Regulation of serotonin1A, 
glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for 
the neurobiology of depression.Biol Psychiatry. 43(8):547-73. 
Lorenzetti V, Allen NB, Fornito A, Yücel M. (2009). Structural brain abnormalities in major 
depressive disorder: a selective review of recent MRI studies. J Affect Disord. 117(1-2):1-17. 
Review. 
Loureiro M, Lecourtier L, Engeln M, Lopez J, Cosquer B, Geiger K, Kelche C, Cassel JC, 
Pereira de Vasconcelos A. (2011). The ventral hippocampus is necessary for expressing a spatial 
memory. Brain Struct Funct.  
Ludewig S, Geyer MA, Ramseier M, Vollenweider FX, Rechsteiner E, Cattapan-Ludewig K. 
(2005).  Information-processing deficits and cognitive dysfunction in panic disorder. J Psychiatry 
Neurosci. 30(1):37-43. 
Luine V, Villegas M, Martinez C, McEwen BS. (1994). Repeated stress causes reversible 
impairments of spatial memory performance. Brain Res. 639(1):167-70. 
Lupien SJ, Maheu F, Tu M, Fiocco A, Schramek TE. (2007). The effects of stress and stress 






Lupien SJ, McEwen BS, Gunnar MR, Heim C. (2009). Effects of stress throughout the lifespan 
on the brain, behaviour and cognition.Nat Rev Neurosci. 10(6):434-45. Review. 
Lyford GL, Yamagata K, Kaufmann WE, Barnes CA, Sanders LK, Copeland NG, Gilbert DJ, 
Jenkins NA, Lanahan AA, Worley PF. (1995). Arc, a growth factor and activity-regulated gene, 
encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron. 
14(2):433-45. 
Maciag D, Simpson KL, Coppinger D, Lu Y, Wang Y, Lin RC, Paul IA. (2006a). Neonatal 
antidepressant exposure has lasting effects on behavior and serotonin circuitry. 
Neuropsychopharmacology. 31(1):47-57. 
Maciag D, Williams L, Coppinger D, Paul IA. (2006b). Neonatal citalopram exposure produces 
lasting changes in behavior which are reversed by adult imipramine treatment. Eur J Pharmacol. 
532(3):265-9. 
MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT, Nahmias C, 
Young LT. (2003). Course of illness, hippocampal function, and hippocampal volume in major 
depression. Proc Natl Acad Sci U S A. 100(3):1387-92.  
Magarinos A. M., Verdugo J. M., McEwen B. S. (1997). Chronic stress alters synaptic terminal 
structure in hippocampus. Proc. Natl. Acad. Sci. U S A. 94, 14002–14008. doi: 
10.1073/pnas.94.25.14002 
Magariños AM, Deslandes A, McEwen BS. (1999). Effects of antidepressants and 
benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic 
stress. Eur J Pharmacol. 371(2-3):113-22. 
Magariños AM, Li CJ, Gal Toth J, Bath KG, Jing D, Lee FS, McEwen BS. (2011). Effect of 
brain-derived neurotrophic factor haploinsufficiency on stress-induced remodeling of 
hippocampal neurons. Hippocampus. 21(3):253-64. doi: 10.1002/hipo.20744. 
Magariños AM, McEwen BS. (1995). Stress-induced atrophy of apical dendrites of hippocampal 
CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. 
Neuroscience. 69(1):89-98. 
Mann JJ, Currier D. (2006). Effects of genes and stress on the neurobiology of depression. Int 
Rev Neurobiol. 73:153-89. Review. No abstract available.  
Mannoury la Cour C, Boni C, Hanoun N, Lesch KP, Hamon M, Lanfumey L. (2001). Functional 
consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of 
dorsal raphe and hippocampal cell activity. J Neurosci. 21(6):2178-85. 
Maren S. (2008). Pavlovian fear conditioning as a behavioral assay for hippocampus and 





Marrosu F, Fornal CA, Metzler CW, Jacobs BL. (1996). 5-HT1A agonists induce hippocampal 
theta activity in freely moving cats: role of presynaptic 5-HT1A receptors. Brain Res. 739(1-
2):192-200. 
Martínez-Téllez RI, Hernández-Torres E, Gamboa C, Flores G. (2006). Prenatal stress alters 
spine density and dendritic length of nucleus accumbens and hippocampus neurons in rat 
offspring. Synapse. 63(9):794-804. 
Matus-Amat P, Higgins EA, Barrientos RM, Rudy JW. (2004). The role of the dorsal 
hippocampus in the acquisition and retrieval of context memory representations. J Neurosci. 
24(10):2431-9. 
Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, Jerabek PA.(2000). 
Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to 
clinical response. Biol. Psychiatry 48, 830–843. 
Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, 
Kennedy SH. (2005).  Deep brain stimulation for treatment-resistant depression. Neuron 45, 
651–660.  
Mayberg, H.S. (2003). Positron emission tomography imaging in depression: a neural systems 
perspective. Neuroimaging Clin. N. Am. 13, 805–815. 
McEwen BS, Conrad CD, Kuroda Y, Frankfurt M, Magarinos AM, McKittrick C. (1997). 
Prevention of stress-induced morphological and cognitive consequences. Eur 
Neuropsychopharmacol. 7 Suppl 3:S323-8. Review. 
McHugh SB, Deacon RM, Rawlins JN, Bannerman DM (2004) Amygdala and ventral 
hippocampus contribute differentially to mechanisms of fear and anxiety. Behav Neurosci 118: 
63-78 
McHugh TJ, Blum KI, Tsien JZ, Tonegawa S, Wilson MA. (1996). Impaired hippocampal 
representation of space in CA1-specific NMDAR1 knockout mice. Cell. 87(7):1339-49. 
McHugh TJ, Jones MW, Quinn JJ, Balthasar N, Coppari R, Elmquist JK, Lowell BB, Fanselow 
MS, Wilson MA, Tonegawa S. (2007). Dentate gyrus NMDA receptors mediate rapid pattern 
separation in the hippocampal network. Science. 317(5834):94-9.  
McHugh TJ, Tonegawa S. (2009). CA3 NMDA receptors are required for the rapid formation of 
a salient contextual representation. Hippocampus. 19(12):1153-8. 
McKittrick CR, Magariños AM, Blanchard DC, Blanchard RJ, McEwen BS, Sakai RR. (2000). 
Chronic social stress reduces dendritic arbors in CA3 of hippocampus and decreases binding to 





McLaughlin KJ, Harman JS, Foltz C, Wieczorek L, Lightner E, Wright RL. (2007). Chronic 
glucocorticoids increase hippocampal vulnerability to neurotoxicity under conditions that 
produce CA3 dendritic retraction but fail to impair spatial recognition memory. Conrad CD, J 
Neurosci. 27(31):8278-85. 
Meaney M.J, J Diorio, D Francis, S Larocque, D O’Donnell, J.W Smythe, S Sharma and B 
Tannenbáum. (1994). Environmental regulation of the development of glucocorticoid receptor 
systems in the rat forebrain: the role of serotonin. Ann. NY Acad. Sci. U S A. 746, pp. 260–274. 
Milad MR, Quirk GJ. (2002). Neurons in medial prefrontal cortex signal memory for fear 
extinction. Nature. 2002 Nov 7;420(6911):70-4. 
Milad MR, Wright CI, Orr SP, Pitman RK, Quirk GJ, Rauch SL. (2007). Recall of fear 
extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. 
Biol Psychiatry. 62(5):446-54.  
Moffitt TE, Caspi A, Harrington H, Milne BJ, Melchior M, Goldberg D et al. (2007). 
Generalized anxiety disorder and depression: childhood risk factors in a birth cohort followed to 
age 32. Psychol Med 37: 441–452. 
Mokler DJ, Torres OI, Galler JR, Morgane PJ. (2007). Stress-induced changes in extracellular 
dopamine and serotonin in the medial prefrontal cortex and dorsal hippocampus of prenatally 
malnourished rats. Brain Res. 1148:226-33.  
Molteni R, Cattaneo A, Calabrese F, Macchi F, Olivier JD, Racagni G et al. (2010). Reduced 
function of the serotonin transporter is associated with decreased expression of BDNF in rodents 
as well as in humans. Neurobiol Dis 37: 747–755. 
Monroe, S. M., & Simons, A. D. (1991). Diathesis-stress theories in the context of life stress 
research: Implications for the depressive disorders. Psychological Bulletin, 110, 406–425. 
Morelli E, Moore H, Rebello TJ, Gray N, Steele K, Esposito E, Gingrich JA, Ansorge MS. 
(2011). Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia 
dysfunction. J Neurosci. 31(44):15742-50. 
Morgan MA, LeDoux JE. (1995). Differential contribution of dorsal and ventral medial 
prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behav Neurosci. 
109(4):681-8. 
Moser E, Moser MB, Andersen P. (1993). Spatial learning impairment parallels the magnitude of 
dorsal hippocampal lesions, but is hardly present following ventral lesions. J Neurosci. 
13(9):3916-25. 
Moser EI, Kropff E, Moser MB. (2008). Place cells, grid cells, and the brain's spatial 





Moser MB, Moser EI, Forrest E, Andersen P, Morris RG. (1995). Spatial learning with a 
minislab in the dorsal hippocampus. Proc Natl Acad Sci U S A. Oct 10;92(21):9697-701. 
Moser MB, Moser EI. (1998). Functional differentiation in the hippocampus. Hippocampus. 
8(6):608-19. Review. 
Mössner R, Schmitt A, Hennig T, Benninghoff J, Gerlach M, Riederer P, Deckert J, Lesch KP. 
(2004). Quantitation of 5HT3 receptors in forebrain of serotonin transporter deficient mice. J 
Neural Transm. 111(1):27-35. 
Mueller D, Porter JT, Quirk GJ. (2008). Noradrenergic signaling in infralimbic cortex increases 
cell excitability and strengthens memory for fear extinction. J Neurosci. 28(2):369-75. 
Muller JM, Morelli E, Ansorge M, Gingrich JA. (2011). Serotonin transporter deficient mice are 
vulnerable to escape deficits following inescapable shocks. Genes Brain Behav. 10(2):166-75. 
doi: 10.1111/j.1601-183X.2010.00652.x.  
Murmu MS, Salomon S, Biala Y, Weinstock M, Braun K, Bock J. (2006). Changes of spine 
density and dendritic complexity in the prefrontal cortex in offspring of mothers exposed to 
stress during pregnancy. Eur J Neurosci. 24(5):1477-87.  
Murphy DL, Li Q, Engel S, Wichems C, Andrews A, Lesch KP, Uhl G. (2001). Genetic 
perspectives on the serotonin transporter. Brain Res Bull. 2001 Nov 15;56(5):487-94. Review. 
Mychasiuk R, Gibb R, Kolb B. (2011). Prenatal bystander stress induces neuroanatomical 
changes in the prefrontal cortex and hippocampus of developing rat offspring. Brain Res. 
1412:55-62. Epub 2011 Jul 20. 
Myers CE, Scharfman HE. (2011). Pattern separation in the dentate gyrus: a role for the CA3 
backprojection.Hippocampus. 21(11):1190-215. doi: 10.1002/hipo.20828. 
Nachev P. (2006). Cognition and medial frontal cortex in health and disease.Curr Opin Neurol. 
19(6):586-92. Review. 
Nakamura K, Koyama Y, Takahashi K, Tsurui H, Xiu Y, Ohtsuji M et al. (2006). Requirement 
of tryptophan hydroxylase during development for maturation of sensorimotor gating. J Mol Biol 
363: 345–354. 
Nakashiba T, Young JZ, McHugh TJ, Buhl DL, Tonegawa S. (2008). Transgenic inhibition of 
synaptic transmission reveals role of CA3 output in hippocampal learning. Science. 
319(5867):1260-4. Epub 2008 Jan 24. 
Nakazawa K, Quirk MC, Chitwood RA, Watanabe M, Yeckel MF, Sun LD, Kato A, Carr CA, 
Johnston D, Wilson MA, Tonegawa S. (2002). Requirement for hippocampal CA3 NMDA 





Nakazawa K, Sun LD, Quirk MC, Rondi-Reig L, Wilson MA, Tonegawa S. (2003). 
Hippocampal CA3 NMDA receptors are crucial for memory acquisition of one-time experience. 
Neuron. 38(2):305-15. 
Narboux-Nême N, Sagné C, Doly S, Diaz SL, Martin CB, Angenard G, Martres MP, Giros B, 
Hamon M, Lanfumey L, Gaspar P, Mongeau R. (2011). Severe serotonin depletion after 
conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural 
and behavioral consequences. Neuropsychopharmacology. 36(12):2538-50. doi: 
10.1038/npp.2011.142. 
Nascimento Häckl LP, Carobrez AP. (2007). Distinct ventral and dorsal hippocampus AP5 
anxiolytic effects revealed in the elevated plus-maze task in rats. Neurobiol Learn Mem. 
88(2):177-85. 
Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. (2002). Neurobiology of 
depression. Neuron. 34(1):13-25. Review. 
Neumeister A, Konstantinidis A, Stastny J, Schwarz MJ, Vitouch O, Willeit M et al. (2002). 
Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and 
behavioral responses to tryptophan depletion in healthy women with and without family history 
of depression. Arch Gen Psychiatry 59: 613–620. 
Nietzer SL, Bonn M, Jansen F, Heiming RS, Lewejohann L, Sachser N, Asan ES, Lesch KP, 
Schmitt AG. (2011). Serotonin transporter knockout and repeated social defeat stress: impact on 
neuronal morphology and plasticity in limbic brain areas. Behav Brain Res. 220(1):42-54. Epub 
2011 Jan 14. 
Ninan PT, Berger J (2001). Symptomatic and syndromal anxiety and depression. Depress 
Anxiety 14: 79–85. 
Norrholm SD, Ouimet CC. (2001). Altered dendritic spine density in animal models of 
depression and in response to antidepressant treat Vogel ment. Synapse. 42(3):151-63. 
Nutt D.J. and Ballenger J.C. (2003). Anxiety Disorders (1st ed.) Wiley-Blackwell. 
Nutt DJ. (2002). The neuropharmacology of serotonin and noradrenaline in depression. Int Clin 
Psychopharmacol. 17 Suppl 1:S1-12. Review. 
Nutt DJ. (2005). Overview of diagnosis and drug treatments of anxiety disorders. CNS Spectr. 
10(1):49-56. Review. 
O'Brien JT, Lloyd A, McKeith I, Gholkar A, Ferrier N. (2004). A longitudinal study of 






Olivier  J.D., L.A. Jans, G.A. Korte-Bouws, S.M. Korte, P.M. Deen, A.R. Cools, B.A. 
Ellenbroek and A. Blokland. (2008). Acute tryptophan depletion dose dependently impairs object 
memory in serotonin transporter knockout rats. Psychopharmacology. 243–254. 
Pang RD, Wang Z, Klosinski LP, Guo Y, Herman DH, Celikel T, Dong HW, Holschneider DP. 
(2011). Mapping functional brain activation using [14C]-iodoantipyrine in male serotonin 
transporter knockout mice. PLoS One. 6(8):e23869. Epub 2011 Aug 23. 
Park SK, Nguyen MD, Fischer A, Luke MP, Affar el B, Dieffenbach PB, Tseng HC, Shi Y, Tsai 
LH. (2005). Par-4 links dopamine signaling and depression. Cell. 122(2):275-87. 
Parker G, Wilhelm K, Mitchell P, Austin MP, Roussos J, Gladstone G (1999). The influence of 
anxiety as a risk to early onset major depression. J Affect Disord 52: 11–17. 
Parsons LH, Kerr TM, Tecott LH (2001) 5-HT1A receptor mutant mice exhibit enhanced tonic, 
stress-induced and fluoxetine-induced serotonergic neurotransmission. J Neurochem 77: 607-617 
Paul IA, Skolnick P. (2003). Glutamate and depression: clinical and preclinical studies. Ann N Y 
Acad Sci. U S A. 1003:250-72. Review. 
Peters J, Dieppa-Perea LM, Melendez LM, Quirk GJ. (2010). Induction of fear extinction with 
hippocampal-infralimbic BDNF. Science. 328(5983):1288-90. 
Peters MF, Zacco A, Gordon J, Maciag CM, Litwin LC, Thompson C, Schroeder P, Sygowski 
LA, Piser TM, Brugel TA. (2011). Identification of short-acting κ-opioid receptor antagonists 
with anxiolytic-like activity. Eur J Pharmacol. 661(1-3):27-34. 
Petty F, Kramer G, Wilson L, Jordan S. (1994). In vivo serotonin release and learned 
helplessness. Psychiatry Res. 52(3):285-93. 
Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, 
Egan MF, Mattay S, Hariri AR, Weinberger DR (2005). 5-HTTLPR polymorphism impacts 
human cingulate-amygdala Interactions: a genetic susceptibility mechanism of depression. Nat 
Neurosci 8:828–834. 
Phelps EA. (2004). Human emotion and memory: interactions of the amygdala and hippocampal 
complex. Curr Opin Neurobiol.14(2):198-202. Review. 
Phillips RG, LeDoux JE. (1992). Differential contribution of amygdala and hippocampus to cued 
and contextual fear conditioning.Behav Neurosci. 106(2):274-85. 
Pittenger C, Duman RS. (2008). Stress, depression, and neuroplasticity: a convergence of 
mechanisms. Neuropsychopharmacology.33(1):88-109. Review. 
Plotsky and M.J Meaney, (1997). Maternal care, hippocampal glucocorticoid receptors, and 





Ponnusamy R, Poulos AM, Fanselow MS. (2007). Amygdala-dependent and amygdala-
independent pathways for contextual fear conditioning. Neuroscience. 147(4):919-27.  
Popa D, Léna C, Alexandre C, Adrien J. (2008). Lasting syndrome of depression produced by 
reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and 
behavior. J Neurosci. 28(14):3546-54. 
Price JL, Drevets WC. (2010). Neurocircuitry of mood disorders. Neuropsychopharmacology. 
35(1):192-216. Epub. Review. 
Quirk GJ, Garcia R, González-Lima F. (2006). Prefrontal mechanisms in extinction of 
conditioned fear. Biol Psychiatry. 60(4):337-43. Review. 
Rabinak CA, Zimmerman JM, Chang CH, Orsini CA. (2008). Bidirectional changes in the 
intrinsic excitability of infralimbic neurons reflect a possible regulatory role in the acquisition 
and extinction of Pavlovian conditioned fear. J Neurosci. 28(29):7245-7. Review.  
Radley JJ, Rocher AB, Janssen WG, Hof PR, McEwen BS, Morrison JH. (2005). Reversibility of 
apical dendritic retraction in the rat medial prefrontal cortex following repeated stress. Exp 
Neurol. 196(1):199-203.  
Radley JJ, Sisti HM, Hao J, Rocher AB, McCall T, Hof PR, McEwen BS, Morrison JH. (2004). 
Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the 
medial prefrontal cortex. Neuroscience. 125(1):1-6. 
Ravindran LN, Stein MB. (2010). The pharmacologic treatment of anxiety disorders: a review of 
progress. J Clin Psychiatry. 71(7):839-54. Review. 
Reagan LP, McEwen BS. (1997). Controversies surrounding glucocorticoid-mediated cell death 
in the hippocampus. J Chem Neuroanat. 13(3):149-67. Review. 
Rebsam, A., Seif, I. & Gaspar, P. (2002). Refinement of thalamocortical arbors and emergence 
of barrel domains in the primary somatosensory cortex: role of 5-HT. J. Neurosci. 22, 8541–
8552. 
Richardson-Jones JW, Craige CP, Nguyen TH, Kung HF, Gardier AM, Dranovsky A, David DJ, 
Guiard BP, Beck SG, Hen R, Leonardo ED. (2011). Serotonin-1A autoreceptors are necessary 
and sufficient for the normal formation of circuits underlying innate anxiety. J Neurosci. 
20;31(16):6008-18. 
Rosoklija G, Mancevski B, Ilievski B, Perera T, Lisanby SH, Coplan JD, Duma A, Serafimova 
T, Dwork AJ. (2003). Optimization of Golgi methods for impregnation of brain tissue from 
humans and monkeys. J Neurosci Methods. 131(1-2):1-7. 
Roy MA, Neale MC, Pedersen NL, Mathe AA, Kendler KS (1995). A twin study of generalized 





Sahay A, Hen R Adult hippocampal neurogenesis in depression. (2007). Nat Neurosci 10: 1110–
1115. 
Sairanen M, O'Leary OF, Knuuttila JE, Castrén E. (2007). Chronic antidepressant treatment 
selectively increases expression of plasticity-related proteins in the hippocampus and medial 
prefrontal cortex of the rat. Neuroscience.144(1):368-74. 
Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, 
Arancio O, Belzung C, Hen R.(2003). Requirement of hippocampal neurogenesis for the 
behavioral effects of antidepressants. Science 301: 805–809. 
Santini E, Quirk GJ, Porter JT. (2008). Fear conditioning and extinction differentially modify the 
intrinsic excitability of infralimbic neurons. J Neurosci. 28(15):4028-36. 
Sapolsky R. M. (2000). Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. 
Arch. Gen. Psychiatry 57, 925–935. doi: 10.1001/archpsyc.57.10.925. 
Sarnyai Z, Sibille EL, Pavlides C, Fenster RJ, McEwen BS, Toth M. (2000). Impaired 
hippocampal-dependent learning and functional abnormalities in the hippocampus in mice 
lacking serotonin(1A) receptors. Proc Natl Acad Sci USA. 97:14731. 
Savitz J, Lucki I, Drevets WC. 5-HT(1A) receptor function in major depressive disorder. Prog 
Neurobiol. 2009 May;88(1):17-31. Epub 2009 Feb 7. Review. 
Saxe M. D., Battaglia F., Wang J. W., Malleret G., David D. J., Monckton J. E., Garcia A. D., 
Sofroniew M. V., Kandel E. R., Santarelli L., Hen R., Drew M. R. (2006). Ablation of 
hippocampal neurogenesis impairs contextual fear conditioning and synaptic pefpasticity in the 
dentate gyrus. Proc. Natl. Acad. Sci. U.S.A. 103, 17501–17506. doi: 10.1073/pnas.0607207103. 
Scharfman HE.(2007). The CA3 "backprojection" to the dentate gyrus. Prog Brain Res. 163:627-
37. Review. 
Scoville WB, Milner B. (1957). Loss of recent memory after bilateral hippocampal lesions. J 
Neurol Neurosurg Psychiatry. 20(1):11-21. 
Segal M. (1990). Developmental changes in serotonin actions in rat hippocampus. Brain Res Dev 
Brain Res. 52(1-2):247-52. 
Seidenbecher T, Laxmi TR, Stork O, Pape HC (2003) Amygdalar and hippocampal theta rhythm 
synchronization during fear memory retrieval. Science 301: 846-850. 
Seligman , M. E. P. (1972). Learned helplessness. Annual Review of Medicine, 1972, 23, 407-
412. 
Seminowicz DA, Mayberg HS, McIntosh AR, Goldapple K, Kennedy S, Segal Z, Rafi-Tari S. 






Shansky RM, Hamo C, Hof PR, McEwen BS, (2009). Morrison JH. Stress-induced dendritic 
remodeling in the prefrontal cortex is circuit specific. Cereb Cortex. 19(10):2479-84.  
Sheline Y. I., Gado M. H., Kraemer H. C. (2003). Untreated depression and hippocampal volume 
loss. Am. J. Psychiatry 160, 1516–1518. doi: 10.1176/appi.ajp.160.8.1516. 
Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. (1996). Hippocampal atrophy 
in recurrent major depression. Proc Natl Acad Sci U S A. 93(9):3908-13. 
Sibille E, Pavlides C, Benke D, Toth M. (2000). Genetic inactivation of the Serotonin(1A) 
receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction 
of GABA(A) receptor binding, and benzodiazepine-resistant anxiety. J Neurosci. 20:2758 
Sierra-Mercado D Jr, Corcoran KA, Lebrón-Milad K, Quirk GJ. (2006). Inactivation of the 
ventromedial prefrontal cortex reduces expression of conditioned fear and impairs subsequent 
recall of extinction. Eur J Neurosci. 24(6):1751-8. 
Sierra-Mercado D, Padilla-Coreano N, Quirk GJ. (2011). Dissociable roles of prelimbic and 
infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and 
extinction of conditioned fear. Neuropsychopharmacology. 36(2):529-38.  
Sigurdsson T, Stark KL, Karayiorgou M, Gogos JA, Gordon JA. (2010). Impaired hippocampal-
prefrontal synchrony in a genetic mouse model of schizophrenia. Nature. 464(7289):763-7. 
Smit-Rigter LA, Champagne DL, van Hooft JA. (2009). Lifelong impact of variations in 
maternal care on dendritic structure and function of cortical layer 2/3 pyramidal neurons in rat 
offspring. PLoS One. 4(4):e5167.  
Smit-Rigter LA, Noorlander CW, von Oerthel L, Chameau P, Smidt MP, van Hooft JA. (2011). 
Prenatal fluoxetine exposure induces life-long serotonin 5-HT(3) receptor-dependent cortical 
abnormalities and anxiety-like behaviour. Neuropharmacology. 62(2):865-70. 
Smythe JW, Rowe WB, Meaney MJ. (1994). Neonatal handling alters serotonin (5-HT) turnover 
and 5-HT2 receptor binding in selected brain regions: relationship to the handling effect on 
glucocorticoid receptor expression.Brain Res Dev Brain Res. 80(1-2):183-9. 
Sodhi MS, Sanders-Bush E. (2004). Serotonin and brain development. Int Rev Neurobiol. 
59:111-74. Review. 
Soetanto A, Wilson RS, Talbot K, Un A, Schneider JA, Sobiesk M, Kelly J, Leurgans S, Bennett 
DA, Arnold SE. (2010). Association of anxiety and depression with microtubule-associated 
protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of 
older humans. Arch Gen Psychiatry.67(5):448-57. 
Sotres-Bayon F, Quirk GJ. (2010). Prefrontal control of fear: more than just extinction. Curr 





Sousa N, Lukoyanov NV, Madeira MD, Almeida OF, Paula-Barbosa. (2000). MM. 
Reorganization of the morphology of hippocampal neurites and synapses after stress-induced 
damage correlates with behavioral improvement. Neuroscience. 97(2):253-66. 
Staubli U, Xu FB (1995) Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, 
memory, and LTP induction in the freely moving rat. J Neurosci 15: 2445-2452 
Stewart MG, Davies HA, Sandi C, Kraev IV, Rogachevsky VV, Peddie CJ, Rodriguez JJ, 
Cordero MI, Donohue HS, Gabbott PL, Popov VI. (2005). Stress suppresses and learning 
induces plasticity in CA3 of rat hippocampus: a three-dimensional ultrastructural study of thorny 
excrescences and their postsynaptic densities. Neuroscience. 131(1):43-54. 
Stockmeier CA, Howley E, Shi X, Sobanska A, Clarke G, Friedman L, Rajkowska G. (2009). 
Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive 
disorder. J Psychiatr Res. 43(10):887-94. Epub 2009 Feb 12.  
Stockmeier CA, Mahajan GJ, Konick LC, Overholser JC, Jurjus GJ, Meltzer HY, Uylings HB, 
Friedman L, Rajkowska G. (2004). Cellular changes in the postmortem hippocampus in major 
depression. Biol Psych 56: 640–650. 
Strand AD, Aragaki AK, Baquet ZC, Hodges A, Cunningham P, Holmans P, Jones KR, Jones L, 
Kooperberg C, Olson JM. (2007). Conservation of regional gene expression in mouse and human 
brain. PLoS Genet. 3(4):59. 
Sunanda, Rao MS, Raju TR. (1995). Effect of chronic restraint stress on dendritic spines and 
excrescences of hippocampal CA3 pyramidal neurons--a quantitative study. Brain Res. 694(1-
2):312-7.  
Swann JW, Brady RJ, Martin DL. (1989). Postnatal development of GABA-mediated synaptic 
inhibition in rat hippocampus. Neuroscience. 28(3):551-61. 
Tadic A, Rujescu D, Szegedi A, Giegling I, Singer P, Möller HJ, Dahmen N. (2003). Association 
of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major 
depression. Am J Med Genet B Neuropsychiatr Genet. 117B(1):1-6. 
Tansey EP, Chow A, Rudy B, McBain CJ (2002). Developmental expression of potassium-
channel subunit Kv3.2 within subpopulations of mouse hippocampal inhibitory interneurons. 
Hippocampus 12: 137–148. 
Tarantino LM, Bucan M. (2000). Dissection of behavior and psychiatric disorders using the 
mouse as a model. Hum Mol Genet. 9(6):953-65. Review. 
Tau GZ, Peterson BS. (2010). Normal development of brain circuits. 





Taylor Tavares JV, Clark L, Cannon DM, Erickson K, Drevets WC, Sahakian BJ. (2007). 
Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II 
depression. Biol Psychiatry. 62(8):917-24.  
Taylor WD, Steffens DC, Payne ME, MacFall JR, Marchuk DA, Svenson IK, Krishnan KR. 
(2005). Influence of serotonin transporter promoter region polymorphisms on hippocampal 
volumes in late-life depression. Arch Gen Psychiatry. 62(5):537-44. 
Tolwani RJ, Buckmaster PS, Varma S, Cosgaya JM, Wu Y, Suri C, Shooter EM. (2002). BDNF 
overexpression increases dendrite complexity in hippocampal dentate gyrus. Neuroscience. 
114(3):795-805. 
Torborg CL, Nakashiba T, Tonegawa S, McBain CJ. (2010). Control of CA3 output by 
feedforward inhibition despite developmental changes in the excitation-inhibition balance. J 
Neurosci. 30(46):15628-37. 
Torgersen (1986). Genetic factors in moderately severe and mild affective disorders. Arch Gen 
Psychiatry, 43, pp. 222–226 
Trivedi MA, Coover GD. (2004). Lesions of the ventral hippocampus, but not the dorsal 
hippocampus, impair conditioned fear expression and inhibitory avoidance on the elevated T-
maze. Neurobiol Learn Mem. 81(3):172-84. 
Turrigiano GG. (2008). The self-tuning neuron: synaptic scaling of excitatory synapses. Cell. 
135(3):422-35. Review. 
Uylings HB, Groenewegen HJ, Kolb B. (2003). Do rats have a prefrontal cortex? Behav Brain 
Res. 146(1-2):3-17. Review. 
van der Hart MG, Czéh B, de Biurrun G, Michaelis T, Watanabe T, Natt O, Frahm J, Fuchs E. 
(2002). Substance P receptor antagonist and clomipramine prevent stress-induced alterations in 
cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume. Mol Psychiatry. 
7(9):933-41. 
Vasic N, Walter H, Höse A, Wolf RC. (2008). Gray matter reduction associated with 
psychopathology and cognitive dysfunction in unipolar depression: a voxel-based morphometry 
study. J Affect Disord. 109(1-2):107-16.  
Vertes RP, Hoover WB, Viana Di Prisco G. (2004). Theta rhythm of the hippocampus: 
subcortical control and functional significance. Behav Cogn Neurosci Rev 3: 173-200. 
Vertes RP, Kocsis B (1997) Brainstem-diencephalo-septohippocampal systems controlling the 
theta rhythm of the hippocampus. Neuroscience 81: 893-926. 
Vertes RP. (2006). Interactions among the medial prefrontal cortex, hippocampus and midline 





Vicentic A, Francis D, Moffett M, Lakatos A, Rogge G, Hubert GW, Harley J, Kuhar MJ. 
(2006). Maternal separation alters serotonergic transporter densities and serotonergic 1A 
receptors in rat brain. Neuroscience. 140(1):355-65. Epub 2006 Mar 13. 
Vidal-Gonzalez I, Vidal-Gonzalez B, Rauch SL, Quirk GJ. (2006). Microstimulation reveals 
opposing influences of prelimbic and infralimbic cortex on the expression of conditioned fear. 
Learn Mem. 13(6):728-33. 
Villarreal DM, Gross AL, Derrick BE. (2007). Modulation of CA3 afferent inputs by novelty and 
theta rhythm. J Neurosci. 27(49):13457-67. 
Vogel, G. Neill, D. Hagler, M. Kors, D. (1990). A new animal model of endogenous depression: 
a summary of present findings. Neurosci. Biobehav. Rev. 14, 85-91. 
Vyas A, Mitra R, Shankaranarayana Rao BS, Chattarji S. (2002). Chronic stress induces 
contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J 
Neurosci. 22(15):6810-8. 
Vyas A, Pillai AG, Chattarji S. (2004). Recovery after chronic stress fails to reverse amygdaloid 
neuronal hypertrophy and enhanced anxiety-like behavior. Neuroscience. 128(4):667-73. 
Wallace W, Bear MF. (2004). A morphological correlate of synaptic scaling in visual cortex. J 
Neurosci. 24(31):6928-38. 
Watanabe Y, Gould E, Daniels DC, Cameron H, McEwen BS. (1992). Tianeptine attenuates 
stress-induced morphological changes in the hippocampus. Eur J Pharmacol. 222(1):157-62. 
Weissman MM, Wickramaratne P, Nomura Y, Warner V, Verdeli H, Pilowsky DJ et al. (2005). 
Families at high and low risk for depression: a 3-generation study. Arch Gen Psychiatry 62: 29–
36. 
Wellman CL, Izquierdo A, Garrett JE, Martin KP, Carroll J, Millstein R, Lesch KP, Murphy DL, 
Holmes A. (2007). Impaired stress-coping and fear extinction and abnormal corticolimbic 
morphology in serotonin transporter knock-out mice. J Neurosci. 27(3):684-91. 
Whitaker-Azmitia PM, Druse M, Walker P, Lauder JM (1996) Serotonin as a developmental 
signal. Behav Brain Res 73:19–29. 
Whitaker-Azmitia PM. (2001). Serotonin and brain development: role in human developmental 
diseases. Brain Res Bull. 56(5):479-85. Review. 
Withall A, Harris LM, Cumming SR. (2010). A longitudinal study of cognitive function in 
melancholic and non-melancholic subtypes of major depressive disorder. J Affect Disord. 123(1-
3):150-7.  
Yamaguchi Y, Sato N, Wagatsuma H, Wu Z, Molter C, Aota Y. (2007). A unified view of theta-






Yan W, Wilson CC, Haring JH. (1997). Effects of neonatal serotonin depletion on the 
development of rat dentate granule cells. Brain Res Dev Brain Res. 98(2):177-84. 
Yau JL, Noble J, Seckl JR. (2001). Acute restraint stress increases 5-HT7 receptor mRNA 
expression in the rat hippocampus. Neurosci Lett. 309 (3):141-4. 
Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ, O'Shea DJ, Sohal VS, Goshen I, 
Finkelstein J, Paz JT, Stehfest K, Fudim R, Ramakrishnan C, Huguenard JR, Hegemann P, 
Deisseroth K. (2011). Neocortical excitation/inhibition balance in information processing and 
social dysfunction. Nature. 477(7363):171-8. doi: 10.1038/nature10360. 
Yoon T, Otto T. (2007). Differential contributions of dorsal vs. ventral hippocampus to auditory 
trace fear conditioning. Neurobiol Learn Mem. 87(4):464-75.  
Yuen EY, Jiang Q, Chen P, Gu Z, Feng J, Yan Z. (2005). Serotonin 5-HT1A receptors regulate 
NMDA receptor channels through a microtubule-dependent mechanism. J Neurosci. 
25(23):5488-501. 
Zakzanis KK, Leach L, Kaplan E.(1998). On the nature and pattern of neurocognitive function in 
major depressive disorder. Neuropsychiatry Neuropsychol Behav Neurol. 11(3):111-9. 
Zhang J, Richards LJ, Miller MI, Yarowsky P, van Zijl P, Mori S. (2006). Characterization of 
mouse brain and its development using diffusion tensor imaging and computational techniques. 
Conf Proc IEEE Eng Med Biol Soc.1:2252-5. 
Zhou J, Li L, Tang S, Cao X, Li Z, Li W, Li C, Zhang X. (2008). Effects of serotonin depletion 
on the hippocampal GR/MR and BDNF expression during the stress adaptation. Behav Brain 
Res. 195(1):129-38.  
Zhuang X, Gross C, Santarelli L, Compan V, Trillat AC, Hen R. (1999). Altered emotional states 
in knockout mice lacking 5-HT1A or 5-HT1B receptors.Neuropsychopharmacology.21(2 
Suppl):52S-60S. Review. 
Zoladz PR, Park CR, Muñoz C, Fleshner M, Diamond DM.(2008). Tianeptine: an antidepressant 











This section contains the specific dendritic morphology data from serotonin transporter 
knockout  (5-htt -/-) mice, (generated as previously described in Lira et al., 2003) referred to in 
the main text. Data were analyzed using one-way analysis of variance (ANOVA) using genotype 
and are presented as mean +/- SEM. 
 
Medial prefrontal cortex (mPFC) 
Infralimbic (IL) region  
 
Fig. B.1.  No observable differences in the dendritic complexity of apical dendrites of pyramidal 
cells in layer 2/3 of the IL of 5-htt -/- mice, relative to controls.  N = 15-16 cells/treatment, 3 
mice/group.  
 
Fig. B.2.  Apical dendrites of pyramidal cells in layer 5 of the IL of 5-htt -/- mice display 









Cornu Ammonis (CA3) neurons 
 
Fig. B.3.  Apical dendrites of pyramidal cells in the CA3 of 5-htt -/-  mice display significantly 
increased number of nodes (F1,32 = 8.434; p = 0.0066), intersections (F1, 32 = 6.037; p=0.0196) 
and total dendritic material (F1,32 = 8.125; p = 0.0076), relative to controls. N = 16-17 
cells/treatment, 3 mice/group.  
 
Fig B.4. No significant differences in how far the CA3 apical arbors of KO and WT mice extend 





       
Fig. B.5.  Basilar dendrites of pyramidal cells in the CA3 of 5-htt -/-  mice display significantly 
increased number of nodes, (F1,30 = 8.780; p =  0.0069), intersections (trend effect: F1,31 = 3.660; 
p = 0.0654) and total dendritic material (F1, 31 =7.047; p = 0.0124), relative to controls. N = 15-
16 cells/treatment, 3 mice/group.  
 
Fig B.6. No significant differences in how far the CA3 basilar arbors of KO and WT mice extend 
out from the soma. N = 15-16 cells/treatment, 3 mice/group.  
Dentate gyrus granule cells 
 
Fig. B.7.  Apical dendrites of granule cells in the dentate gyrus from 5-htt -/-  mice display 





p = 0.0236) and total dendritic material (F1, 33 = 4.845; p = 0.0348), relative to WT controls. N = 
16-17 cells/treatment, 3 mice/group.  
 
Cornu Ammonis 1 (CA1) pyramidal neurons 
  
Fig. B.8.  Apical dendrites of CA1 neurons of 5-htt -/- do not significantly differ from those of 
WT controls. N = 18 cells/treatment, 3 mice/group.  
 
  
Fig. B.9.  Basilar dendrites of pyramidal cells in the CA1 of 5-htt -/-  do not significantly differ 










These data display the results from the cued fear conditioning and extinction paradigms 
done on a second group of PN-FLX and PN-Veh mice (“cohort 2”), referred to in chapter 2. No 
cued deficits were found in cohort 2, but they did display pronounced extinction learning deficits 
as was characterized in the cohort described in the main text. This demonstrates that the cued 
deficits are not replicable, whereas the extinction deficits are.  
 
 
Fig C.1. No differences in % freezing to cue between PN-Veh and PN-FLX mice in a separate 







Fig C.2. Pronounced deficits in fear extinction learning displayed by PN-FLX mice (treatment x 
time interaction = 0.0051) in cohort 2.  
 
 
